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Abstract 
Serotonin (5-HT) has been implicated in the regulation of emotions as well as in its 
pathological states, such as anxiety disorders and depression. Mice with targeted deletion of 
genes encoding various mediators of central serotonergic neurotransmission therefore 
provides a powerful tool in understanding contributions of such mediators to homeostatic 
mechanisms as well as to the development of human emotional disorders. Within this thesis a 
battery of electrophysiological recordings were conducted in the dorsal raphe nucleus (DRN) 
and the hippocampus of two murine knockout lines with deficient serotonergic systems. 
Serotonin transporter knockout mice (5-Htt KO), which lack protein responsible for reuptake 
of 5-HT from the extracellular space and tryptophan hydroxylase 2 knockout (Tph2 KO) mice, 
which lack the gene encoding the neuronal 5-HT-synthesising enzyme. First, 5-HT1A receptor-
mediated autoinhibition of serotonergic neuron firing in the DRN was assessed using the 
loose-seal cell-attached configuration. Stimulation of 5-HT1A receptors by a selective agonist, 
R-8-hydroxy-2-(di-n-propylamino)tetralin (R-8-OH-DPAT), showed a mild sensitisation and 
a marked desensitisation of these receptors in Tph2 KO and 5-Htt KO mice, respectively. 
While application of tryptophan, a precursor of 5-HT and a substrate of Tph2, did not cause 
autoinhibition in Tph2 KO mice due to the lack of endogenously produced 5-HT, data from 5-
Htt KO mice as well as heterozygous mice of both KO mice lines demonstrated the presence 
of autoinhibitory mechanisms as normal as seen in wildtype (WT) controls. When the Tph2-
dependent step in the 5-HT synthesis pathway was bypassed by application of 5-
hydroxytryptophan (5-HTP), serotonergic neurons of both Tph2 KO and 5-Htt KO mice 
showed decrease in firing rates at lower concentrations of 5-HTP than in WT controls. 
Elevated responsiveness of serotonergic neurons from Tph2 KO mice correspond to mild 
sensitisation of 5-HT1A receptors, while responses from 5-Htt KO mice suggest that excess 
levels of extracellular 5-HT, created by the lack of 5-Htt, stimulates 5-HT1A receptors strong 
enough to overcome desensitisation of these receptors. Second, the whole-cell patch clamp 
recording data from serotonergic neurons in the DRN showed no differences in basic 
electrophysiological properties between Tph2 KO and WT mice, except lower membrane 
resistances of neurons from KO mice. Moreover, the whole-cell patch clamp recording from 
CA1 pyramidal neurons in the hippocampus of 5-Htt KO mice showed increased conductance 
both at a steady state and at action potential generation. Lastly, magnitude of long-term 
potentiation (LTP) induced by the Schaffer collateral/commissural pathway stimulation in the 
ventral hippocampus showed no differences among Tph2 KO, 5-Htt KO, and WT 
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counterparts. Taken together, lack and excess of extracellular 5-HT caused sensitisation and 
desensitisation of autoinhibitory 5-HT1A receptors, respectively. However, this may not 
directly translate to the level of autoinhibitory regulation of serotonergic neuron firing when 
these receptors are stimulated by endogenously synthesised 5-HT. In general, KO mice 
studied here showed an astonishing level of resilience to genetic manipulations of the central 
serotonergic system, maintaining overall electrophysiological properties and normal LTP 
inducibility. This may further suggest existence of as-yet-unknown compensatory 
mechanisms buffering potential alterations induced by genetic manipulations.  
 
 
 
 
 
Zusammenfassung 
Serotonin (5-HT) ist an der Regulation von der Emotionen, sowie ihrer pathologischen 
Zustände, wie Angststörungen und Depressionen beteiligt. Mäuse denen, mittels einer 
zielgerichteteten Deletion von Genen, die verschiedenste Proteine involviert in der zentralen 
serotonergen Nerotransmission fehlen, dienen daher als ein nützliches Tiermodell, um die 
Rolle dieser Mediatoren bei Homöostasemechanismen und der Entwicklung emotionaler 
Störungen beim Menschen zu verstehen. Im Rahmen dieser Thesis wurde eine Batterie von 
elektrophysiologischen Ableitungen im Hippocampus sowie in der dorsalen Raphe Nucleus 
(DRN) zweier Knockout-Mauslinien mit einem defizienten serotonergen Systems 
durchgeführt. Serotonintransporter Knockout-Mäuse (5-Htt KO), denen das Protein zur 
Wiederaufnahme von 5-HT aus dem extrazellulären Raum fehlt und Tryptophanhydroxylase 
2 Knockout-Mäuse (Tph2 KO), denen das Gen für das 5-HT-synthetisierende Enzym im 
Gehirn fehlt. Zunächst wurde mittels der “loose-seal cell-attached” Aufnahmemethode die 
Eigenhemmung der serotonergen Neuronen untersucht, die durch 5-HT1A Rezeptoren in der 
DRN vermittelt wird. Stimulierung der 5-HT1A Rezeptoren durch einen selektiven Agonist, R-
8-hydroxy-2-(di-n-propylamino)tetralin (R-8-OH-DPAT), zeigte eine milde Sensibilisierung 
und eine deutliche Desensibilisierung dieser Rezeptoren in Tph2 KO bzw. in 5-Htt KO 
Mäusen. Während die Anwendung von Tryptophan, eine Vorstufe von 5-HT und ein Substrat 
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der Tph2, keine Eigenhemmung, aufgrund des Mangels an endogen produziertem 5-HT, in 
Tph2 KO Mäusen verursachte, wiesen Daten von 5-Htt KO Mäusen sowie von heterozygoten 
Mäusen beider KO Mauslinien die Existenz der Eigenhemmungsmechanismen wie in den 
Wildtypen (WT) nach. Wurde der Tph2-abhängige Schritt im 5-HT Syntheseweg durch 
Anwendung von 5-Hydroxytryptophan (5-HTP) umgangen, zeigten sowohl Tph2 KO als auch 
5-Htt KO Mäuse eine Verminderung der serotonergen neuronalen Feuerungsrate bei 
niedrigeren Konzentrationen von 5-HTP im Vergleich zu den WT. Die erhöhte 
Reaktionsfähigkeit der serotonergen Neuronen von Tph2 KO Mäusen entsprechen der milden 
Sensibilisierung der 5-HT1A Rezeptoren. Stattdessen deuten die Reaktionen der serotonergen 
Neuronen von 5-Htt KO Mäusen darauf hin, dass das überschüssige Niveau von 
extrazellularem 5-HT, welches durch den Mangel an 5-Htt verursacht wird, 5-HT1A 
Rezeptoren stark genug stimuliert, um eine Desensibilisierung dieser Rezeptoren zu 
überwinden. 
Zweitens zeigten die Daten der whole-cell Patch Clamp Ableitung von serotonergen 
Neuronen im DRN keine Unterschiede in grundlegenden elektrophysiologischen 
Eigenschaften zwischen Tph2 KO und WT, außer niedrigen Membranwiderständen in KO 
Mäusen. Darüber hinaus zeigte die whole-cell Patch Clamp Ableitungen von CA1 
Pyramidenzellen im Hippocampus der 5-Htt KO Mäuse eine erhöhte Leitfähigkeit sowohl bei 
Ruheständen als auch bei Aktionspotentialerzeugungen. Schließlich zeigte die Stärke der 
Langzeitpotenzierung (long-term potentiation: LTP) durch die Stimulation der Schaffer-
Kollateralen/kommissuralen Fasern im ventralen Hippocampus keine Unterschiede zwischen 
Tph2 KO, 5-Htt KO, und jeweiligen WT. Zusammengefasst verursachten der Mangel und der 
Überschuss von extrazellularen 5-HT eine Sensibilisierung bzw. Desensibilisierung der 
autoinhibitorischen 5-HT1A Rezeptoren. Dies kann jedoch nicht direkt in die Regulierung von 
serotonergen Neuronen Feuerung umgesetzt werden, wenn die 5-HT1A Rezeptoren durch 
endogen synthetisiertes 5-HT stimuliert werden. Im Allgemeinen zeigten die hier 
untersuchten KO Mäuse, ein erstaunliches Maß an Widerstandskraft, die die allgemeinen 
elektrophysiologischen Eigenschaften und die normale LTP Induzierbarkeit trotz genetischer 
Manipulationen des zentralen serotonergen Systems aufrechterhielt. Weiterhin deutet dies auf 
die Existenz noch unbekannter Kompensationsmechanismen hin, die diese potentiellen 
Veränderungen abzudämpfen scheinen. 
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1 . Introduction 
1.1. Serotonin and affective disorders 
1.1.1. Depression and monoamine neurotransmitters 
Major depressive disorder (MDD) is one of the most common and yet debilitating psychiatric 
disorders, affecting about 121 million people worldwide (WHO, 2012 ) and being one of the 
major causes of productivity loss worldwide. In 2004, it was ranked as the third most leading 
cause of burden of disease and is estimated to reach the first place in 2030 (WHO, 2008). Its 
epidemiology is socio-economic dependent, yielding the average lifetime prevalence of 
14.6% in high-income countries, whereas 11.1% in low- to middle-income counties (Bromet 
et al., 2011). Symptoms of depression include: persistent sad feelings, feelings of guilt, low 
self-esteem, irritability and restlessness, loss of appetite or overeating, loss of interest, 
anhedonia, sleep disturbance, fatigue and low energy, poor concentration, difficulty in 
decision-making, and feeling of hopelessness (NIMH, 2012). In its worst case, depression can 
lead to suicide, taking lives of about 850,000 people every year (WHO, 2012). The 
etiopathogenetic mechanisms of depression are still unknown but it is believed that genetic 
factors which determine certain personality of individuals as well as stressful life events 
trigger the onset of major depression. Neurobiologically, several lines of pharmacological 
evidence suggest involvement of monoamine neurotransmitters, especially serotonin (5-HT) 
and norepinephrine (NE) but also dopamine (DA) (Jacobsen et al., 2012a; Haenisch and 
Bonisch, 2011; Robinson, 2007). For instance, tricyclic antidepressants (TCAs) exert its 
therapeutic effects through primarily blocking reuptake of 5-HT and NE. Moreover, 
monoamine oxidase inhibitors (MAOIs), which inhibit enzymes metabolising monoamine 
neurotransmitters and thus enhances neurotransmission of 5-HT, NE, and DA, are known to 
alleviate some depressive symptoms. At present, selective serotonin reuptake inhibitors 
(SSRIs), which inhibit 5-HT reuptake and thus elevate synaptic 5-HT levels, are considered to 
be the first-line antidepressants, while therapeutic efficacy of serotonin norepinephrine 
reuptake inhibitors (SNRIs), e.g. venlafaxine and duloxetine, as well as norepinephrine 
dopamine reuptake inhibitors (NDRIs), e.g. nomifensine and bupropion, are also 
acknowledged. The involvement of 5-HT in depression is further evidenced by the 
observation that dietary supplementation of 5-HT precursor, 5-hydroxy-L-tryptophan (5-HTP), 
works positively to alleviate depressive symptoms (reviewed in Turner et al., 2006), forming 
together with other findings the so-called “5-HT deficiency theory of depression”. 
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1.1.2. Depression and anxiety disorders 
In humans, depression and anxiety disorders fall in different categories of psychiatric 
disorders under the Diagnostic and Statistical Manual of Mental Disorders, 4
th
 edition (DSM-
IV) as well as under the 10
th
 revision of International Classification of Diseases (ICD10) 
definition. Depression and anxiety, however, share dimensionally overlapping symptoms such 
as sleep disturbance, appetite disturbance, irritability, fatigue, impaired concentration, 
oversensitivity to criticism, self-consciousness, dysphoria, feelings of rejection, as well as 
subjective experiences of nervousness, restlessness, and worry (Gorman, 1996; Ressler and 
Nemeroff, 2000). The difference between anxiety and depression is rather subjectively 
defined, whether the patient primarily has a depressed or anxious mood (Ressler and 
Nemeroff, 2000). Moreover, it has been suggested that depression may occur secondary to a 
generalized anxiety disorder (GAD) or panic disorder (Mongeau et al., 1997 and references 
therein). Indeed, SSRIs have been shown to exert their therapeutic effects on these two 
anxiety disorders, too (Hirschfeld, 2001), indicating that dysfunctional serotonergic system is 
involved in the pathogenesis of anxiety disorders (Gorman, 1996 and references therein). In 
this context, depression may be understood as a maladaptive defence mechanism of 
individuals when they experience unresolvable anxiety or aversive events, developing a false 
concept that they cannot control recurrent stress or obtain gratification (Mongeau et al., 1997). 
This model well explains high comorbidity of depression and anxiety. Based on a number of 
studies, it is generally established that approximately two thirds of depressive patients have a 
comorbid anxiety disorder whereas about one third or more of patients with GAD or panic 
disorder have comorbid depression (Gorman, 1996 and references therein). In addition to the 
serotonergic system, a series of experimental data suggest existence of other common 
biological substrates between anxiety and depression, such as the gamma-aminobutyric acid 
(GABA) neurotransmitter system (Paul, 1988; Kalueff and Nutt, 2007), the hypothalamic-
pituitary-adrenal (HPA) axis and secretion of associated hormones (Gorman, 1996; Kalueff 
and Nutt, 2007 and references therein), the noradrenergic system (Weiss et al., 1994), brain 
metabolism associated with mitochondrial functions and brain derived neurotrophic factor 
(BDNF) (Burroughs and French, 2007). Familial studies also indicate common genetic 
predispositions between depression and anxiety; a higher incidence for developing anxiety 
disorders was reported among relatives of patients with major depression alone (Paul, 1988). 
Although there are still on-going debates whether depression and anxiety exist as separate, 
comorbid, or mixed symptoms (Gorman, 1996) and whether depression sequentially develops 
after anxiety disorders or vice versa (Moffitt et al., 2007), a multitude of pharmacological and 
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biological findings indicate that depression and anxiety disorders are closely related and that 
several neurotransmitters including 5-HT link these two psychiatric disorders. 
1.1.3. Animal models of depression and anxiety disorders 
When animals are exposed to uncontrollable aversive events, they exhibit behavioural deficits 
called “learned helplessness” which have certain resemblance to human depressive 
behaviours. Depression, however, is highly human-specific, implicating complex socio-
economic constellations along with biological factors. Modelling depression in animals, thus, 
has a certain limitation. Anxiety-related traits, on the other hand, are considered to be more 
biologically ancient and can be observed in non-human primates as well as in rodents. 
Furthermore, while anxiety-like behaviours of animals are indicative of defensive adaptation 
to potential distant threats, such as potential attack from predators, animals develop fear 
responses against immediate inescapable threats such as electric shocks in experimental 
contexts. Similarly, human anxiety is defined as a diffuse, unpleasant, vague sense of 
apprehension and thus often objectless (Sadock and Sadock, 2000). Whereas fear is an 
emotional response to a known and immediate threat and has a clear object. Since fear and 
anxiety are closely related and depression can be seen as an exacerbated extension of anxiety 
disorders, investigation of fear- and anxiety-related behaviours of animals are believed to 
contribute to the understanding of human depression. Since the advent of transgenic 
techniques, animals with targeted deletion of genes encoding various mediators of 
neurotransmitters implicated in emotional regulation further enhanced our understanding of 
the contribution of such mediators to the development of human disorders of emotion 
regulation. Given that monoamine transporters, such as the serotonin transporter (5-HTT), the 
norepinephrine transporter (NET), and the dopamine transporter (DAT), are the major targets 
of antidepressant drugs (see section 1.1.1.), knockout mice lacking genes encoding these 
transporters were created as model organisms for investigating neural mechanisms of anxiety 
disorders and depression (Haenisch and Bonisch, 2011; Perona et al., 2008). Moreover, mice 
with disrupted genes of the central serotonin-synthesising enzyme, tryptophan hydroxylase-2 
knockout (Tph2 KO) mice, have been generated as novel models for investigating human 
emotional disorders (Gutknecht et al., 2008; Savelieva et al., 2008; Alenina et al., 2009). The 
validity of such animal models is generally assessed in three aspects (Haenisch and Bonisch, 
2011): face validity, i.e. animal models represent similar disease symptoms as in humans; 
predictive validity, i.e. pharmacological correlation between humans and animal models can 
be detected; construct validity, i.e. symptoms in animal models should be based on the same 
neurobiological mechanisms as in humans. Since the precise neurobiological mechanisms of 
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depression are yet to be elucidated, construct validity of animal models of depression is only 
of theoretical value. Despite this limitation, reductionistic approaches embodied by animal 
models of depression are expected to represent symptom characteristics, causative 
relationships, and treatment reactions of depression as seen in humans.  
1.2. Serotonin and serotonergic neurons 
1.2.1. Synthesis and metabolism 
5-HT plays multifaceted physiological roles in both the peripheral and the central nervous 
system (CNS), including eating, gastrointestinal activity, reproductive activity, sensory 
processing, pain perception, motor activity, sleep, aggression, cognition, and mood. The 
diversity of serotonergic functions has been bolstered by the presence of more than 14 
different 5-HT receptor subtypes (reviewed in Barnes and Sharp, 1999). 5-HT is stored in 
three main cell types (Sigma-RBI, 2006): serotonergic neurons in the CNS and in the 
intestinal myenteric plexus; enterochromaffin cells in the mucosa of the gastrointestinal tract; 
blood platelets. Among them, only serotonergic neurons and enterochromaffin cells can 
produce 5-HT themselves, while platelets uptake and store externally synthesised 5-HT. 
Biosynthesis of 5-HT is summarised in Fig. 1.1. First, an essential amino acid L-tryptophan 
(Trp), which can be found in such foods as banana, milk, eggs, cheese, and oats, is converted 
into 5-HTP by tryptophan hydroxylase (TPH), requiring O2 and tetrahydrobiopterin (BH4) as 
cofactors. Synthesised 5-HTP is then converted to 5-HT by 5-hydroxy-tryptophan 
decarboxylase (and aromatic L-amino acid decarboxylase; AADC) (Carlsson et al., 1972) 
with pyridoxal phosphate as a cofactor. Of these, the catalysis mediated by TPH is the rate-
limiting step. Two isoforms of TPH are known to exist: TPH1 in the periphery and the pineal 
gland; TPH2 in the CNS (see section 1.6.1.). 5-HT synthesised in the pineal gland serves as a 
precursor for the subsequent enzymatic pathway leading to the formation of the pineal 
hormone, melatonin. Produced 5-HT is then converted to 5-hydroxyindole acetaldehyde by 
monoamine oxidase (MAO), which can be found in two molecular subtypes, namely MAO-A 
and MAO-B. MAO-A has higher affinity for 5-HT than MAO-B and metabolise 5-HT with a 
much lower Km value than MAO-B. Contradictorily, however, immunohistochemical studies 
have shown that serotonin-containing neurons themselves may contain only MAO-B. 5-
hydroxyindole acetaldehyde is in turn metabolised mainly by an isoform of aldehyde 
dehydrogenase (ALDH2) located in mitochondria to 5-hydroxyindoleacetic acid (5-HIAA), 
which then is excreted into the urine (Sigma-RBI, 2006). 
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1.2.2. Anatomy of brain serotonin system 
In mammals, most serotonergic neurons originate from the raphe nuclei of the brainstem. Fig. 
1.2 illustrates the organisation of serotonergic neurons in the rat brain, where serotonergic 
neurons in the raphe nuclei are grouped into nine nuclei (B1-B9). B1-3 comprise the caudal 
group, consisting of the raphe pallidus nucleus (B1), the raphe obscurus nucleus (B2), and the 
raphe magnus nucleus (B3), and send descending projections to the medulla, cerebellum, and 
spinal cord to control motor activity, pain perception, and the autonomic nervous system. B7-
9, on the other hand, form the rostral group, including the dorsal raphe nucleus (DRN; B7) 
and the medial raphe nucleus (MRN; B8). The rostral group of serotonergic neurons send 
ascending projections to the forebrain, including the cortex, amygdala, basal ganglia, 
hippocampus, thalamus and hypothalamus to control cognition, emotion, perception, as well 
as food intake, circadian rhythms, and reproduction (reviewed in Cools et al., 2008; Lesch et 
Fig. 1.1. Biosynthesis of serotonin. An amino 
acid L-tryptophan is converted into 5-hydroxy-
L-tryptophan (5-HTP) by the rate limiting 
enzyme tryptophan hydroxylase (TPH). TPH 
requires tetrahydrobiopterin (BH4) as a cofactor. 
Produced 5-HTP is then converted to serotonin 
(5-HT) by 5-hydroxytryptophan decarboxylase 
and aromatic L-amino acid decarboxylase. 5-HT 
is metabolised to 5-hydroxyindoleacetic acid (5-
HIAA) by monoamine oxidase (MAO). (Figure 
source: 
http://en.wikipedia.org/wiki/File:Serotonin_bios
ynthesis.svg) 
1. Introduction 
19 
al., 2012; Waider et al., 2011). B4-6 are an intermediate group and may send projections both 
into the ascending and descending groups.   
 
The raphe nuclei, on the other hand, receives afferent inputs from the forebrain structures 
such as the prefrontal cortex and superior vestibular nuclei, as well as nucleus propositus of 
hypoglossy, nucleus of solitary tract, hypothalamus, amygdala, locus coeruleus (LC), lateral 
habenula, ventral tegmental area (VTA), and bed nucleus of stria terminalis (BNST) 
(reviewed in Gobbi, 2005). Moreover, intercellular connections within the DRN as well as 
reciprocal connections between the DRN and MRN also exist (reviewed in Hensler, 2006). 
Local connections between serotonergic neurons in the DRN bear particular importance in 
that firing of serotonergic neurons is controlled by somatodendritic 5-HT1A autoreceptors, 
which are activated by released 5-HT. It should also be noted that not all the cells in the DRN 
are serotonergic, although they are the major type of cells in this nucleus. Neurons releasing 
glutamate, DA, GABA, nitric oxide and various neuropeptides (e.g., galanin, neuropeptide Y, 
thyrotropin-releasing hormone, somatostatin) are also known to be present along with 
Fig. 1.2. Anatomy of serotonergic system in the rat brain. Bold branching lines show 
neuroanatomical projections. B7-B9: the rostral group of neurons in the upper midbrain which send 
ascending projections into the forebrain. B1-B3: the caudal group of neurons in the lower brainstem 
which send descending projections into the medulla and spinal cord. B4-B6: an intermediate group, 
which may have both ascending and descending projections. B7: the dorsal raphe nucleus (DRN). 
B8: the medial raphe nucleus (MRN). MFB: medial forebrain bundle. Septal n.: septal nucleus. DS: 
dorsal striatum. VS: ventral striatum. PFC: prefrontal cortex. (Figure source: Cools et al., 2008. 
Serotoninergic regulation of emotional and behavioural control processes. Trends in cognitive 
sciences, 12(1): 31) 
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serotonergic neurons (Lesch and Waider, 2012). For further description of the anatomy of 
brain serotonergic system, see Araragi and Lesch (submitted). 
1.2.3. Serotonergic neurons 
i). Electrophysiological signature 
One of the most prominent electrophysiological characteristics of serotonergic neurons in the 
dorsal raphe nucleus (DRN) is its slow (0.5-2.5 Hz) and regular firing rate with a long action 
potential width (0.8-1.2 ms) (Aghajanian et al., 1968 as in Gobbi, 2005). Furthermore, it has 
been reported that serotonergic neurons have high input resistance (150-400MΩ; Burlhis and 
Aghajanian, 1987) and large afterhyperpolarisation (AHP) (amplitude: 10-20 mV, duration: 
200-800 ms; Vandermaelen and Aghajanian, 1983). It should be noted, however, that recent 
study revealed that these parameters are not statistically different between serotonergic and 
non-serotonergic neurons in the DRN (Kirby et al., 2003). In the study of Kirby and 
colleagues, input resistances of non-serotonergic neurons were somewhat higher than those of 
serotonergic neurons, and both fell within the range of input resistances of serotonergic 
neurons previously reported. Moreover, AHP amplitude and duration of non-serotonergic 
neurons also fell within the range of serotonergic neurons previously reported. It was 
proposed that the time constant of the initial phase of AHP and the membrane time constant 
are more reliable parameters to distinguish serotonergic and non-serotonergic neurons. On the 
other hand, Beck et al. (2004) reported that serotonergic neurons and non-serotonergic 
neurons are very different from each other in the MRN (see the previous section). Moreover, 
serotonergic neurons in the DRN and MRN are different in that serotonergic neurons in the 
MRN had a shorter membrane time constant and larger AHP amplitude than serotonergic 
neurons in the DRN. While, in the DRN, both serotonergic and non-serotonergic neurons 
responded to 5-HT1A receptor agonists, non-serotonergic neurons in the MRN did not respond 
to 5-HT1A receptor stimulation. The response of serotonergic neurons in the DRN to 5-HT1A 
receptor stimulation was larger in its efficacy compared to serotonergic neurons in the MRN, 
implying that autoinhibitory mechanisms (see section 1.2.3.iii).) of serotonergic neuron firing 
is more robust in the DRN (Beck et al., 2004) 
 
ii). Spontaneous firing 
The slow rhythmic pacemaker activity of serotonergic neurons is generated by interaction 
between a calcium-activated potassium current (IK(Ca
2+
)), low-threshold Ca
2+
 conductance, and 
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a voltage-dependent early transient outward K
+
 current (IA). (Burlhis and Aghajanian, 1987). 
Both low-threshold Ca
2+
 conductance and IA are inactive at rest and can be relieved from 
inactivation (i.e. de-inactivated) with membrane hyperpolarisation. During the action potential, 
Ca
2+ 
enters neurons through high-threshold Ca
2+
 channels and activates outward IK(Ca
2+
) 
current, generating a large AHP, which is characteristic of serotonergic neurons (Aghajanian, 
1985; Vandermaelen and Aghajanian, 1983). AHP then de-inactivates both low-threshold 
Ca
2+
 current and IA. Due to the sequestration and extrusion of intracellular Ca
2+
, AHP 
diminishes gradually, bringing the membrane potential back to the appropriate voltage rage (-
60 to -58 mV) to activate both currents, which compete with each other, i.e. IA tends to slow 
the rate of depolarisation, the low-threshold Ca
2+
 conductance tends to facilitate it. Under 
normal physiological conditions, the low-threshold Ca
2+
 conductance is more dominant in this 
competition, generating a slow depolarising voltage ramp until it reaches the threshold of the 
next action potential initiation (Burlhis and Aghajanian, 1987 and references therein).  
 
It is known that, in living animals, the spontaneous activity of serotonergic neurons depends 
on tonic noradrenergic input (Baraban and Aghajanian, 1980a; Baraban and Aghajanian, 
1980b as in Burlhis and Aghajanian, 1987). However, the spontaneous rhythmic activity itself 
is intrinsic since such an activity can be observed in vitro as well, although the pacemaker 
activity can be greatly enhanced by application of α1-adrenoceptor agonist, such as 
phenylephrine (Burlhis and Aghajanian, 1987 and references therein). Such a facilitating 
effect of noradrenergic inputs is mediated by the suppression of IA current and reduction of a 
resting K
+
 conductance (Aghajanian, 1985 as in Burlhis and Aghajanian, 1987), which bring 
the membrane potential to the action potential threshold. Evidence suggests that most of the 
noradrenergic inputs to DRN derive not from the LC but from nuclei outside the LC (Levine 
and Jacobs, 1992 and references therein).  
Spontaneous firing activity of serotonergic neurons in known to be regulated under the sleep-
wake cycle. Namely, extracellular electrophysiological recordings in freely moving cats have 
demonstrated that serotonergic neurons in the DRN fire tonically during wakefulness, 
decrease its firing rate during slow-wave sleep (SWS) and nearly stops its activity during the 
rapid-eye-movement (REM) sleep (Trulson and Jacobs, 1979). It is assumed that GABA 
exerts its inhibitory effects on serotonergic neuron firing during sleep although its precise 
mechanism is still under investigation. Studies in the awake cat by Levine and Jacobs (1992) 
reported that microiontophoretic application of the GABAA antagonist bicuculline into the 
DRN reversed suppression of firing during SWS while it did not generally affect suppression 
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of firing during the REM sleep, neither had any effect on the spontaneous firing during 
wakefulness. Moreover, the same study revealed that further application of norepinephrine or 
phenylephrine during wakefulness does not alter the spontaneous firing, indicating that the 
noradrenergic input in living animals already exerts its maximum facilitative effects during 
wakefulness. On the contrary, in studies by Gervasoni et al. (2000) in the awake rat, 
bicuculline levelled suppression of serotonergic firing during SWS as well as the REM sleep 
and increased firing rates during quiet waking, too. Findings from a more recent study by 
Brown et al. (2008) suggest that GABAergic neurons in the subcoeruleus and a subset of 
GABAergic neurons in the pontine nucleus oralis are excited by cholinergic inputs, which 
then suppress activity of serotonergic neuorns in the DRN through inhibitory projections 
during the REM sleep.  
Measuring spontaneous firing activity of dorsal raphe serotonergic neurons bears importance 
from the following reasons. First, firing activity corresponds to the amount of 5-HT release 
and thus affects activity of target cells (Jacobs and Azmitia, 1992 and references therein). 
Second, several classes of antidepressant drugs (e.g. SSRIs, TCAs, MAOIs, and bupropion) 
and drugs of abuse as well as neurotoxins (e.g. 3,4-methylenedioxymethamphetamine 
[MDMA], lysergic acid diethylamide [LSD], amphetamine, and cocaine) modulates firing rate 
(for review; Gobbi, 2005). Third, several genetically modified animal models of emotional 
disorders, such as 5-Htt KO mice, show an altered baseline firing rate (Gobbi et al., 2001; 
Lira et al., 2003). Importantly, a series of studies done by Gobbi and colleagues demonstrated 
a strong correlation between serotonergic neuron firing activity and the effect of acute and 
chronic antidepressant administration (Gobbi, 2005 and references therein).  
 
iii). Autoinhibition of serotonergic neuron firing 
Activity of serotonergic neurons is limited by a homeostatic control, which is mediated by 
negative feedback exerted by extracellular 5-HT via somatodendritic inhibitory 5-HT1A 
autoreceptors of serotonergic neurons (Audero et al., 2008 and references therein). The role of 
5-HT1A receptors in suppression/regulation of serotonergic neuron firing activity is considered 
to be important in the pathophysiology of emotional disorders (Pineyro and Blier, 1999; Sharp 
et al., 2007). The importance of 5-HT1A receptor function is further bolstered by the proposed 
mechanism of antidepressant drugs such as SSRI and MAOIs (Pineyro and Blier, 1999; Blier 
and de Montigny, 1998; Blier et al., 1998). After acute administration of such antidepressant 
drugs, extracellular 5-HT contents transiently increase. Therapeutic doses of SSRIs are known 
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to decrease 5-HTT function as much as 60-80% (Stein et al., 2006). Extracellular excess of 5-
HT, in turn, activates somatodendritic 5-HT1A receptors on serotonergic neurons, leading to a 
decrease in serotonergic neuron firing activity. After chronic administration of antidepressant 
drugs, these 5-HT1A receptors are desensitised, resulting in the net increase of 5-HT levels. 
This mechanism explains why antidepressant drugs start to exert their therapeutic effects with 
a certain time lag. Further evidence supporting the notion that increased 5-HT 
neurotransmission mediates therapeutic effects of antidepressants comes from the fact that 
administration of para-chlorophenylalanine (PCPA), a 5-HT synthesis inhibitor, caused 
relapse of depression in patients who had responded to antidepressants (Mongeau et al., 1997 
and references therein).  
In this context, dysfunction of autoinhibitory 5-HT1A receptors has been proposed as a 
potential factor contributing to the pathogenesis of emotional disorders. However, reports on 
the expression level of 5-HT1A receptors in depressed patients measured by positron emission 
tomography (PET) or in postmortem brains of depressed patients have not reached consensus: 
Some reported decreased expression (Arango et al., 2001; Drevets et al., 1999; Meltzer et al., 
2004; Bhagwagar et al., 2004), while some others reported enhanced expression (Stockmeier 
et al., 1998) or no difference compared to controls (Stockmeier et al., 1997; Lowther et al., 
1997; Parsey et al., 2006). Moreover, PET imaging data revealed reduced 5-HT1A binding in 
several brain regions including the raphe nucleus in panic disorder patients either with or 
without comorbid depression (Neumeister et al., 2004). To date, most studies concentrated on 
association between expression levels of 5-HT1A receptors with depressive disorders and there 
has been no direct evidence demonstrating how altered 5-HT1A receptor levels translate to 
magnitude of autoinhibition. The discrepancies among literature describing relationship 
between 5-HT1A receptor expression levels and depression imply the need for understanding 
precise mechanisms linking 5-HT1A receptor levels with autoinhibition. 
 
iv). Serotonin release 
As reviewed by Zoli et al. (1998), it has been suggested that interneuronal communication can 
be categorised into two different types; wiring transmission and volume transmission (VT; 
also termed paracrine transmission). Wiring transmission occurs in a spatially constrained 
cellular chain (wire), i.e. across the synaptic clefts. On the other hand, VT is three-
dimensional diffusion of neurotransmitters in the extracellular fluid beyond the realm of 
synaptic contacts (Zoli et al., 1998). Using carbon fibre microelectrodes, Bunin and 
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Wightman (1998) demonstrated that 5-HT release in the substantia nigra reticulate and the 
DRN is primarily of the VT type. This is also in agreement with anatomical findings that 5-
HT uptake sites are not synaptically localised but rather are widely distributed across the 
serotonergic neurons so that they can optimally control the extracellular 5-HT levels (Bunin 
and Wightman, 1998 and references therein). Further in accordance with the VT concept, the 
DRN is known to display little synaptic specialisation (Bunin and Wightman, 1998). Thus, 
VT allows 5-HT to interact with many extrasynaptic elements.  
The VT type of 5-HT release has important consequences in the mechanism of autoinhibition. 
Namely, if the autoinhibition is regulated by pulsatile release of vesicular 5-HT, as is seen in 
the wiring transmission mode of neurotransmission, serotonergic neuronal firing becomes 
erratic, while in fact the firing of serotonergic neurons is very regular. The paracrine type of 
5-HT release, on the other hand, creates homogeneous concentration of extracellular 5-HT, 
enabling tonic autoinhibition, leading to the typical regular firing of serotonergic neurons. 
 
v). Mechanism of 5-HT1A receptor action 
When activated by their ligands, 5-HT1A receptors stimulate the opening of Kir.3 K
+
 channels, 
also known as voltage-dependent G-protein-coupled inwardly rectifying K
+ 
(GIRK) channels, 
via pertussis toxin-sensitive G-proteins (Gi/o) both in the DRN (Innis and Aghajanian, 1987; 
Colmers and Williams, 1988; Innis et al., 1988; Williams et al., 1988; as in Mannoury la Cour 
et al., 2004) and in CA1 pyramidal cells of the hippocampus (Andrade et al., 1986). 
Subsequent outflow of K
+
 ions from the intracellular to the extracellular space hyperpolarises 
the neuron. This inhibitory effects on neuronal excitability is complemented by inhibition of 
N- and P/Q-type Ca
2+
 channels (Millan et al., 2008). Although 5-HT1A receptors are known to 
be negatively coupled to adenylyl cyclase via α-subunit of Gi/o, the level of cAMP apparently 
does not affect opening of GIRK channels. This is because neither intracellular injection of 
cAMP nor bath application of 8-Br-cAMP, the membrane-soluble analogue of cAMP, reduces 
the hyperpolarising effect of 5-HT1A receptor activation (Aghajanian, 2000). On the contrary, 
evidence suggests that the opening of GIRK channels by 5-HT1A receptor activation is 
mediated through the interaction between G-protein βγ-subunits of Gi/o (Doupnik et al., 1996, 
1997 as in Raymond et al., 2001). 
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1.2.4. The DRN and emotion regulation 
The DRN is seen as a structure playing a critical role in the modulation of emotion. This is 
indicated by its unique anatomical connections with limbic and prefrontal cortical structures. 
Graeff et al. (1996) proposed an integrative theory accounting for two different roles of 5-HT 
in the regulation of emotion, namely anxiety and unconditioned fear such as fight/flight 
escape response. In their theory, serotonergic innervation from DRN to the amygdala 
facilitates anxiety to potential threat via postsynaptic 5-HT2A/2C and 5-HT3 receptors, whereas 
afferents from DRN to the periaqueductal grey (PAG) suppress panic-like fight/flight 
behaviours in response to immediate threat via postsynaptic 5-HT2A/2C and 5-HT1A receptors. 
On the contrary, afferents from the MRN to the hippocampus is hypothesised to help 
organisms to cope with chronic stress by disconnecting impacts of aversive events from 
psychobiological processes underlying appetitive and social behaviours by activating 
postsynaptic 5-HT1A receptors.  
Serotonergic innervation to the amygdala attracts particular attention because the amygdala 
has been repeatedly implicated in literature describing neural mechanisms of anxiety and fear 
responses. Anatomically, the amygdala comprises three major nuclei, the lateral nucleus (LA), 
the basolateral nucleus (BLA), and the central nucleus (CeA). It is understood that LA serves 
as an input station for sensory stimuli, BLA relays the information, and the CeA sends 
projections to effector structures mediating fear responses, such as PAG for panic response or 
freezing (Kim and Jung, 2006). Serotonergic regulation of amygdaloid activity is supported 
by a number of experimental observations. In anatomical terms, both pyramidal neurons and 
interneurons in the BLA receive intense serotonergic innervation. Immunohistochemical 
studies also demonstrated expression of 5-HT1A receptors on pyramidal cells and of 5-HT2A 
and 5-HT3A receptors on interneurons of the basolateral complex (Muller et al., 2007; 
Mascagni and McDonald, 2007; McDonald and Mascagni, 2007). This is in correspondence 
with a previous electrophysiological study by Stutzmann and LeDoux (1999) showing that 
application of 5-HT activates GABAergic interneurons in the LA through 5-HT2 and 5-HT3 
receptors, which then inhibits pyramidal neurons activated by glutamatergic innervation from 
the sensory afferents. In a clinical setting, it was demonstrated in an imaging study, that the 
amygdala of patients with anxiety or mood disorders was overactive, whereas the chronic 
SSRI treatment, which is supposed to enhance serotonergic neurotransmission, normalised the 
amygdala activity along with amelioration of clinical symptoms (Muller et al., 2007). 
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Not only sending projections to other brain areas, the DRN is known to receive inputs from 
other brain areas. Particularly, the DRN receives virtually all of its cortical inputs from the 
infralimbic (IL) and the prelimbic (PL) areas of the ventral medial prefrontal cortex (mPFCv). 
Amat et al. (2005) reported that this mPFCv imput sends information to the DRN whether a 
stressor to the organism is controllable or not. When a stressor is controllable, mPFCv imput 
suppresses stress-induced activation of the DRN and subsequent behavioural consequences of 
uncontrollable stress. 
Finally, a retrograde staining study revealed a unique afferent input into the DRN originating 
from the BNST, a structure implicated in the mediation of anxiety-related behaviours (Lowry 
et al., 2005). Evidence suggests that BNST exerts its influence on DRN through 
corticotrophin-releasing hormone (CRH) (Hammack et al., 2003; Davis et al., 2010). 
Conversely, serotonergic neurons in the DRN also send projections to the BNST and 
modulate anxiety (Robinson et al., 2012). It has been proposed that the BNST receives 
excitatory CRH release from the amygdala in response to aversive stimuli and express 
anxious behaviours. By activating 5-HT1A receptors, serotonergic inputs from the DRN 
suppress this excitatory effect of CRH on BNST (Robinson et al., 2012; Hammack et al., 
2009). Importantly, this DRN control on BNST is, in turn, controlled by top-down regulation 
from medial prefrontal cortex (mPFC) on the DRN, as mentioned earlier.  
 
Taken together, multiple lines of evidence indicate elaborated interaction between the DRN 
and other limbic and cortical structures in mediating anxiety and fear. This interaction is 
mediated by several different types of excitatory and inhibitory 5-HT receptors. The DRN and 
other structures are often connected in a hierarchical manner, i.e. the DRN receives 
commands from some other structures such as mPFC and then send afferents to other 
subordinate structures which are more directly related to the expression of fear and anxiety. 
 
1.3. Serotonin transporter (5-HTT) and its association with emotional disorders 
The 5-HTT is a plasma membrane protein, which reuptakes 5-HT from the extracellular space 
into the serotonergic neurons by coupling the transport of 5-HT to the electrochemical 
gradients for Na
+
 and Cl
-
. The 5-HTT has been implicated in emotional regulation based on 
three lines of evidence: i) Several classes of antidepressants inhibit the 5-HTT, such as SSRI, 
and TCA; ii) it is also a target of drugs of abuse such as MDMA and cocaine; iii) genetic 
polymorphisms which lead to variability in 5-HTT expression and function has been 
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associated with anxiety, depression, suicidal behaviour, substance abuse, irritable bowel 
syndrome, autism, obsessive-compulsive disorder, and schizophrenia (Quick, 2003; Canli and 
Lesch, 2007; Murphy and Lesch, 2008). With regard to the last point, the human 5-HTT 
protein is known to be encoded by a single gene, SLC6A4, whose transcriptional activity is 
modulated by several gene variants including a repetitive sequence termed 5-HTT linked 
polymorphic region (5-HTTLPR; reviewed in Canli and Lesch, 2007). The short variant (s-
allele) of the 5-HTTLPR is known to lead to less expression of 5-HTT compared to the long 
variant (l-allele), resulting in an increased level of 5-HT in the synaptic cleft. At the 
phenotypic level, s-allele has been associated with depression (Collier et al., 1996) and 
anxiety-related personality traits (Lesch et al., 1996). Moreover, it was found that s-carriers 
show higher rates of a particular type of anxiety disorders, namely post-traumatic stress 
disorder (PTSD) (Lee et al., 2005a). Functional magnetic resonance imaging (fMRI) study by 
Hariri and colleagues provided direct evidence that s-carriers have higher amygdala activity in 
response to fearful facial stimuli in comparison to non-carriers (Hariri et al., 2002). In 
addition, structural MRI revealed reduced grey matter volume in s-allele carriers in the 
perigenual anterior cingulate cortex (pACC) and the amygdala, limbic regions involved in the 
processing of negative emotion (Pezawas et al., 2005). The same group, using fMRI, further 
demonstrated functional coupling of pACC and the amygdala during perceptual processing of 
fearful stimuli. Importantly, s-allele carriers were shown to have weaker coupling of these 
structures, which may lead to dysregulation of the amygdala in response to fearful stimuli 
(Pezawas et al., 2005; reviewed in Canli and Lesch, 2007). Subsequently, Canli and associates 
(Canli et al., 2005) provided evidence that the increased amygdala activation in s-carriers in 
response to negative stimuli, as reported earlier, were in fact due to the decreased activation to 
neutral stimuli which were used as a control in earlier studies. Overall, influence of 5-
HTTLPR polymorphism on brain structure and function, especially emotion regulation and 
cognition, seems even more complicated than initially perceived. 
S-allele of 5-HTTLP has been shown to influence learning abilities as well (Borg et al., 2009 
and references therein). For example, carriers of the s-allele were shown to have enhanced 
acquisition in fear-conditioning tasks (Garpenstrand et al., 2001). Interestingly s-carriers were 
shown to perform better than l-carriers in some cognitive tasks such as sustained attention 
task (Strobel et al., 2007), risky decision-making and a visual-planning task (Roiser et al., 
2006), and episodic memory and attention tests (Roiser et al., 2007). 
It should be noted that genetic variability in 5-HTTLPR does not directly determine the onset 
of a particular affective disorder. Rather, it represents an individual’s predisposition which 
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influences its reactivity to certain aversive environmental factors. Studies done in primates 
demonstrated an influence of rh5-HTTLPR (rhesus monkey 5-HTTLPR; orthologous to the 
human 5-HTTLPR) and early life stress (e.g. maternal separation) on variation in serotonergic 
function, which led to emotion dysregulation, increased stress reactivity, social incompetence, 
aggression, increased alcohol consumption observed in their later life (reviewed in Canli and 
Lesch, 2007). Similarly, in human cohorts, the number of stressful life events (childhood 
maltreatment, socioeconomic factors, personal relationship, health status, employment 
stressors) was more strongly correlated with major depression episodes and suicide 
ideation/attempts in s-carriers than l-carriers of 5-HTTLPR (Caspi et al., 2003). 
 
1.4. Serotonin transporter knockout (5-Htt KO) mice as a model for depression-related 
emotionality 
1.4.1. Characteristics of 5-Htt KO mice 
Given the importance and complexity of 5-HTTLPR functions in humans mentioned above, 
mice with reduced or completely absent 5-Htt protein were generated by targeted disruption 
of murine 5-htt gene (Slc6a4) (Bengel et al., 1998) to better understand functions of 5-HTT. 
Mice with complete lack of 5-Htt protein (5-Htt KO mice) have 60-80 % reduction in brain 
serotonin content (Bengel et al., 1998; Kim et al., 2005), although 5-HT synthesis itself is 30-
60 % increased in different brain regions, reflecting an inadequate compensatory mechanism 
(Kim et al., 2005). In contrast, the extracellular 5-HT concentrations at baseline are ~3-fold 
and ~6-fold elevated in 5-Htt heterozygous (Het) and KO mice, respectively (Fabre et al., 
2000; Mathews et al., 2004; Shen et al., 2004, as in Fox et al., 2010). 5-HT clearance rate was 
shown to be decreased in Het mice and more markedly so in KO mice, as expected from the 
decreased expression and complete absence of 5-Htt, respectively (Montanez et al., 2003). 
Moreover, the total number of serotonergic neurons in the DRN appears to be reduced (Lira et 
al., 2003; Rumajogee et al., 2004). 
5-Htt KO mice exhibit more than 50 different phenotypic alterations (reviewed in Murphy and 
Lesch, 2008) including gastrointestinal dysfunction, skeletal fragility, change in 
somatosensory cortex (whisker barrels), hypothermia (Li et al., 1999, 2000; Bouali et al., 
2003), sleep disturbance and late-onset obesity driven by metabolic syndrome (Erritzoe et al., 
2010; Uceyler et al., 2010; as in Gutknecht et al., 2012), and physiological responses to 
stressors (Lanfumey et al., 2000; Li et al., 1999; Tjurmina et al., 2002;Tjurmina et al., 2004). 
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At the behavioural level, 5-Htt KO mice are known to exhibit increased anxiety-like 
behaviour and diminished exploratory locomotion, manifested in behavioural paradigms such 
as elevated plus maze (EPM), light-dark exploration/emergence, and open field (OF) test 
(Holmes et al., 2003). In contrast, transgenic mice overexpressing 5-Htt exhibited less anxiety 
behaviours in EPM and hyponeophagia tests (Jennings et al., 2006). The low anxiety observed 
in the EPM test was reversed by acute administration of the SSRI paroxetine. The finding 
further corroborates the link between the low expressing variant of the 5-HTTLPR with 
anxious phenotypes. Additionally, 5-Htt KO mice are known to burry fewer marbles than 
their wildtype (WT) counterparts, a behavioural test often used as an indication of obsessive-
compulsive traits (Zhao et al., 2006). 
Moreover, depression-like behaviours of 5-Htt KO mice have been reported, reflected as 
increased immobility time in paradigms such as forced swim test (FST) (Wellman et al., 
2007; Renoir et al., 2008) and tail suspension (TS) test (Zhao et al., 2006; Lira et al., 2003). 
Since immobility represents behavioural despair in these experimental paradigms, it is 
interpreted that KO mice have higher tendency toward the “depression-like” behavioural trait. 
However, the opposite result, i.e. reduction in immobility, was also reported in TS test 
(Renoir et al., 2008), possibly due to the difference in genetic background (i.e. 129 or 
C57BL/6Jx129S6 mixed background vs. C57BL/6J. See also discussion in Savelieva et al., 
2008). 
5-Htt KO mice are also known to feature alterations in their learning abilities. For example, 
Wellman et al. (2007) showed that KO mice had impaired extinction recall in fear extinction 
learning although they had normal fear conditioning and extinction capabilities compared to 
WT counterparts. Since the deficit in acquiring or retaining extinction memory is a defining 
feature of anxiety disorders in humans, the result from this behavioural test suggests that 
genetic loss of 5-HTT function may be a risk factor for this disorder. In fact, it was found that 
individuals carrying the low-expressing variant 5-HTTLPR show higher rates of a particular 
type of anxiety disorders which has close relevance to extinguishing negative memories, 
namely PTSD (Lee et al., 2005a; Wellman et al., 2007). 
On the other hand, 5-Htt KO mice exhibit improvements in certain domains of learning which 
require cognitive flexibility such as reversal learning, where mice have to switch from 
responding to a previously rewarded stimulus to a previously unrewarded stimulus in the 
same stimulus dimension. Brigman et al. (2010) showed that both constitutive 5-Htt null 
mutants and mice treated with chronic fluoxetine made fewer errors in reversal learning than 
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control animals. On the other hand, constitutive 5-HT depletion by Pet1 KO or acute 5-HT 
depletion by PCPA did not change reversal learning efficiency compared to control mice. A 
probabilistic reversal learning test in 5-Htt KO mice also revealed that 5-HT modulates 
processes mediating reward-stay and punishment-shift behaviour (Ineichen et al., 2012). The 
findings suggests involvement of the serotonergic system in cognitive flexibility and bears 
importance since growing evidence indicates that deficient cognitive flexibility prevails 
among several neuropsychiatric disorders including depression (Cools et al., 2008). 
Importantly, evidence suggests that various behavioural changes in 5-Htt KO mice as 
compared to WT mice could be, to some extent, traced down to cellular and molecular levels. 
Indeed, increased depressive-like behaviours and impaired fear extinction recall in 5-Htt KO 
mice were accompanied by morphological changes in key limbic structures such as the IL and 
the BLA (Wellman et al., 2007). Specifically, they found that the apical dendritic branches of 
Golgi-stained pyramidal neurons in the IL of 5-Htt KO mice were significantly increased in 
length. Moreover, pyramidal neurons in the BLA had significantly greater spine density in 5-
Htt KO mice, although their dendritic morphology was not different from that of WT 
counterparts. Nietzer et al. (2011) also reported a spine density increase in several dendritic 
compartments of pyramidal neurons in the BLA and LA. In addition, they found that, in 
general, the dendritic morphology of the cingulate cortex (CG), CA1 pyramidal neurons, and 
of amygdaloid interneurons does not differ between genotypes. In contrast to the findings of 
Wellman et al. (2007), however, they reported that pyramidal neurons in the IL tended to have 
shorter and less spinous distal apical dendrites in KO mice. The authors speculated that this 
discrepancy could be due to the behavioural paradigms used prior to sacrificing of animals 
and the time period elapsed after the cessation of such behavioural paradigms. 
It is beyond the scope of this section to cover all the behavioural changes of 5-Htt KO mice, 
which include reduced aggression (Holmes et al., 2002), reduced locomotion and resultant 
late-onset obesity (Uceyler et al., 2010), serotonin syndrome-like behaviours (Kalueff et al., 
2007b), and behavioural responses to various stress paradigms, e.g. mild predator stress 
(Adamec et al., 2006); mild early life stress (Carroll et al., 2007); social defeat (Jansen et al., 
2010); low maternal care (Carola et al., 2008). For further description of behavioural changes 
in 5-Htt KO mice, refer to more comprehensive reviews (Murphy and Lesch, 2008; Haenisch 
and Bonisch, 2011). Pharmacological studies done on 5-Htt KO mice, especially effects of 
psychoactive drugs working on the serotonergic system, are described in Araragi and Lesch 
(submitted). 
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1.4.2. Electrophysiology 
i). In vitro electrophysiology  
Using extracellular recording, Mannoury la Cour et al. (2001) demonstrated that the potency 
of 5-HT1A receptor partial agonists ipsapirone and 5-carboxamidotryptamine (5-CT) in 
inhibiting the discharge of serotonergic neurons in the DRN was markedly decreased in 5-Htt 
KO compared to WT mice. Similarly, their intracellular recording data showed that the 
potency of 5-CT to hyperpolarise serotonergic neurons in the DRN was significantly lower in 
5-Htt KO than in 5-Htt WT animals. On the contrary, 5-CT was equipotent to hyperpolarise 
CA1 pyramidal neurons of the hippocampus in both mutant and wildtype mice. In line with 
this, there were no significant differences between WT and KO in the basic membrane 
properties of CA1 pyramidal neurons, such as the resting membrane potential and the input 
resistance. Based on these results, the authors concluded that 5-Htt knockout induced a 
marked desensitisation of 5-HT1A autoreceptors in the DRN without altering postsynaptic 5-
HT1A receptor function in the hippocampus. Loucif et al. (2006) showed enhanced 5-HT1A 
receptor desensitisation in the DRN of female in comparison to male mice in their patch 
clamp experiments. In detail, they demonstrated that the 5-Htt KO mutation reduced the 
GIRK current density induced by Gpp(NH)p (a nonhydrolysable GTP analogue) in females 
but not in males. Since 5HT1A receptors are coupled to GIRK channels via G-proteins, the 
data suggest that the decreased response of 5-HT1A receptors to their agonists in KO mice is 
likely to be mediated by alteration in this G-protein coupling in females but not in males. 
Immunohistochemical investigations also support this brain region specific desensitisation of 
5HT1A receptors. Namely, the number of somatodendritic 5HT1A autoreceptors in the 
brainstem raphe is reduced (>60%) in 5-Htt KO mice with slightly greater reduction in 
females compared to males and intermediate reduction in Het mice. On the other hand, 
postsynaptic 5-HT1A receptors are partially reduced only in females in the hypothalamus, 
septum, and amygdala. By contrast, no changes were observed in the frontal cortex or 
hippocampus (Fabre et al., 2000; Mannoury la Cour et al., 2001; Li et al., 1999, 2000; 
Murphy and Lesch, 2008 and references therein).  
Since both 5-HT1A receptors and GABAB receptors activate the GIRK current, it has been 
postulated that both receptor types share a common pool of G-proteins, and that alterations in 
the homeostasis of the serotonergic system may therefore influence GABAB receptor 
functions. In vitro brain slice recording showed that the GABAB receptor agonist baclofen 
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induced a lower hyperpolarisation and inhibition of neuronal firing of DRN serotonergic cells 
in 5-Htt KO mice compared to their WT counterparts. On the other hand, GABAB receptors in 
the hippocampus are functionally identical both in KO and WT mice (Mannoury la Cour et al., 
2004). This brain-region specific desensitisation of GABAB receptors in 5-Htt KO mice 
exhibits close resemblance to that of 5HT1A receptors (Mannoury la Cour et al., 2001), further 
supporting the existence of common downstream pathways between these two receptor types.  
ii). In vivo electrophysiology 
Gobbi et al. (2001) reported that the spontaneous firing rate of serotonergic neurons in the 
DRN was significantly decreased by 66% in 5-Htt KO and 36% in Het mice, compared to WT 
controls. Lira et al. (2003) also reported about four-fold reduction of spontaneous firing rate 
which was accompanied by 50% reduction of the serotonergic cell number in the DRN. It 
should be noted that such a decrease in the baseline firing rate of DRN serotonergic neurons 
was not observed in in vitro conditions (Mannoury la Cour et al., 2001, 2004; Renoir et al., 
2008). Moreover, Gobbi et al. (2001) showed desensitisation of 5-HT1A receptor in response 
to a 5-HT1A/5-HT7 agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) both in 
KO and Het mice in the DRN. In addition, the time required for hippocampal CA3 pyramidal 
neurons to return to the baseline firing rate after 5-HT iontophoretic application was 
significantly increased. Most likely, this is due to the deficiency of rapid clearance of 5-HT 
from extracellular fluid, as has been demonstrated using high-speed chronoamperometry 
(Montanez et al., 2003). Gobbi et al. (2001) also demonstrated that hippocampal CA3 neurons 
in KO mice showed an attenuated response to 8-OH-DPAT, but not to 5-HT itself. Their 
finding that 5-HT1A receptor is desensitised also in the hippocampus is in contrast to the 
finding of Mannoury la Cour and coworkers (2001). Although there are some differences in 
the responsiveness of CA1 and CA3 pyramidal neurons to 5-HT1A receptor agonists (Beck et 
al., 1992 as in Gobbi et al., 2001), no significant differences were found in another in vivo 
electrophysiological approach (Blier et al., 1993 as in Gobbi et al., 2001). For this reason, 
Gobbi et al. (2001) speculated that the major reason for the discrepancy is that in vitro 
methodology as was adopted by Mannoury la Cour et at. (2001) is generally less sensitive to 
detect moderate-to-small alteration in receptor responsiveness. For example, micromolar 
concentrations of 5-HT agonists are usually required to cause membrane hyperpolarisation of 
several milivolts in vitro, whereas in vivo microiontophoretic approach applies a few 
nanoamperes to a mililimorlar solution to eject agonists. 
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Similar to the in vitro work by Loucif et al. (2006), an in vivo study by Bouali et al. (2003) 
demonstrated enhanced desensitisation of 5HT1A receptors in response to 8-OH-DPAT in the 
DRN of 5-Htt female KO mice (CD-1 strain) compared to their male counterparts. By 
applying gonadectomy, they showed that this gender difference is mediated by sex hormones; 
namely, castrated 5-Htt KO males showed a downregulation, and ovariectomised females an 
upregulation of these receptors, which are restored by administering testosterone or estradiol 
to gonadectomised males or females, respectively. 
Regarding the desensitisation of 5-HT1A receptors, detailed analyses of alteration in G-protein 
coupling in 5-Htt KO mice have been conducted. For further details see Araragi and Lesch 
(submitted). 
Recent in vivo recording on behaving 5-Htt KO mice investigated impact of social defeat on 
fear extinction learning and on theta synchronisation between the IL cortex and the LA 
(Narayanan et al., 2011). It was found that naïve 5-Htt KO mice as well as socially defeated 
5-Htt Het and KO mice had impairment in fear extinction recall. Moreover, socially defeated 
5-Htt Het and KO mice showed a delay in fear extinction learning. Interestingly, both 
impaired extinction learning and extinction recall were accompanied by augmentation in the 
IL-LA theta synchronisation. The result indicates that 5-HT modulates fear extinction 
learning and consolidation of fear extinction via influencing the theta coupling between the IL 
cortex and LA activities. The result further implies that such interaction is influenced by 
environmental stressors. 
 
1.5. Hippocampus and depression 
1.5.1. Memory and depression 
A number of experimental findings demonstrated that aversive stimuli, such as foot shocks, 
which are known to induce fearful memories, alter activity-dependent hippocampal synaptic 
plasticity in rodents (Sarkisyan and Hedlund, 2009 and references therein). Anxiety disorders 
and depression then involve consolidation of fearful memories. When organisms experience 
unresolvable or inescapable stressful events, they develop so-called “learned helplessness”. It 
is generally accepted that memory functions play a major role in the formation of learned 
helplessness. The hippocampus, on the other hand, is known to integrate information about 
space, time and context and thus plays a crucial role for declarative learning and memory 
(reviewed in Millan et al., 2012). The so-called “Cognitive-Learning Theory of affective 
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disorders” links the concept of learned helplessness to depression (Mongeau et al., 1997). 
Several hormones and neurotransmitters are known to modulate memory formation. While 
stress hormones such as adrenal corticosteroids are proposed to facilitate consolidation of 
stressful memories, 5-HT counteracts the consolidation (Graeff et al., 1996). For example, 
application of selective 5-HT1A receptor agonists, both systemic and in the dorsal 
hippocampus, is known to disrupt spatial learning in a water maze or impairs performance in 
a passive avoidance task (Graeff et al., 1996 and references therein). Moreover, application of 
buspirone or lesion of MRN is shown to interfere with the electrical activity of the 
hippocampus (Graeff et al., 1996). Based on these findings, it has been proposed that the 
MRN-dorsal hippocampus 5-HT neurotransmission promotes resilience to chronic, 
unavoidable stress through the activation of hippocampal 5-HT1A receptors, disengaging 
behavioural memories that could lead to aversive outcomes. In this way, increased 5-HT 
transmission in the hippocampus leads to tolerance to chronic aversive events, preventing the 
onset of depressive reactions against them (Graeff et al., 1996). According to this model, 
depression occurs when this coping mechanism fails. 
In rodent studies, it was demonstrated that 5-Htt deficiency in rats leads to impairment in 
object memory. Since the s-allele of 5-HTTLPR is associated with developmental structural 
changes in the hippocampus and the object memory is mediated by the hippocampus (Olivier 
et al., 2009 and references therein), it may be postulated that lower 5-HTT function 
predisposes individuals both to affective disorders and memory impairments due to common 
neurodevelopmental alterations in the hippocampus. 
Several lines of evidence point to the involvement of hippocampus in emotional regulation by 
way of forming fear memories. In experimental fear conditioning, several lesion and 
pharmacological inactivation studies demonstrated the involvement of hippocampus in 
contextual fear conditioning (Deacon et al., 2002; McEown and Treit, 2009, 2010) in contrast 
to the amygdala, which mediates cued fear conditioning. Moreover, it has been suggested that 
the ventral hippocampus (vHPC) mediates contextual fear conditioning, while its dorsal part 
(dHPC) plays a role for cognitive tasks such as spatial memory. Anatomical evidence also 
supports the idea that vHPC regulates fear learning (reviewed in Fanselow and Dong, 2010); 
the ventral CA1 sends direct projections to the CeA and receives substantial inputs from the 
LA and BLA. Particularly, it has been shown that the vHPC has a direct efferent to the mPFC 
(Ferino et al., 1987), a neural region playing a critical role for the modulation of anxiety. For 
example, Adhikari and colleagues (2010) demonstrated synchronisation of the theta-
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frequency activity between the mPFC and vHPC of mice in anxiogenic behavioural 
environments.  
Modulation of hippocampal activity by 5-HT has been linked to the control of mood and 
emotion, in particular anxiety-related phenotypes and depression (Morini et al., 2011 and 
references therein). For example, increased 5-HT release was reported in the vHPC during the 
anxious state induced by the EPM (Rex et al., 2005 as in Morini 2011; Bickerdike et al., 1993 
as in Graeff et al., 1996) or in the caudal hippocampus (which may contain both the dorsal 
and ventral hippocampus) in response to gentle experimental handling and tail-pinch (Kalen 
et al., 1989 as in Graeff et al., 1996). The relationship between increased 5-HT release and 
anxious states is also in accordance with the fact that acute administration of SSRIs used to 
treat anxiety disorders provokes anxiogenic-like effects in animals submitted to tests for 
anxiety (Rex et al., 2005 and references therein). 
 
1.5.2. Hippocampus and stress 
It has been shown that exposing adult rodents to adverse events leads to deficits in long-term 
potentiation (LTP) and working memory (Millan et al., 2012 and references therein). 
Importantly, such chronic-stress induced cognitive deficits are often accompanied by neuronal 
structural changes, including dendritic spine atrophy, decreased neurogenesis in the 
hippocampus and disruption in the prefrontal cortex-hippocampus coupling (Millan et al., 
2012 and references therein). In fact, it has previously demonstrated that the rate of 
neurogenesis in the hippocampus is associated with spatial learning and memory 
consolidation (Sarkisyan and Hedlund, 2009). Moreover, several lines of evidence link 
decreased hippocampal volume with affective disorders, such as PTSD, bipolar disorder, and 
depression (Fanselow and Dong, 2010 and references therein). It has been reported that the 
volume loss in some depressed patients reaches as much as 20% (Sapolsky, 2001). The 
drawback of the hypothesis linking adult neurogenesis with hippocampal volume, however, is 
that the adult hippocampal neurogenesis occurs in a rather limited area, i.e. dentate granule 
layer, and it is still unknown to what extent such a restricted neurogenesis and alteration of 
morphology in a single neuron level contributes to the total volume of the hippocampus. 
Moreover, the hippocampal volume may well be determined not only by adult neurogenesis 
but the rate of cell death of already existing neurons should also be taken into account.  
One notion for a hypothetical mechanism directly linking stress and the hippocampus claims 
that stress-related hormone, glucocorticoids (in humans it is called cortisol, in mice 
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corticosterone) inhibits neurogenesis either directly or indirectly, thus leading to the atrophy 
of the hippocampus (Sapolsky, 2001). This hypothesis seems plausible given that brain 
glucocorticoid receptors are expressed mainly in the hippocampus (Bickerdike et al., 1993 as 
in Graeff et al., 1996) and corticosteroid hormones were shown to influence hippocampal 
morphology (Woolley et al., 1990 as in Graeff et al., 1996). Moreover, past investigation 
suggests that the negative feedback on the secretion of glucocorticoids released during stress 
takes place mainly in the hippocampus. Thus, it has been suggested that depression might be 
linked to an aberrant feedback mechanism at the level of the hippocampus. Indeed, one of the 
most consistent observations among depressed patients is their hypercortisolism and in animal 
models of depression-like behaviours, inhibition of fast glucocorticoid receptors and down-
regulation of glucocorticoid receptors have been reported selectively in the hippocampus after 
the animals experienced chronic stress (Mongeau et al., 1997 and references therein). 
As outlined here, the precise mechanism linking adult neurogenesis, hippocampal volume loss, 
and depression is still under investigation. However, the data available to date at least indicate 
that the hippocampus is one of the most vulnerable regions to stress and stress-related 
hippocampal dysfunction may convincingly explain some of the well-documented 
hippocampus-related cognitive deficits that accompany severe depression, including deficits 
in declarative memory such as episodic and semantic memory. 
 
1.5.3. Pharmacologic interventions on the hippocampus ~Antidepressants, anxiolytics, and 
drugs of abuse~ 
 
Further evidence suggesting the involvement of the hippocampus in depression is based on 
the fact that long-term treatment with SSRIs, which results in a net increase in 5-HT 
transmission, induces adult neurogenesis (Schmitt et al., 2007). This action seems to be 
mediated by postsynaptic 5-HT1A receptors since therapeutic effects of SSRIs were absent in 
5-HT1A receptor KO mice. Accordingly, blocking hippocampal neurogenesis appears to 
abolish some of the therapeutic effects of SSRIs (Santarelli et al., 2003 as in Graeff and 
Zangrossi, 2010). Moreover, acute or chronic antidepressant treatment induces 
autophosphorylation and activation of receptors for BDNF in the hippocampus as well as in 
the prefrontal and anterior cingulate cortex (Saarelainen et al., 2003 as in Graeff and 
Zangrossi, 2010). It is assumed that the clinical effects of antidepressants thus may be 
mediated by enhanced neurotrophin signalling and subsequent formation and stabilisation of 
synaptic connectivity. 
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Pharmacologically, infusion of benzodiazepines to the hippocampus is known to be anxiolytic 
(Menard and Treit, 1999 as in Klemenhagen et al., 2006). Moreover, such drugs are shown to 
impair the theta activity of hippocampus (Gray and McNaughton, 2000 and references 
therein). In fact, most anxiolytic drug actions are similar to septo-hippocampal lesions in their 
behavioural effects. Experimentally, it was shown that the behavioural deficits of learned 
helplessness were rescued by hippocampal lesions (Mongeau et al., 1997 and references 
therein). Based on these findings, Gray and McNaughton (2000) put much importance on 
hippocampus in the regulation of anxiety. In detail, they proposed that the hippocampus 
works as a “comparator” that would compare actual stimuli with expected stimuli, resolving 
the conflict between different goals of behaviours. In that way, the hippocampus increases the 
weighting of stimuli which lead to potential harm, shifting behavioural approach-avoidance 
conflict toward the direction of avoidance both in the present and future events (Gray and 
McNaughton, 2000). Therefore, the fact that moderate doses of benzodiazepine lead to 
resolution of conflict between approach and avoidance in favour of approach can be explained 
as hippocampal dysfunction (Bannerman et al., 2004 and references therein). 
Furthermore, the hippocampus is known to be one of the most susceptible brain regions to 
MDMA-induced serotonergic axotomy. Importantly, long-lasting behavioural impairments 
observed in frequent MDMA users are characterised not only by deficits of learning and 
memory but also increased anxiety (Morini et al., 2011 and references therein).  
1.5.4. 5-HT receptors in the hippocampus 
Several distinct subtypes of 5-HT receptors are known to be present in the hippocampus. 5-
HT1A receptors are abundantly expressed on hippocampal pyramidal neurons. On the other 
hand, GABAergic interneurons possess 5-HT3 receptors. Moreover, 5-HT2 receptor family (5-
HT2A and 5-HT2C) is present in all areas of the hippocampus. 5-HT7 receptors are also known 
to be expressed in the hippocampus and their roles in spatial memory and contextual learning 
have recently attracted attention (Sarkisyan and Hedlund, 2009; Renner et al., 2012). A role 
for 5-HT1B, 5-HT4 and 5-HT6 receptors in learning and memory has also been proposed (King 
et al., 2008; Buhot et al., 2000; Perez-Garcia and Meneses, 2008). Although all these 
receptors are implicated in the context of anxiety and depression, focus will be placed on 5-
HT1A, 5-HT3, and 5-HT7 receptors for their particular relevance to the present study (for the 
roles of 5-HT2 receptors in the hippocampus, see Araragi and Lesch (submitted)). 
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i). 5-HT1A receptors 
The involvement of 5-HT1A receptors in emotional disorders has long been established by the 
fact that activation of 5-HT1A receptors by partial agonists (e.g. buspirone) or indirectly via 
SSRIs is effective in treating anxiety disorders (Freeman-Daniels et al., 2011 and references 
therein). In addition, behavioural deficits of learned helplessness in rats can be rescued by 
activation of 5-HT1A receptors (Mongeau 1997 and references therein). In postmortem brain 
of depressed suicides, reduction in the number or mRNA levels of hippocampal 5-HT1A 
receptors has been reported (Lopez et al., 1998; Cheetham et al., 1990; Graeff et al., 1996; 
Mongeau et al., 1997). Moreover, high levels of glucocorticoids were shown to decrease the 
density of 5-HT1A receptors in the rat hippocampus (Lopez et al., 1998; Mendelson and 
McEwen, 1992).  
In animal studies, 5-HT1A receptor KO mice are known to display increased anxiety-like 
behaviours, specifically in hippocampal-dependent spatial tasks such as contextual fear 
conditioning or the OF test, but not in paradigms that do not recruit the hippocampus, such as 
cued fear conditioning or the Vogel test (Klemenhagen et al., 2006). Other behavioural 
phenotypes include aberrant performances in hippocampus-dependent learning and memory 
tasks as well as antidepressant-like phenotypes in FST and TS test (Freeman-Daniels et al., 
2011 and references therein). Importantly, the regulatory effect of 5-HT1A receptors on 
emotion seems to be of developmental origin and to act via those receptors expressed 
postsynaptically, particularly in the hippocampus. For example, using conditional tissue-
specific rescue strategies, Gross and co-workers (Gross et al., 2002) demonstrated that the 
restoration of 5-HT1A receptors in the hippocampus but not in the raphe nuclei recovered 
normal anxiety-like behaviours of adult mice when the restoration took place during the first 
three weeks of postnatal development (i.e. until P21) rather than in adulthood.  
Several electrophysiological correlates of enhanced anxiety in 5-HT1A receptor KO mice have 
been found in CA1 pyramidal neurons of the hippocampus such as enhanced neuronal 
excitability and increased theta oscillations (Gordon et al., 2005 as in Freeman-Daniels et al., 
2011), decreased paired-pulse inhibition (Sibille et al., 2000 as in Klemenhagen et al., 2006), 
and enhanced evoked-EPSC amplitude (Freeman-Daniels et al., 2011). Moreover, impaired 
hippocampal-dependent learning was shown to be accompanied by impaired paired-pulse 
facilitation in the dentate gyrus (DG) of the hippocampus (Sarnyai et al., 2000). 
As mentioned above (see section 1.2.4.), serotonergic projections to the hippocampus 
originates from the MRN. Direct interaction between dHPC and MRN has been 
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experimentally demonstrated. In the study by Dos Santos and coworkers (2008), the elevated 
T-maze test was used to assess anxiety-related behaviours of rats. In this test, inhibitory 
avoidance response and escape response are seen as a model for generalised anxiety and panic 
disorders, respectively. In their study, anxiogenic effects, i.e. inhibitory avoidance, of direct 
injection of WAY-100635 (WAY), a 5-HT1A receptor antagonist, into the MRN was 
counteracted by pre-injection of WAY into the dHPC, although WAY injection into dHPC 
alone had no effect. On the other hand, direct excitation of serotonergic neurons in the MRN 
by kainic acid facilitated inhibitory avoidance and suppressed escape, both of which were not 
blocked by pre-injection of WAY into the dHPC. The results suggest 5-HT1A receptor-
mediated complex interaction between the dHPC and MRN in the regulation of anxiety and 
panic related behaviours.  
In summary, 5-HT1A receptors are probably one of the most relevant serotonergic receptors 
for depression. For a more comprehensive review on 5-HT1A receptors in human depression, 
refer to Drevets et al., 2007 and Savitz et al., 2009. 
ii). 5-HT3 receptors 
Hippocampal interneurons express 5-HT3 receptors. 5-HT3 is unique in that it is the only 
ligand-gated ion channel receptor as opposed to other 5-HT receptor subtypes, which are 
coupled to G-proteins. When activated, 5-HT3 receptors excite neurons which possess these 
receptors. Using quantitative autoradiography, Mössner et al. (2004) found upregulation of 5-
HT3 receptors in the stratum oriens of the hippocampal CA3 region (+18%) in 5-Htt KO mice 
along with increases in the frontal cortex(+46%) and parietal cortex (+42%). No difference 
was found in the stratum oriens and radiatum of the CA1 region, nor in the stratum radiatum 
of the CA3 region. However, quantitative in situ hybridisation detected significant increases 
in the density of 5-HT3 receptor mRNA in the CA1 region of the hippocampus in 5-Htt Het 
mice (+64.8%) but not in KO mice. Since 5-HT3 receptors exert excitatory effects on the 
GABAergic interneurons in the hippocampus, 5-HT may generate inhibitory postsynaptic 
potentials in the hippocampal pyramidal neurons. Alteration of 5-HT3 receptor expression in 
5-Htt KO mice indicates changes in this inhibitory regulation, which may in turn implicate 
significant influence on the cognitive processing in the hippocampus. Indeed, 5-HT3 receptors 
have been implicated not only in memory formation but also in a number of disorders 
including depression, anxiety and bipolar disorders, schizophrenia, and the development of 
substance dependence (Martin and Humphrey, 1994 as in Mössner et al., 2004; Savitz et al., 
2009 and references therein). Pharmacologically, 5-HT3 antagonists such as ondansetron and 
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tropisetron have been shown to improve learning and memory. As mentioned earlier, 5-HT3 
receptors are located on GABAergic interneurons in the hippocampus and antagonism of 5-
HT3 receptors was shown to decrease firing activity of CA1 interneurons, which consequently 
increased the firing rate of pyramidal neurons (Reznic and Staubli, 1997). Moreover, it was 
demonstrated that inactivation of 5-HT3 receptors increased the frequency of the hippocampal 
theta rhythm and the magnitude and duration of LTP in the CA1 field in freely moving rats 
(Staubli and Xu, 1995). Such 5-HT3 receptor-mediated control of theta rhythm in the 
hippocampus as well as firing activity and LTP of CA1 pyramidal neurons is believed to 
underpin the memory-enhancing effects of 5-HT3 receptor antagonists (Buhot et al., 2000). 
iii). 5-HT7 receptors 
The 5-HT7 receptor is one of the recently characterised 5-HT receptor subtypes. It is a G 
protein-coupled receptor and facilitates cAMP formation by activating adenylyl cyclase 
isoforms through Gs proteins. The hippocampus, along with the thalamus and the frontal 
cortex, is one of the regions where 5-HT7 receptors are highly expressed (Sarkisyan and 
Hedlund, 2009). Accumulating evidence suggests that 5-HT7 receptors play an important role 
in learning and memory, anxiety, depression, obsessive-compulsive disorder, circadian 
rhythm, and REM sleep (Hedlund, 2009; Fox et al., 2008). Of clinical relevance, 5-HT7 
receptors have been proposed as a target for a new class of antidepressant drugs (Bonaventure 
et al., 2007; Sarkisyan et al., 2010; Leopoldo et al., 2011; Mnie-Filali et al., 2011). 
As discussed earlier, the hippocampus plays a crucial role for contextual fear learning. 
Roberts and colleagues (2004) demonstrated that 5-HT7 receptor knockout mice have specific 
deficits in contextual fear conditioning and such deficits are accompanied by reduced LTP 
inducibility in the CA1 region of hippocampal slices. Using the Barnes maze test, it was 
shown that 5-HT7 knockout mice have impairments in allocentric spatial memory, one of the 
hippocampus-dependent spatial memory functions, while striatum-dependent egocentric 
memory was intact (Sarkisyan and Hedlund, 2009). Emerging evidence suggests that 5-HT7 
receptors form heterodimers with 5-HT1A receptors in certain brain regions, including the 
hippocampus and the DRN (Renner et al., 2012). Dimerisation of 5-HT1A receptors with 5-
HT7 receptors reduces coupling of 5-HT1A receptors to GIRK channels. Moreover, 
heterodimerisation facilitates 5-HT-induced internalisation of 5-HT1A-5-HT7 heteromers from 
the cell membrane. Importantly, the expression of 5-HT7 receptors in the hippocampus 
decreases throughout development, whereas 5-HT7 receptor expression is kept at high level in 
the DRN. The resultant dominant form of 5-HT1A homomers in the hippocampus, which is 
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resistant to receptor agonist-mediated internalisation, may explain why 5-HT1A receptors in 5-
Htt KO mice were desensitised only presynaptically in the DRN but not postsynaptically in 
the hippocampus (see section 1.4.2.) (Renner et al., 2012). 
 
1.5.5. Effects of serotonin on learning and synaptic plasticity 
Evidence suggests that depletion of 5-HT enhances learning abilities especially in the domain 
of negative emotionality, such as fear learning. Burghardt and colleagues (Burghardt et al., 
2004; 2007) demonstrated that acute administration of SSRI enhanced the acquisition of fear 
memories in rats, whereas chronic treatment reduced it. Due to the presence of autoinhibitory 
5-HT1A receptors on serotonergic neurons, acute administration of SSRI leads to transient 
reduction of the net 5-HT transmission, while the chronic SSRI treatment elevates the net 5-
HT transmission possibly via adaptive desensitisation of 5-HT1A receptors. In humans, mild 
5-HT depletion can be achieved by an experimental procedure called “acute tryptophan 
depletion (ATD)”, where human subjects are given diets which lead to reduced availability of 
Trp in the brain. Subjects who underwent ATD were shown to exhibit exaggerated aversive 
processing and deficient response inhibition towards previously rewarded but now punished 
behaviours (Cools et al., 2008). In detail, subjects after ATD can predict future punishment 
better than non-ATD subjects. This seems to be achieved by firmly establishing cue-
punishment contingency. On the other hand, when the cue-reward/punishment association is 
swapped, subjects with ATD still responded to cues previously paired with rewards. 
Interestingly similar results are obtained among subjects given acute SSRI administration, 
which is also supposed to reduce 5-HT transmission. These results indicate that 5-HT 
depletion, at least transient depletion, promotes performance of probabilistic learning 
paradigms, presumably by abnormally enhancing the impact of punishment (Cools et al., 
2008). 
Compared to other neurotransmitter systems, effects of 5-HT on synaptic transmission and 
LTP in the neuronal level have much less been explored and remarkably divergent findings 
were reported in earlier studies. The first study which investigated the effect of 5-HT 
depletion reported reduction of LTP in the DG in vivo (Bliss et al., 1983 as in Andersen et al., 
2007). A more recent investigation by Shutoh et al. (2000) demonstrated that 5-HT depletion 
induced by PCPA led to an increase of the GluR2 subunit of the AMPA receptor, which is 
known to inhibit Ca
2+
 influx into the neuron. Since Ca
2+
 plays an important role in LTP 
induction and enhancement of hippocampal LTP in GluR2 null mutant mice had been 
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reported (Shutoh et al., 2000 and references therein), the authors postulated that reduction of 
LTP following 5-HT depletion would have been mediated by the increase of GluR2 subunit. 
The authors also postulated that reduction in LTP was caused by an extensive degree of 
synaptic loss, which was previously reported in another study using the same 5-HT depletion 
method (Chen et al., 1994). On the contrary, Stanton and Sarvey (1985) demonstrated that 
depletion of 5-HT does not affect LTP inducibility either in the DG or CA1 in vitro.  
 
Reduction of LTP inducibility following 5-HT depletion may indicate that 5-HT positively 
modulates and thus facilitates LTP induction. Indeed, activation of certain receptor subtypes 
such as 5-HT4 receptors has been shown to enhance LTP. Application of 5-HT4 receptor 
agonist SC 53116 was shown to attenuate learning impairment induced by antagonism of 
muscarinergic acetylcholine receptors in a passive avoidance test (Matsumoto et al., 2001). As 
a potential mechanism of such 5-HT4 receptor action, SC 53116 was shown to enhance the 
population spike amplitude (PSA) in the hippocampal CA1 area evoked by Schaffer collateral 
stimulation. Moreover, SC 53116 was shown to enhance the tetanus-induced LTP. A 
following study by Matsumoto et al. (2002) found that SSRI, fluvoxamine, increased PSA in 
the CA1 and CA3 fields concentration dependently. Using specific antagonists, it was 
revealed that SSRI fluvoxamine-induced facilitation in the CA1 was mediated by 5-HT1A and 
5-HT4/5-HT7 receptors in an inhibitory and a stimulatory manner, respectively. On the other 
hand, in the CA3 field, both 5-HT1A and 5-HT7 receptors contribute to the facilitatory effects 
of 5-HT on PSA. A whole-cell patch clamp recording by Mlinar and coworkers (2006) 
showed that an excitability increase in CA1 pyramidal neurons induced by 5-HT4 receptor 
activation is attributable to inhibition of a Ba
2+
-sensitive inwardly rectifying K
+
 current. It 
should be noted, however, that in the DG of rats, stimulation of the 5-HT4 receptor was shown 
to inhibit basal synaptic transmission and LTP (Kulla and Manahan-Vaughan, 2002). 
 
Of particular interest is that stimulation of 5-HT receptors outside of the hippocampus 
modulates hippocampal LTP. Abe et al. (2009) demonstrated that injection of 5-HT2C receptor 
agonist MK212 into the BLA facilitated the induction of LTP at the perforant path (pp)-DG 
granule cell synapses in anesthetised rats, whereas injection of 5-HT2 antagonist cinanserin 
into the BLA inhibited the pp-DG LTP. As mentioned earlier (see section 1.5.1.), the 
hippocampus and the amygdala are anatomically connected. It is likely that this connection 
enabled the amygdala to modulate hippocampal LTP. 
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On the other hand, inhibitory effects of 5-HT on LTP have also been reported. Villani and 
Johnston (1993) demonstrated that 5-HT inhibits induction of LTP at 
commissural/associational synapses onto CA3 in vitro. Similarly, specific antagonists for 5-
HT2A receptors (Wang and Arvanov, 1998) and antagonists for 5-HT3 receptors (Staubli and 
Xu, 1995; see also section 1.5.4. ii).) have been shown to enhance LTP in the hippocampus. 
As for the inhibitory effects of 5-HT on LTP, it has been demonstrated that such effects are in 
part mediated by activation of 5-HT1A receptors in the CA1 in vitro (Pugliese et al., 1990; 
Corradetti et al., 1992; Tachibana et al., 2004) and in vivo (Kojima et al., 2003) as well as in 
the DG in vitro (Sakai and Tanaka, 1993). It was shown that such an inhibitory effect of 5-HT 
on LTP in the CA1 and DG is mediated by hyperpolarisation of pyramidal cells via 5-HT1A 
receptors (Sakai and Tanaka, 1993; Kojima et al., 2003; Corradetti et al., 1992; Tachibana et 
al., 2004). Moreover, suppression of LTP in CA1 by increase in spontaneous discharges of 
GABAergic interneurons induced by activation of 5-HT3 receptors (Staubli and Xu, 1995; 
Andersen et al., 2007; Corradetti et al., 1992) has been proposed.  
 
Additional support for the notion that 5-HT prevents LTP derives from the finding that rats 
with serotonergic deafferentation to the hippocampus induced by 5,7-dihydroxytryptamine 
(5,7-DHT) showed enhanced spatial discrimination learning (Altman et al., 1990) and LTP in 
the hippocampus-mPFC pathway in vivo (Ohashi et al., 2003). Contribution of 5-HT to LTP 
becomes even more complicated when different modes of behavioural learning are considered. 
For example, Sanberg et al. (2006) demonstrated that 5-HT1A receptor antagonist (WAY-
100635) blocked pp-DG LTP in freely moving rats when LTP was induced only in novel, but 
not familiar, environments. Since application of a 5-HT1A agonist to the DG reduced somatic 
GABAergic inhibition and serotonergic projections from the MRN terminate on inhibitory 
interneurons in the DG, the authors concluded that 5-HT1A receptors contribute to LTP 
induction via inhibition of GABAergic interneurons. Contribution of 5-HT1A receptor 
stimulation to LTP induction was reported in another study demonstrating that stimulation of 
5-HT1A receptors specifically impairs associative long-term depression (LTD) of the Schaffer 
collateral-CA1 synapse and, as an inference, may facilitate LTP (Normann et al., 2000). 
 
The serotonergic system is one of the most relevant targets of psychoactive drugs. 
Considering the above-mentioned effects that 5-HT exerts on synaptic plasticity, it is 
reasonable to assume that psychoactive drugs affect synaptic plasticity. MDMA leads to 
release of monoamine transmitters including 5-HT, NE and DA and transporters such as 5-
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HTT and NET mediate the psychoactive effects of MDMA. Moreover, repeated 
administration of MDMA is known to induce serotonergic deficits, memory impairment, as 
well as increased anxiety. Recent studies, however, demonstrated that both acute (Rozas et al., 
2012) and repeated (Morini et al., 2011) administration of MDMA enhances LTP in the CA1 
area of rat brain slices, implying that MDMA-induced memory deficits are not associated 
with LTP impairment in the hippocampus. Rozas and associates (2012) further demonstrated 
that such LTP-enhancing effects of MDMA are mediated by presynaptic 5-HT2 receptors and 
postsynaptic D1/D5 dopaminergic receptors. Moreover, Mlinar et al. (2008) showed that 
MDMA induces potentiation of excitatory postsynaptic potential (EPSP)-spikes and its effects 
are prevented by blockade of both 5-HTT and NET. Simultaneous direct stimulation of both 
5-HT4 and adrenergic β1 receptors, on the other hand, mimicked MDMA-induced EPSP-spike 
potentiation, indicating crucial roles for these receptors in MDMA-mediated alterations in 
neuronal excitability and synaptic plasticity. 
 
Taken together, multiple lines of evidence indicate that 5-HT modulates LTP inducibility and 
synaptic transmission in the hippocampus. Its effects are, however, exceedingly complicated 
with both facilitatory or inhibitory mechanisms of action. It is rather likely that the net effects 
of 5-HT on synaptic plasticity depend on availability of certain receptor subtypes, which are 
subject to the subregion in the hippocampus, and on behavioural learning paradigms in 
question. Since hippocampal synaptic plasticity is highly relevant to emotions, serotonergic 
modulation of synaptic plasticity presented here may indicate that 5-HT controls emotions 
through changing synaptic plasticity of the hippocampus. 
 
1.6. Tryptophan-hydroxylase 2 (Tph2) and Tph2 KO mice 
1.6.1. Discovery of two isoforms of Tph and generation of Tph2 KO mice 
The second isoform of Tph, designated as Tph2, has been identified based on the fact that 
Tph1 KO mice, while having no 5-HT in the periphery, possessed normal levels of 5-HT in 
brain (Walther et al., 2003; Côté et al., 2003). Tph2 is predominantly expressed in the 
brainstem and additionally in neurons of the myenteric plexus, whereas Tph1 is expressed in 
the peripheral tissues (e.g. enterochromaffin cells of the  gastrointestinal tract, spleen, thymus) 
as well as in the pineal gland (Walther and Bader, 2003; Côté et al., 2003). Although 
subsequent studies have generated substantial controversies regarding the distribution of Tph1 
and Tph2 isoforms (reviewed in Waider et al., 2011), generation of Tph2 KO mice has 
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facilitated understanding of the differential distribution of the two isoforms (Gutknecht et al., 
2008; Savelieva et al., 2008; Alenina et al., 2009). In detail, it has been demonstrated that in 
Tph2 KO mice, Tph2 immunoreactivity and 5-HT are completely absent in the brain implying 
that Tph2 is the only isoform expressed in the brain. Surprisingly, these mice maintain 
apparently normal serotonergic-like neurons in their DRN. Their neurons have all the 
serotonergic neuron-specific markers; 5-Htt, transcription factor Pet1, vesicular monoamine 
transporter-2 (Vmat2) and 5-HT receptors (Gutknecht et al., 2008, 2009; Kriegebaum et al., 
2010). Recordings from brain slices showed that raphe neurons from Tph2 KO mice retain 
electrophysiological properties typical of normal serotonergic neurons, i.e. slow and regular 
firing rate, broad action potential width (Gutknecht et al., 2012). Moreover, using 5-HT1A 
receptor-mediated autoinhibition of serotonergic neuron firing as a functional assay, it was 
confirmed that serotonergic neurons in Tph2 KO mice are able to produce 5-HT from 5-HTP 
but not from tryptophan (Gutknecht et al., 2012). Upregulation of 5-HT1A and 5-HT1B 
receptors as well as reduction in NE concentrations and accompanying reduction in the 
noradrenergic cell number in the LC were also detected, presumably as an adaptive change in 
response to the absence of endogenous 5-HT (Gutknecht et al., 2012). Although not 
serotonergic neuron-specific, levels of MAO-A and neuronal nitric oxidase (nNOS) were also 
measured (Angoa-Perez et al., 2012). Tph2 KO mice had normal levels of these enzymes 
except in the frontal cortex where slight but significant reduction was observed in Tph2 KO 
mice. 
 
1.6.2. Characteristics of Tph2 KO mice 
Tph2 KO mice exhibit numerous physiological and behavioural alterations (reviewed in 
Waider et al., 2011; Lesch et al., 2012). Prominently, they show increased mortality rates and 
are delayed in the development and during the first two months of postnatal days as reflected 
by a reduced body weight and size (Alenina et al., 2009; Gutknecht et al., 2012; Savelieva et 
al., 2008). Correspondingly, Tph2 KO mice were shown to have lower bone mass, significant 
decrease in appetite, and increase in energy expenditure at early stages of development 
(Yadav et al., 2009). On the other hand, age-dependent and sex-specific overweight was 
observed in female Tph2 KO mice (Gutknecht et al., 2012). Moreover, deficiency of Tph2 
leads to dysregulation of several physiological and autonomic parameters. While the body 
temperature of Tph2 KO at the baseline condition was not different from wildtype controls, 
they showed significant drop in the body temperature when exposed to a cold environment 
(4°C), suggesting deficits in thermoregulation. In addition, the respiration rate of Tph2 KO 
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mice was significantly reduced, although the circadian variations were normal. Finally, Tph2 
KO mice showed extended daytime sleep and a decrease in blood pressure and heart rate 
during night time (Alenina et al., 2009). 
 
Behaviourally, Tph2 KO males display more aggression (Angoa-Perez et al., 2012; Mosienko 
et al., 2012; Gutknecht et al., submitted). In a modified resident-intruder test, where a resident 
mouse was singly caged only shortly before the introduction of a group-caged intruder, even 
female KO mice and weanlings (3-4 weeks old) of both sexes showed elevated aggressive 
behaviours compared to controls (Angoa-Perez et al., 2012). Moreover, female Tph2 null 
mutant mice show impaired maternal care, which may lead to poor survival of their pups 
(Alenina et al., 2009). Further, Tph2 KO mice exhibit increased obsessive-compulsive-like 
traits, reflected as frequent burying of marbles (Savelieva et al., 2008; Angoa-Perez et al., 
2012). In the OF test, they did not differ from wildtype counterparts in terms of total 
locomotor activity or exploratory behaviours but spent less time in the central field, indicating 
elevated anxiety-like traits (Savelieva et al., 2008). On the other hand, in the light-dark box 
test, Tph2 KO mice showed less anxiety-like behaviours, while they are no different from 
controls in the EPM test (Angoa-Perez et al., 2012). Other phenotypes such as acoustic startle 
response and sensorimotor gating, motor coordination, learning and memory, and tonic 
inflammatory pain sensitivity did not differ between KO and wildtype as assessed by pre-
pulse inhibition, inverted screen, cued fear conditioning, and formalin paws tests, respectively 
(Savelieva et al., 2008). Recently, it was discovered that Tph2 KO male mice lose sexual 
preference to females over males, and such a phenotype was restored by application of 5-HTP, 
an immediate precursor of 5-HT (Liu et al., 2011). Another defining behavioural feature of 
Tph2 KO mice observed is enhanced fear acquisition and retention in Pavlovian fear 
conditioning (Gutknecht et al., submitted). After pairing an auditory tone (conditional 
stimulus, CS) with an electric footshock (unconditional stimulus, US), mice establish 
association between the tone and the aversive footshock (cued fear conditioning) or between 
the footshok and the context where the footshock was given (contextual fear conditioning). 
Both in fear conditioning and fear memory retention tests, Tph2 KO mice exhibited prolonged 
freezing time in response to both cue and context stimuli and shorter latencies to freezing 
when placed in the conditioning context. Enhanced fear learning and retention of Tph2 KO 
mice were even more pronounced when mice underwent chronic mild stress (CMS) prior to 
fear conditioning (Gutknecht et al., submitted).  
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Finally, evidence suggests that GABAergic interneurons play an important role for disorders 
of emotion regulation (Goren et al., 2007; Tunnicliff et al., 1999; Tunnicliff and Malatynska, 
2003; Ehrlich et al., 2009). A recent study revealed that GABA concentrations were 
significantly increased in the hippocampus of Tph2 KO mice and in the amygdala of Tph2 
Het mice, while GABA concentrations were significantly decreased in the PFC of Tph2 Het 
mice (Waider et al., 2012). On the other hand, the number of GABAergic neurons in the 
anterior BLA was significantly decreased in Tph2 KO mice. The results indicate that neuronal 
5-HT is involved in the development and maintenance of the GABAergic system. Given the 
importance of the GABAergic system in emotional regulation, disruption of serotonergic 
transmission may have contributed to the altered emotional behaviours of Tph2 KO mice by 
acting on the GABAergic system. 
 
1.6.3. Association of TPH2 with neuropsychiatric disorders 
Analysis of SNPs in the upstream regulatory region of TPH2 revealed significant genotype 
frequency differences between the control and the patient group comprising either cluster B 
(dramatic-emotional, i.e. borderline, antisocial, narcissistic, and histrionic) or cluster C 
(anxious-fearful, i.e. obsessive-compulsive, avoidant, and dependent) according to the DSM-
IV criteria (Gutknecht et al., 2007). In both patient groups, overrepresentation of the T-allele 
in the SNP (G703T, rs4570625) was observed. Furthermore, in the control group, significant 
effect of TPH2 variation on anxiety-related personality traits (defined by Tridimensional 
Personality Questionnaire (TPQ) Harm Avoidance) was found. Importantly, the SNP was 
previously shown to be associated with attention-deficit/hyperactivity disorder (ADHD) 
(Walitza et al., 2005; Canli et al., 2005) and bias responsiveness of the amygdala (Brown et 
al., 2005; Canli et al., 2005; see below). Taken together, these studies link a TPH2 functional 
polymorphism with anxiety-related personal trait as well as neuropsychiatric symptoms, both 
reflected in the activity of the neuronal system involved.  
 
Functional MRI study provided the first in vivo evidence that the functional variant rs4570625 
of TPH2 modulates amygdala activity. T-allele carriers had greater amygdala activity in 
response to fearful or angry faces (Brown et al., 2005) as well as sad and happy faces (Canli 
et al., 2005). Taken together, Canli and colleagues (2005) concluded that this genetic variance 
affects the responsiveness of amygdala to emotionally relevant stimuli, both with positive and 
negative valence. The additive effects of both TPH2 and 5-HTT variation have been 
demonstrated using event related potentials (ERP) focusing early posterior negativity (EPN). 
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Herrmann et al. (2007) found that when the subjects carry both the short variant of 5-HTT and 
T-variant of TPH2, they show the highest neuronal activity to emotional stimuli. 
Subsequently, the finding was replicated in fMRI study (Canli et al., 2008) revealing the 
putamen as the most robust site where the gene-by-gene interaction takes place, as well as the 
amygdala, at a less stringent threshold. The additive effects were more robust for visuospatial 
stimuli than for verbal, and more robust for negatively than positively valenced stimuli. 
 
ADHD, manifested as deficient response inhibition and failing emotion regulation, has been 
hypothesised to be linked to reduced PFC function. Baehne and colleagues investigated the 
influence of TPH2 functional variants, which have previously been shown to be linked to 
ADHD (rs4570625 and rs11178997), on the PFC function in the Go-NoGo task (Baehne et al., 
2009). It was found that carriers of risk alleles had reduced NoGo-anteriorisation (NGA) in 
the ERP, indicative of lower prefrontal function, both in the healthy and ADHD cohort. As 
expected, carriers in the ADHD group had an even smaller mean NGA value than those in the 
healthy group.  
 
Moreover, an elevated level of TPH2 was detected in the raphe nuclei of the postmortem 
brains of depressed individuals who committed suicides (Bach-Mizrachi et al., 2006, 2008; 
Evans et al., 2008). This is interpreted as a regulatory response to counteract deficient 5-HT 
levels in the brains of depressed individuals. It has also been shown that allelic variation of 
TPH2 function can be a genetic predictor of depression, suicide risk among depressed patients, 
and antidepressant treatment response (Evans et al., 2008 and references therein). In sum, 
multiple lines of evidence implicate TPH2 variation in the anxious and fearful personality 
traits as well as in a wide spectrum of disorders characterised by emotion dysregulation 
ranging from depression, anxiety and obsessive-compulsive disorders, to ADHD. 
 
1.7. Aims of the study 
The primary aim of the present study is to understand how deferent levels of brain 5-HT, 
which is induced by genetic deletion of major mediators of 5-HT neurotransmission, alter 
neurophysiological properties of the serotonergic neurons and their projection areas. 
Moreover, since 5-HT has been implicated in emotional regulation and indeed mice used in 
this study, i.e. 5-Htt KO mice and Tph2 KO mice, have been shown to exhibit anxiety-like 
and depression-like behaviours, the present study aims to infer functional relevance of 
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potential neurophysiological changes. In sum, the aim of the present study can be summarised 
as follows: 
 
- Investigate homeostatic regulatory mechanisms of serotonergic neuronal activity in the 
DRN in the continuum of deferent levels of extracellular 5-HT (Study 1) 
  To this end, the loose-seal cell-attached recording configuration was used to monitor firing 
of serotonergic neurons for a long duration with minimum perturbation to the recorded 
neuron. Firing of serotonergic neurons reflects release of 5-HT and is under homeostatic 
regulation, which is influenced by synthesis of 5-HT and sensitivity of autoinhibitory 5-
HT1A receptors. For this reason, functionality of autoinhibition was assessed by artificially 
inducing 5-HT synthesis in vitro as well as directly applying a 5-HT1A receptor agonist. 
 
- Detect potential neurophysiological changes in brain regions involved in emotion 
regulation (Study 2, Study 3) 
  For this purpose, the whole-cell recording configuration was applied in order to detect 
potential subtle electrophysiological alterations in a single neuron level. Here detailed 
analyses of basic membrane properties and action potential shapes were conducted on 
serotonergic neurons in the DRN of Tph2 KO mice and on CA1 pyramidal neurons in the 
hippocampus of 5-Htt KO mice. 
 
- Link electrophysiological alterations with functional consequences (Study 4) 
For this aim, potential functional alterations which may have derived from changes in 5-HT 
levels were investigated in one of the postsynaptic target areas of the central serotonergic 
system, the hippocampus. The hippocampus plays a crucial role in learning and memory and 
it has been maintained that LTP of synaptic transmission in the hippocampus is the neuronal 
correlate of learning and memory. Moreover, alteration of synaptic plasticity has been 
implicated in depression. In particular, it has been proposed that the ventral hippocampus is 
involved in the context of anxiety and fear learning (see section 1.5.1.). Given this, 
extracellular field potential recording was conducted to study magnitude of LTP in the CA1 
area of the ventral hippocampus in response to the Schaffer collateral/commissural pathway 
stimulation. It is assumed that LTP inducibility could have been modified by the lack or 
excess level of extracellular 5-HT in Tph2 KO and 5-Htt KO mice, respectively.  
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2 . Materials and Methods 
2.1. Animal handling and strains 
Procedures for animal handling followed the European Community guidelines for animal care 
(DL 116/92, application of the European Communities Council Directive 86/609/EEC) and 
approved by the local committees. The generation of Tph2 KO animals was described 
previously (Gutknecht et al., 2008). Their genetic background is composed theoretically of 
97% C57BL/6N and 3% Sv129/Ola. The 5-Htt KO mice line (Bengel et al., 1998) was 
backcrossed to a C57BL/6J background for more than ten generations. Animals were housed 
under a 12 h light and a 12 h dark cycle (lights: from 08:00 to 20:00 h) at ambient temperature 
of 22±1 °C and the relative humidity of 40–50% 
2.2. Genotyping of mice 
The following genotyping protocol was used in the laboratory of Prof Corradetti and is a 
modified version of the original developed in the laboratory of Prof Lesch. Since reagents 
used in the two laboratories were not the same, it was necessary to modify the original 
protocol. The protocol described below is the one which worked the best in Prof Corradetti’s 
laboratory. 
2.2.1. Tail digestion and DNA purification 
A Tip of mouse tail (c.a. 3 mm) was cut and put into an autoclaved 1.5 ml microcentrifuge 
tube. Tubes were kept in ice until starting digestion. Mixture of lysis buffer (LB buffer, Table 
1; 500 µl per sample) and proteinase K (lyophilised, Novagen: 70663, 20 mg/ml; 5 µl per 
sample) were premade in a 50 ml falcon tube for all the samples and dispensed 500 µl each 
into microcentrifuge tubes. Tubes were then placed in a hot water bath (55 °C) for overnight 
(c.a. 16-17 hours). Ideally, tubes should be under constant shaking during this procedure to 
facilitate tissue digestion. On the second day, the tubes were removed from the heat and 
vortexed shortly (~ 2 seconds). A second set of clean microcentrifuge tubes were labelled and 
provided with 540 µl of isopropanol (2-propanol) and cooled down in an ice bath. When this 
was done, the samples were centrifuged at the maximum speed (14,000 – 15,000 rpm) for 5 
mins (room temperature is fine). By inclining the tubes containing lysed probes, the 
supernatant was transferred directly to the tubes with isopropanol. Each tube was mixed 
gently by inversion till a white glob of DNA precipitate became visible. The probes were 
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centrifuged again at the maximum speed for 10 mins (4°C). The supernatant was poured off 
and the liquid was removed as much as possible by patting the tubes onto paper towels several 
times. At this stage, the DNA pellet should be stuck to the bottom of the tubes. 
500 µl of 70 % EtOH (precooled in a fridge at 4°C) was then added to each probe. 
Subsequently, the probes were centrifuged at the maximum speed for 20 mins. EtOH was 
discarded and removed as much as possible by patting the tubes onto paper towels several 
times. EtOH was completely removed by 3-4 hours of air drying and 50 µl of TE buffer 
(Table 2) was added to each probe. DNA was resuspended by constant shaking at 4 °C for at 
least overnight.  
Table 1. LB buffer (final concentration)  
 3.33 ml  1.5M Tris, pH 8.5 (100 mM) 
 0.5 ml  0.5 M EDTA (Na2EDTA x 2H2O, Sigma), pH 8.0 (5 mM) 
 1 ml 10 % SDS (0.2 %) 
 2 ml 5 M NaCl (200 mM) 
 measure up to 50 ml with deionised water 
 
 
Table 2. TE buffer (final concentration) 
 1 ml    1M Tris, pH 8.0 (10 mM) 
 20 μl   0.5M EDTA, pH 8.0 (0.1 mM) 
 measure up to 100 ml with distilled water 
 Autoclave the whole solution 
 
2.2.2. PCR 
i). 5-htt 
Composition of PCR mixture (for 1 sample) for 5-htt is as follows (µl): 0.76 Primer 1 (5htt-
wt-F: 6.67 µM stock); 0.76 Primer 2 (5htt-wt-R: 6.67 µM stock); 0.76 Primer 3 (5htt-mut-F: 
6.67 µM stock); 0.76 Primer 4 (5htt-mut-R: 6.67 µM stock); 1.0 dNTP mix (2.5 mM stock); 
2.5 Goldstar PCR buffer 10x; 1.5 MgCl2 (25 mM stock); 1.0 Taq DNA polymerase (native 
without BSA, Fermentas: EP0282, 5u/µl); 10.96 H2O. 5 µl of DNA suspension was taken 
from each probe. Primer sequences and the PCR program for 5-htt genotyping are shown 
below: 
Primer 1: 5htt-wt-F: 5’- AAG ATG GAT TTC CTC CTG TC-3’ 
Primer 2: 5htt-wt-R: 5’- TTT AGG CTC ACG TCA GCT AC-3’ 
Primer 3: 5htt-mut-F: 5’- CTT CTA TCG CCT TCT TGA CG-3’ 
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Primer 4: 5htt-mut-R: 5’- GAC TGG AGT ACA GGC TAG C-3’ 
 
 Cycle 1: (x1)   step 1: 95°C for 5 min 
 Cycle 2: (x35) step 1: 95°C for 1 min 
step 2: 55°C for 1 min 
step 3: 72°C for 1 min 
 Cycle 3: (x1)  step 1: 72°C for 8 min 
step 2: 30°C for 10 min 
end: 10 °C       ∞ 
 
 
ii). Tph2 
Composition of PCR mixture (for 1 sample) for Tph2 is as follows (µl): 1.0 Primer 1 (3’Del 
mTph2 F: 10 pmol/µl); 1.0 Primer 2 (5’arm over const. Tph2 F: 10 pmol/µl); 1.0 Primer 3 
(3’over constr. Tph2 R: 10 pmol/µl); 1.0 dNTP mix (2.5 mM stock); 2.5 Goldstar PCR buffer 
10x; 1.5 MgCl2 (25 mM stock); 1.0 Taq DNA polymerase (5u/µl); 11 H2O. 5 µl of DNA 
suspension was taken from each probe. Primer sequences and the PCR program for Tph2 
genotyping are shown below: 
Primer 1: 3’Del mTph2 F: 5’- TGG GGC ATC TCA GGA CGT AGT AGT -3’  
Primer 2: 5’arm over const. Tph2 F: 5’- CAC CCC ACC TTG CAG AAA TGT TTA -3’ 
Primer 3: 3’over constr. Tph2 R: 5’- TGG GGC CTG CCG ATA GTA ACA C -3’ 
 
 Cycle 1: (x1)   step 1: 95°C for 5 min 
 Cycle 2: (x38) step 1: 95 °C for 40 sec 
step 2: 64 °C for 40 sec 
step 3: 72 °C for 50 sec 
 Cycle 3: (x1)  step 1: 72 °C for 5 min 
step 2: 4 °C for 5 min 
end: 10 °C       ∞ 
 
In order to prevent unspecific amplification of DNA fragments, PCR cycles were commenced 
as soon as possible after adding DNA to PCR mixtures and PCR probes were set into a PCR 
cycler only after the cycler was heated up above ~70 °C. 
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2.2.3. Electrophoresis 
5 µl of BBF dye (6x DNA loading dye) was added to each PCR product and about 15 µl of 
BBF/PCR product mixture was loaded into a well on 2% agarose gel (in TBE buffer, see 
Table 3 and 4) with etidium bromide. As a reference, 10 µl of 90-908 base pair (bp) size 
marker (pBR322 DNA/AluI Marker, 20, ready-to-use; Fermentas) was also loaded into a well. 
Electrophoresis was conducted at 110V for 1 hour and visualised under a UV transilluminator. 
Expected bp sizes for each genotypes are as follows: 
5-htt:  WT  220 bp, KO  550 bp 
Tph2:  WT  437 bp, KO  387 bp 
When there are two bands, it means that the sample has a Het genotype. 
 
Table 3. TBE 5X (final concentration) 
 54 g    Tris Base (MW 121.14; 445 mM) 
 27.g    Boric acid (MW 61.83; 445 mM) 
 20 ml  0.5 M EDTA, pH 8.0 (10 mM) 
 Add distilled water till 1000 ml 
 Filter and autoclave the solution. 
 Dilute this stock 1:10 to obtain TBE 0.5X 
 
Table 4. 2 % agarose gel 
 2 g agarose (Sigma, A5093) in 100 ml TBE 0.5 X 
 Warm up to 100-150 °C under continuous stirring until the solution becomes clear 
 Add 5 μl ethidium bromide (Sigma, E1510) and pure into the form. Cool down till the gel 
becomes solid. 
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2.3. Loose-seal cell-attached recording 
2.3.1. Rationale 
Cell-attached recording is suited for recording the activity of (or stimulating) neurons in brain 
slices without perturbing the cell membrane (for review see Perkins, 2006). As with the 
whole-cell recording configuration, there are two modes of recording, i.e. voltage-clamp and 
current-clamp recording. Voltage-clamp mode is particularly suited for monitoring firing 
activity of neurons, whereas current-clamp mode is suitable for measuring resting membrane 
potentials and synaptic potentials. By adjusting the magnitude of seal resistance, i.e. 
resistance between the glass pipette tip and the cell membrane, two different types of 
experiments are possible: loose-seal voltage-clamp recording enables monitoring of firing 
activities of neurons by measuring current flow induced by action potentials; tight-seal 
current-clamp recording provides a way to evoke action potentials in the attached cell and to 
measure resting membrane and synaptic potentials. Since the aim of the present study is to 
monitor firing activities of neurons, loose-seal cell-attached recording in the voltage-clamp 
mode was used for the above-mentioned reason. 
2.3.2. Preparation of dorsal raphe slices 
Slice preparation procedures followed those described in Gutknecht et al., 2012. Female mice 
were not checked for their estrus cycle because previous studies showed that regulation of 
DRN firing through 5-HT1A receptors does not change due to the cycle (Bouali et al., 2003 as 
in Loucif et al., 2006). Mice (28 to 80 days old) were anaesthetised with isofluorane and 
decapitated. The whole head was immediately immersed in ice-cold artificial cerebrospinal 
fluid (ACSF) comprising the following (mM): 124 NaCl; 2.75 KCl; 1.25 NaH2PO4; 26 
NaHCO3; 1.3 MgCl2; 2 CaCl2; 11 D-Glucose. The ACSF was continuously bubbled with a 
gas composed of 95% O2 and 5% CO2 (pH 7.4). Then the brain was rapidly isolated and 
placed in a Petri dish for dissection, completely submerged by oxygenated, ice-cold, ACSF. 
About one third of the rostral brain and the cerebellum were cut off to leave the block of brain 
containing the raphe nucleus. The caudal edge of this brain block was glued onto the metal 
plate of the vibratome (DSK-1000, Dosaka Co. Ltd, Kyoto, Japan), whose chamber was filled 
with ice-cold ACSF, bubbled with a gas mixture. Brainstem slices with 200 µm thickness 
(typically F66-72 of Mouse Brain Atlas by Paxinos and Franklin, 2001) were made with the 
vibratome and transferred to a multi-well incubation chamber filled with bubbled ACSF, 
which was preheated at 33 ℃ and left at a room temperature after slice transfer.  
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2.3.3. Electrophysiological recording 
Recording procedures followed those described in Gutknecht et al., 2012. After at least 1.5 h 
of recovery time, a single slice was transferred to the recording chamber and perfused with 
ACSF, bubbled and warmed up (34-35 ℃), at the rate of 2 ml/min. ACSF was supplemented 
with a mixture of neurotransmitter blockers to isolate a single neuron from the influence of 
surrounding neurons. The composition of neurotransmitter blockers are as follows (μM): 10 
DNQX; 20 D-APV; 10 strychnine; 1 CGP-55845 (in DMSO); 10 SR-95531. In a living 
mouse, spontaneous firing of serotonergic neurons is mediated by noradrenergic input (Levine 
and Jacobs, 1992). To mimic this noradrenergic input, α1 adrenoceptor agonist phenylephrine 
(10 µM) was added to facilitate firing of serotonergic neurons.  
Neurons were visualised by infrared differential interference contrast video microscopy with a 
Newicon C2400-07 camera (Hamamatsu, Hamamatsu City, Japan) mounted to an Axioskop 
microscope (Zeiss, Göttingen, Germany). Electrophysiological recordings were made with 
PatchMaster software on an EPC10 patch clamp amplifier (HEKA, Lamberecht, Germany). 
Patch pipettes were pulled from thick-walled borosilicate glass capillaries with a P-97 Brown-
Flaming electrode puller (Sutter Instruments, Novato, CA, USA). The pipette had a resistance 
of 2-6 MΩ when filled with a HEPES-based ACSF-like solution (filtered by 0.2 µm pore 
filter) containing (mM): 125 NaCl, 10 HEPES, 2.75 KCl, 2 CaCl2, 1.3 MgCl2 (pH 7.4 with 
NaOH). The pipette was placed in an electrode holder containing a Cl-coated silver wire 
mounted on the headstage of the EPC10 amplifier. Slight positive pressure was given to the 
recoding pipette and lowered onto the surface of a neuron under the visual guidance using a 
motorised micromanipulator (Luigs and Neuman, Ratingen, Germany). Loose-seal (5-20 MΩ 
resistance) between the pipette and the cell surface was formed when the positive pressured 
was released and gentle negative pressure was applied to the pipette. Since the experiments 
depend largely on the synthesis of endogenous 5-HT, neurons located at least 50 µm below 
the surface of the slice were targeted.  
Recordings were made in a voltage-clamp mode with pipette potential maintained at 0 mV. 
Signals were digitised at 10 kHz and filtered at 3 kHz. For action current shape measurement, 
signals were acquired at 100 kHz and filtered at 8 kHz. Recordings were aborted if firing rate 
was sensitive to changes in pipette holding potential or if shape of action current changed. 
Acquired data were analysed using Clampfit 9.2 (Molecular Devices, Foster City, CA, USA) 
and GraphPad Prism version 5.04 (GraphPad Software, San Diego, CA, USA). One 
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experiment was done per one slice to avoid aftereffect of any chemical application from the 
previous experiment. 
2.3.4. Drugs 
SR-95531 (= gabazine; GABAA antagonist >98%), D-AP5 (NMDA glutamate site antagonist 
>99%), DNQX (AMPA / kainate antagonist >99%) were purchased from Ascent Scientific 
Ltd. (Bristol, UK). CGP-55845 hydrochloride (selective GABAB antagonist) and R-8-
hydroxy-2-(di-n-propylamino)tetralin (R-8-OH-DPAT; abbreviated as R8HD) were 
purchased from Tocris Bioscience (Bristol, UK). Strychnine (glycine and acetylcholine 
antagonist) and L-Phenylephrine-HCl were obtained from Sigma-Aldrich S.r.l. (Milan, Italy). 
2.3.5. Identification of serotonergic neurons 
i). Morphological & histological criteria 
Serotonergic neurons have large cell bodies (15 – 35 µm) and have various forms; fusiform, 
triangular or multipolar (Li et al., 2001), while non-serotonergic neurons have relatively small 
cell bodies (~ 10 µm) (Liu et al., 2002), typically with a bipolar shape. Immunohistochemical 
study demonstrated that most serotonergic neurons are located along the midline of the DRN, 
whereas non-serotonergic neurons (such as GABAergic neurons) are distributed lateral to the 
midline and rather scattered (Brown et al., 2008; Day et al., 2004). In the rostral DRN, 
catecholaminergic neurons are also expressed along the midline but to a much lesser extent 
than serotonergic neurons (Day et al., 2004). Thus, it can reasonably be said that neurons with 
large soma located along the midline of DRN are highly likely to be serotonergic neurons.  
ii). Electrophysiological criteria 
Neurons were identified according to electrophysiological criteria (Vandermaelen and 
Aghajanian, 1983; Allers and Sharp, 2003). Neurons were classified as serotonergic if: 1) 
neurons displayed, during at least 5 min-long control period at the beginning of the recording, 
slow and steady firing rate of 1 to 4 Hz with coefficient of variation (COV) less than 15%; 2) 
the shape of action current had an asymmetric shape (ratio of upstroke to downstroke > 3.5) 
(Brown et al., 2002) with long Up-to-Downstroke Interval (UDI. see Fig. 2.1; >0.85 ms. 
Mathematically, this corresponds to action potential half-height width (HHW) measured in 
the whole-cell configuration. See (Bean, 2007)). Typically, serotonergic neurons have clear 
two downstrokes and UDIs are measured based on the second downstroke (referred to as 
UD2I). Whenever possible, a 5-HT1A receptor agonist R8HD (30 nM) was applied at the end 
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of experiment to see the cessation of firing to confirm that the recorded neuron was 
serotonergic.  
40 pA
3 ms
UDI
 
2.3.6. Quality control 
i). Amount of inter-spike current (ISC) 
In ideal loose-seal cell-attached configuration, the membrane of recorded neuron remains 
intact, reflected as minimal ISC (Fig. 2.2.A). Occasionally, as the time lapses during 
recording, ISC increases. In the present study, only recordings showing stable ISC or minimal 
changes were accepted, with an end amplitude of ISC below ~10 pA. Recordings showing 
greater ISC amplitude were discarded because an increase in ISC indicates possible 
deterioration of cell membrane under the recording, which may influence the firing rate of the 
recorded neuron. Fig. 2.2.B shows a non-ideal situation where the amplitude of ISC exceeds 
an acceptable range. The large ISC and thus damaged cell membrane results in unstable 
monitoring of cell firing rate, as shown in Fig. 2.3. 
 
 
 
Fig. 2.1. Illustration of Up-to-Downstroke Interval (UDI) 
of action current measured in loose-seal cell-attached 
recording. Serotonergic neurons typically have clear two 
downstokes and thus UDIs are often expressed as UD2I. 
Fig. 2.2. Ideal and non-ideal recording 
configuration judged by the amplitude 
of inter-spike current (ISC). A) Ideal 
recording configuration with minimum 
ISC. ISC increased at a later stage of 
recording (Wash) but still in an 
acceptable range. B) Non-ideal 
configuration where ISC is notably 
large from the beginning of recording. 
Note that ISC became larger during 
the recording (5-HTP 1 μM, 5-HTP 3 
μM) and later recovered to the control 
level (5-HTP 10 μM). Ctrl: control. 
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ii). Action current shape should remain the same 
As loose-seal cell-attached recording monitors firing rate from a neuron with intact cell 
membrane, the action current shape observed should keep the same shape throughout the 
experiment. Fig. 2.4.A shows a case where the action current shape changed significantly. 
The change in action current shape indicates that the integrity of cell membrane is not 
maintained and therefore the firing rate measured might have been affected by experimental 
manipulation. As shown in Fig. 2.4.B, loss of the membrane integrity results in unstable firing, 
especially evident in the control period (i.e. before tryptophan application) in this case.   
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Fig. 2.4. Change in action current shape. A) Average action current shapes from each experimental 
procedure. Unless otherwise stated, traces were obtained by averaging traces in the last 3 mins of 
each experimental epoch (Trp 30 μM, 100 μM application etc.). B) Time course of firing rate change 
recorded from the same neuron as A. Trp: tryptophan. Ctrl: control. R8HD: R-8-OH-DPAT. 
A A B 
Fig. 2.3. Time course of firing rate 
change from the same neurons as in Fig. 
2.2.B. Firing rate fluctuates substantially, 
which hinders stable measurement of 
firing rate. Note also that there is no 
recovery of firing after 20 mins of 
washing-out of 5-HTP.  
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iii). Action current amplitude should be monitored to avoid false positive effects of drugs 
In the present study, drugs applied all work on 5-HT1A receptors either directly (R8HD) or 
indirectly (Trp, 5-HTP). Stimulation of 5-HT1A receptors reduces/stops firing of a neuron by 
its hyperpolarising effect. Thus, decrease/cessation of firing should not be concomitant with 
decrease in action current amplitude (Fig. 2.5). In fact, due to its hyperpolarising effect, the 
action current of a recorded neuron tends to increase (Fig. 2.6). In the case of Fig. 2.5, firing 
frequency also accelerated despite the presence of increasing concentrations of R8HD, 
indicating that the healthiness of the recorded neuron started to deteriorate. When the decrease 
in firing rate is concomitant with decrease in action current, it is often the case that firing does 
not recover even after a long-duration washout of 5-HT1A receptor agonists (Fig. 2.5). 
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Fig. 2.5. Ceasing of firing was 
accompanied by decrease in action 
current amplitude. At around 41minutes 
of recording, firing frequency started to 
decrease, accompanied by gradual 
decrease in action current amplitude. 
Cessation of firing therefore is therefore 
likely to be due to the deterioration of 
cell healthiness. Note that firing did not 
recover even after 20 minutes of 
washout. 
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iv). Ihold should be monitored to prevent pipette current from affecting firing frequency 
For recording spontaneous firing activities of neurons in the voltage-clamp mode of the loose-
seal cell-attached recording configuration, the command potential should be adjusted so that 
no current flows through the recording pipette. This is because the current flowing through the 
pipette can change the membrane potential of the neuron being recorded and thus may affect 
the firing rate of the neuron. As a default, the command potential is set at 0 mV so that no 
current flows through the pipette. To assure that no current was actually flowing, the baseline 
current (Ihold) was continuously monitored (Fig. 2.7). In case the Ihold substantially deviated 
from 0 pA as a result of changes in the recording status, e.g. contact between the pipette and 
the cell membrane, healthiness of the neuron etc., the offset voltage of the voltage-clamp was 
adjusted so that no current flew. This was achieved by interrupting the recording for a few 
seconds and utilising the auto-offset function of the recording software (PatchMaster, HEKA). 
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Fig. 2.6. Hyperpolarising effects of 5-HT1A 
receptor agonist can be manifested as 
increase in action current amplitude. At 
around 51 minutes of recording, firing 
frequency started to decrease. This 
decrease in the firing rate is accompanied 
by a sudden increase in action current 
amplitude, reflecting the time when 5-
HT1A receptor agonists started to take their 
effects.  
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Fig. 2.7. The baseline current (Ihold) is kept near 0 pA. The figure shows the time course of Ihold change. 
▲ indicates the time when the recording was interrupted and the Ihold was offset to 0 pA by adjusting 
the offset voltage of the voltage-clamp recording. 
 
2.4. Whole-cell (WC) recording 
2.4.1. Rationale 
Whole-cell patch clamp recording is particularly suited to measure subtle electrophysiological 
properties of a single neuron in a detailed manner. In the whole-cell recording configuration, 
the voltage of the patched cell is under tight control, enabling experimenters to interpret 
conductance changes of a recorded neuron at given voltages. Such precise control of voltage 
results from formation of tight seal between the glass pipette rim and the cell membrane, 
commonly called “gigaseal” due to its resistance in the range of gigaohms (109 Ω). This is in 
a clear contrast to the sharp electrode recording technique, in which the electrode penetrates 
the cell and the seal around the pipette results imperfect, as revealed by the lower total 
membrane resistance measured compared with that found with whole-cell recording in the 
same type of neurons. In the whole-cell recording, on the other hand, the patch pipette seals 
onto the cell membrane, producing much less damage to the cell and inducing much smaller 
leakage currents at the electrode-membrane interface. For the formation of the whole-cell 
configuration, patched cell membrane is ruptured by negative suction applied by the 
experimenter. This inevitably involves exchange of the pipette solution with the cell interior. 
This has both advantages and disadvantages. One advantage is that the experimenter can 
control the interior of the cell and record from different neurons under the same cell interior 
condition. One of the major disadvantages is that the exchange of the cell interior may 
“washout” cellular components which may sustain biological phenomena under investigation. 
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For example, exchange of the cell interior with pipette solution may disrupt spontaneous 
firing of serotonergic neurons or formation of LTP. Reasonably enough, the use of whole-cell 
patch clamp in the present study was thus limited to the measurement of biophysical 
properties of neurons within a rather short recording time to minimise this washout effect. The 
sensitivity of the whole-cell recording for measuring electrophysiological parameters in a 
detailed manner at the same time renders this methodology sensitive to potential errors. From 
the perspective of circuitry, the whole-cell recording uses a single electrode for continuously 
measuring voltage from the cell and injecting current into the cell to maintain the membrane 
potential at the intended value. This is in contrast to two-electrode voltage clamp or single-
electrode switch clamp, which, respectively, uses two electrodes for voltage measurement and 
current injection or one electrode does two duties intermittently. The circuitry of the whole-
cell recording therefore introduces an unknown and unstable source of voltage drops across 
the so-called “series resistance” which is comprised from both the electrode resistance and the 
resistance derived from the pipette’s access to the cell. For this reason, a particular attention 
was paid to the quality of the recording data, in order to draw reliable conclusions obtained 
from the experimental data. 
I). Dorsal raphe nucleus recording 
2.4.2. Materials and Methods 
i). Animals 
Dorsal raphe serotonergic neurons from WT and Tph2 KO mice, aged at P21~P32, were used 
for the investigation. 
ii). Preparation of dorsal raphe nucleus slices 
The procedure follows that of cell-attached recording. 
iii). Electrophysiological recording 
The overall recording procedure and setup follows that of loose-seal cell-attached recording. 
The temperature of perfusing ACSF was set at 29-30 ℃ and supplemented with a mixture of 
neurotransmitter blockers (see method for cell-attached recording) without phenylephrine. 
Patch-pipettes were filled with the following intracellular solution (IC) (mM): 120 K-
gluconate, 15 KCl, 2 MgCl2, 0.1 EGTA-K4, 10 HEPES, 10 Na2-phosphocreatine, 0.3 Na3-
GTP, 4 Mg-ATP (pH 7.3 with KOH, 320-330 mOsm, filtered by 0.2 µm pore filter). The 
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pipette had a resistance of 2-4 MΩ. Gigaseal (> 1 GΩ resistance) between the pipette and the 
cell surface was formed when the positive pressured was released and gentle negative 
pressure was applied to the pipette. Data were acquired through PatchMaster software on an 
EPC10 patch-clamp amplifier (HEKA, Lamberecht, Germany) and analysed by Clampfit 9.2 
software (Molecular Devices, Foster City, CA, USA). 
2.4.3. Parameters measured 
From each whole-cell recording, the following parameters were measured to characterise 
electrophysiological properties of a single neuron. 
i). Resting membrane potential (Vm) 
Vm’s were measured several times during the recording whenever a current-clamp protocol 
without current injection was applied. Such protocols were intentionally executed (named “C-
Rest”) or were present at the beginning of protocols intended to measure some other 
parameters, e.g. “C-Search”, “C-IV-Dep”, “C-IV-Hyp”, and “C-Hyp 5x” protocols (see below 
for the meanings of these protocols). The first Vm was measured immediately after the break-
in of the cell (initial Vm). Other Vm´s were measured some time after the break-in of the cell 
when the cell interior was already equilibrated with the pipette solution. The latter was 
obtained not immediately after the break-in but from a relatively early stage of the recording 
(from 20 sec up to 4 mins after the break-in). Preferably, it was obtained immediately 
before/after the “V-Access” protocol where Rm, Cm and Rs values were obtained (see the next 
section). Normally Vm values except the initial Vm were more or less the same since the cell 
interior was already dialysed and therefore a single representative Vm value was chosen as 
“stable Vm”. The initial Vm reflects a resting membrane potential before cell dialysis and 
therefore indicates Vm at the minimum experimental manipulation. On the other hand, the 
stable Vm reflects the stabilised resting membrane potential after cell dialysis and also most of 
the following measurements were done under this Vm value. Therefore both the initial and 
stable Vm’s are of relevance to characterise an electrophysiological property of a single 
recorded neuron and thus both were taken into account to see differences between genotypes. 
ii). Series resistance (Rs), membrane resistance (Rm), cell capacitance (Cm), time constant (τ) 
These parameters were measured in a voltage-clamp mode by applying a square-shaped 
voltage pulse (ΔV = -10mV, 100 ms, called “V-Access” protocol) from a holding potential 
(Vhold) of -65mV. Since a cell membrane works as a capacitor, current flow becomes large 
when the voltage change is large. This is expressed as the following equation. 
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(I: current (A), C: capacitance (F), V: voltage (V), t: time (second)) 
In the case of the protocol adopted in the present study (V-Access), the voltage change is the 
biggest at the beginning and the end of the voltage pulse. Therefore large current flows are 
observed at these time points (denoted as Iin). In the middle of the voltage pulse, current 
response becomes steady (Iss) (Fig. 2.8). In the actual protocol used, this square-shaped 
voltage pulse was given five times (inter-pulse interval of 4 seconds) and responses were 
aligned at the baseline and averaged. Iin and Iss values were taken from the averaged trace. Iin 
values for measurement were taken only from the first Iin, i.e. when the current injection was 
started. Iss values were taken as the average response at the last 40 ms of the voltage pulse. 
 
 
 
 
 
 
 
 
 
 
 
Theoretically, Rs and Rm are calculated as follows: 
Rs = ΔV / Iin 
Rm = ΔV / Iss 
On the other hand, τ of mono-exponential decay is defined as the time required for Iin to decay 
to 37 % (= 1/e) of its peak value. (Fig. 2.9) 
Fig. 2.8. Capacitive current in response to a voltage step. The recorded neuron was voltage-
clamped at its resting membrane potential (-65 mV). A voltage step of -10 mV was applied for 
100 ms to see the capacitive current. Current flow at the beginning and end of the voltage step is 
termed “instantaneous current” (Iin). Current during the voltage step is named “steady state 
current” (Iss). Vp: commanded pipette voltage. 
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τ is experimentally measurable and is mathematically approximated as follows: 
τ = Rs·Cm 
Therefore, Cm can be calculated. Alternatively, Cm values can be obtained as C-Slow values 
from the auto compensation function of HEKA PatchMaster software by pressing “C-Slow 
Auto” button during the recording. 
 
iii). Action potential (AP) shape (amplitude, HHW, τ of AHP) 
If the neuron was spontaneously firing in a current-clamp mode without current injection, 
action potential shapes were measured from the averaged traces of those spontaneous spikes. 
If the neuron was not spontaneously firing, stepwise current injection (called “C-Search” 
protocol; start from 5 pA with the increment of 5 pA, 10 seconds duration) was conducted 
until repetitive firing of minimum 4-5 spikes occurred (firing rate must fall in approximately 
0.4-1.5 Hz). In order to measure the action potential shape under similar conditions between 
different cells, either positive or negative current was injected at the resting state prior to the 
step-wise current injection so that the resting membrane potential is set at around -65 mV. 
Action potential shapes were measured from the averaged traces of the repetitive firings at the 
minimum current injection. When averaging the traces, the first two action potentials were 
excluded (in case there were only a few spikes in total, only the first one was excluded) 
because they had a different shape from the other action potentials. Since current injection 
affects the shape of action potentials, firing frequency in response to current injection was 
I
t
/I
0
 
Fig. 2.9. Time course of current decay with time t (It). The time constant (τ) of the decay is 
defined as a time required for the current to reach 37% (= 1/e) of its initial value (I0).  
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noted as an indication of intensity of current for the cell. If the spike shape was averaged from 
the third to the last spike during current injection, interval between the second to the last spike 
was measured and divided by the number of intervals to calculate average inter-spike interval 
where action potential shape was taken out. Then the firing frequency was expressed as the 
inverse of this average inter-spike interval.  
Action potential amplitude is defined as a voltage difference between the highest voltage of 
the upstroke and the lowest voltage of the downstroke (Fig. 2.10). HHW is defined as the 
width of the action potential at its medial amplitude (in ms). HHW is dependent on the 
kinetics of the repolarising phase of an action potential: when the repolarisation is fast, HHW 
becomes short, when slow, becomes long. Since the repolarising phase of an action potential 
results from inactivation of voltage-gated Na
+
 channels and activation of voltage-gated, 
delayed rectifier K
+
 channels, differences in HHW may indicate changes in these channel 
functions. For this reason, HHW serves as a useful parameter to compare electrophysiological 
properties of neurons between genotypes. Moreover, for recording from neurons in the DRN, 
HHW serves as a criteria to differentiate serotonergic neurons from non-serotonergic neurons. 
Namely, serotonergic neurons have larger HHW, typically more than 1 ms, whereas non-
serotonergic neurons have narrower HHW.  
 
Fig. 2.10. Parameters measured from an action potential shape. Action potential amplitude is defined 
as the difference between the peak and the anti-peak of an action potential. Action potential half-
height width (inset) is defined as the width of the action potential at its medial amplitude (in ms). 
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Time constant (τ) of AHP is measured by fitting two-component exponential curves. This is 
because one-component fit did not produce any reliable fit and there was no noticeable 
improvement in fitting when the number of components was increased to three. The starting 
point of AHP is set at the end of a shoulder of an action potential. To specify this time point 
objectively, the starting point of AHP was set at the time defined as “peak-time of AP + 
HHW”. Mathematically, HHW corresponds to UD2I of the first derivative of APs as is 
experimentally observed in the cell-attached recoding configuration. Since the upstroke in the 
first derivative corresponds to the peak of AP and the two downstrokes in the first derivatives 
derive from the shoulder of AP measured in the WC mode, the time at “peak-time of AP + 
HHW” reliably corresponds to the end of shoulder. On the other hand, the end point of AHP 
fitting was set at 90% of the anti-peak. Setting the end point at the peak of AHP is vulnerable 
to potential errors because the voltage trace near the peak is flat and slight fluctuation of 
voltage, either biological or by noises, influences the position of absolute peak. Moreover, at 
the peak of AHP, it is possible that the recovering process from AHP has already started and 
this may affect time constants measured when the end point was set to the peak of AHP. For 
these reasons, it was considered reasonable to set the end point of AHP time constant 
measurement at 90% of absolute peak value. 
From each exponential fit to the AHP, two values were noted for comparison among cells: the 
time constant of the first component (τ1) and the time constant of the second component (τ2).  
iv). Maximum firing rate 
Maximum firing rate was measured in a current-clamp mode in response to step-wise current 
injection (called “C-IV-Dep” protocol; start from 20 pA, 20 pA increments, 3000 ms duration, 
12-second intervals between current injections; Fig. 2.11). In order to measure the maximum 
firing rate under similar conditions between different cells, either positive or negative current 
was injected at the resting state prior to the step-wise current injection so that the resting 
membrane potential is set at around -65 mV. Normally, when the amount of current injection 
was increased, the number of action potential during the current injection increased 
accordingly. However, the action potential number near the end of current injection becomes 
constant (i.e. saturated) after some amount of current injection and the increase in the number 
of action potentials was observed only at the beginning of current injection. Of interest was 
the highest action potential frequency of this constant phase near the end of current injection, 
which was termed “maximum sustained firing rate”. The maximum sustained firing rate was 
calculated in the following way. First, the time span between the first and the last action 
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potential within the one-second segment was measured (ms). Then this time span was divided 
by the number of inter-spike intervals (= the number of action potentials -1) to calculate the 
mean inter-spike interval in time (ms). Then, the maximum sustained firing rate was 
calculated as the inverse of this averaged inter-spike interval. 
The maximum sustained firing rate was calculated in this way rather than simply counting the 
number of action potentials in the last one-second segment. This is because, in the latter way, 
the firing frequency will be affected by where the first or the last action potential is positioned 
in this one-second segment. In other words, if the action potential is located slightly outside of 
this one-second segment, it substantially reduces the firing frequency because the next action 
potential comes with a certain interval. This is purely artificial outcome imposed by setting 
the one-second segment, and therefore this method for calculating the maximum frequency 
was discarded.  
 
 
 
 
v). Sag amplitude 
When a neuron is hyperpolarised by a negative current injection, Ih current flows through 
HCN channels and exhibits counteracting depolarisation. This is called “sag” (Fig. 2.12). A 
sag was induced by injecting hyperpolarising current (3000 ms duration) which reaches a 
voltage between -110 and -120 mV from a holding potential between -60 and -70 mV (“C-
Hyp 5x” protocol). In practice, current injection was repeated five times and the measurement 
was made on the averaged trace. Prior to this protocol, stepwise negative currents were 
injected (called “C-IV-Hyp” protocol) to know the amplitude of hyperpolarising current 
required to reach the aimed voltage (-110/-120 mV). A sag (Vsag) was defined as a difference 
between the voltage at the end of current injection (Vend) and the maximum negative voltage 
reached (Vpeak) as a result of current injection. Thus,  
Fig. 2.11. The maximum sustained firing rate. 
The maximum sustained firing was obtained 
from the last 1 second segment of step-wise 
current injection where the firing rate reached a 
plateau after a certain amount of current 
injection (typically 200 pA). 
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Vsag = Vend - Vpeak 
For each sag measurement, amount of current injected during the protocol as well as resting 
membrane potential (average of 5 traces) and associated current injection prior to the 
initiation of the protocol were noted.  
Both maximum sustained firing rate and sag serve as parameters to identify serotonergic 
neurons (see the following section).  
 
 
2.4.4. Identification of serotonergic neurons in the WC recording configuration 
i). Morphological & histological criteria 
The same criteria as for the cell-attached recording apply here. 
ii). Electrophysiological criteria 
Putative serotonergic neurons were identified when the cell had 1) a long-duration action 
potential (HHW > ~ 1 ms) with a ‘shoulder’ during the repolarising phase, 2) high input 
resistance (> 200 MΩ), 3) large and slow (10-20 mV, 200-800 ms) AHP, 4) pacemaker firing 
activity either at rest or in response to current injection (Liu et al., 2002; Sharkey et al., 2008; 
Ohliger-Frerking et al., 2003). Mathematically, HHW corresponds to UDI as measured in 
cell-attached recording. Therefore, a wide action potential HHW is in accordance with long 
UDI, which is used as a criterion to recognise serotonergic neurons in cell-attached recording.  
On the other hand, non-serotonergic neurons have fast-spiking, short-duration action potential 
comprising HHW of 0.3-0.5 ms (Liu et al., 2002) or up to 0.9 ms (observation in the 
laboratory of Prof Corradetti) with shorter AHPs. In response to high current injection, non-
serotonergic neurons often cease firing, unlike serotonergic neurons, which maintain its 
regular firing patterns (reflected as “maximum sustained firing rate”; observation in the 
laboratory of Prof Corradetti). 
Fig. 2.12. Sag in response to 
negative current injection. Sag is 
defined as voltage difference 
between the negative peak voltage 
and the voltage at the end of current 
injection. 
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Another feature of serotonergic neurons is that they express rich population of 5-HT1A 
receptors. This leads to the high sensitivity of these neurons to a selective 5-HT1A receptor 
agonist, such as R8HD. Typically, 30 nM of R8HD is sufficient to cease the firing of 
serotonergic neurons by its hyperpolarising action, whereas non-serotonergic neurons do not 
respond to such low concentration of R8HD. 
Moreover, while non-serotonergic neurons express HCN channels, serotonergic neurons lack 
or if at all present only weakly express HCN channels. As a result, when hyperpolarising 
current is injected, non-serotonergic neurons exhibit prominent sags (Li et al., 2001; Brown et 
al., 2008), which may sometimes exceed 10 mV (observation in the laboratory of Prof 
Corradetti). 
 
2.4.5. Quality control 
Since the whole-cell recording measures subtle electrophysiological changes, the quality of 
recording is crucial. Here is the list of criteria to be considered for most of the cases 
(Molleman, 2003). 
i). The series resistance should not exceed ~20 MΩ throughout the recording. 
Since the resistance of the pipette itself does not change during the recording, a high series 
resistance indicates a high access resistance. This causes a serious problem in the voltage-
clamp because the access resistance and the membrane resistance in succession work as a 
voltage divider and the command voltage will be divided to two resistances proportionally to 
their resistance values. In other words, if the access resistance is high, it is not possible to 
clamp the potential of a cell to the intended value. Increase of the access resistance often 
occurs as a result of gradual resealing of the patch after breakthrough of the membrane and 
manifested as the decrease of Iin in the “V-Access” protocol mentioned above. If this was the 
case, subtle suction was applied to reduce the access resistance. In the present study, data with 
series resistance of at around 25 MΩ were sometimes included but in any case no data were 
included when the series resistance exceeded 30 MΩ. 
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ii). The membrane potential should be more negative than -50 mV 
This is the case when high-potassium intracellular solution as in the current study (K-
gluconate) is used. Resting membrane potential more positive than -50 mV may indicate a 
disrupted patch and thus all the subsequent measurements become unreliable. 
 
iii). Membrane capacitance and resistance must be stable at the steady state 
Together with access resistance, these two parameters were repeatedly monitored throughout 
the recording by applying the “V-Access” protocol several times. “Spontaneous” decrease in 
cell membrane resistance indicates that the neuron has become “leaky”. This implies that 
either the integrity of the cell membrane was disrupted, or that a set of channels was durably 
open, due to change of their properties or to the action of an unknown endogenous 
substance/neurotransmitter occasionally released following experimental manipulations. 
Experiments showing unexpected decrease in cell membrane resistance were discarded. 
Decrease in the membrane resistance can be observed as an increase in the ohmic current, i.e. 
Iss value in response to a voltage step (see the preceding section “parameters measured”). 
 
II). Hippocampus recording 
Overall procedures are the same as those of DRN recording. Here only those that differ from 
DRN recording are mentioned.  
2.4.6. Animals 
CA1 pyramidal hippocampal neurons from three different genotypes of 5-Htt transgenic mice, 
i.e. WT, Het, and KO, aged at P14~P18, are used for the investigation. 
2.4.7. Preparation of hippocampal slices 
Brain slices of 300μm thickness (typically F46-52 of Mouse Brain Atlas by Paxinos and 
Franklin, 2001) are made with a vibratome (VT1000S, Leica, Nussloch, Germany) in ice-cold 
sucrose based artificial cerebrospinal fluid (Sucrose-ACSF (mM): 210 sucrose, 26 NaHCO3, 
1.3 MgSO4, 1.2 KH2PO4, 2 MgCl2, 2 KCl, 2 CaCl2, 10 glucose), equilibrated with carbogen 
(95% O2 ⁄ 5% CO2). Slices were then transferred to ACSF (124 NaCl, 26 NaHCO3, 2 KCl, 1.2 
KH2PO4, 1.3 MgSO4, 2 CaCl2, and 10 glucose; pH 7.4), equilibrated with carbogen and 
incubated for one hour at 32℃. 
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2.4.8. Electrophysiological recording 
Slices were then transferred to a recording chamber, constantly perfused with ACSF, 
equilibrated with carbogen. The whole-cell patch clamp technique is applied with a 
borosilicate glass pipette of 3~5MΩ, filled with the following intracellular solution (IC) 
(mM): 140 K-gluconate, 5 NaCl, 2 MgCl2 , 1 CaCl2 , 10 EGTA, 10 HEPES, 2 K2-ATP, 0.5 
Na-GTP, pH 7.2. 0.2% Neurobiotin (Vector Laboratories, Inc., Burlingame, CA, USA) was 
added to the IC for the later morphological reconstruction. Pyramidal neurons in the CA1 area 
were differentiated from interneurons primarily based on their location, i.e. stratum 
pyramidale. Moreover, under infrared DIC microscopy, pyramidal neurons were often visible 
with apical dendrites passing through the stratum radiatum, whereas interneurons typically 
have dendrites projecting in many directions (Nishikawa and MacIver, 2000). 
Electrophysiologically, pyramidal neurons exhibit spike frequency adaptation in response to 
depolarising current injection with gradual decrease in spike amplitude. On the contrary, 
interneurons have action potentials of short duration and sustain high frequency firing with 
minimum reduction in amplitude in response to depolarising current injection (Nishikawa and 
Maclver, 2000; Zhang et al., 2012; Frazier et al., 1998). In the present study, depolarising 
step-wise current was injected to count action potential numbers and to measure action 
potential thresholds. The identity of pyramidal neurons was at the same time confirmed by the 
presence of spike frequency adaptation. 
In order to measure excitatory postsynaptic current (EPSC), the Schaffer 
collateral/commissural pathway from CA3 to CA1 was stimulated with a concentric bipolar 
electrode (SNE-100X100 mm, Rhodes Medical Instruments (RMI), Woodland Hills, CA, 
USA). Stimuli were triggered by PULSE software (HEKA, Lamberecht, Germany) and 
delivered by a stimulus isolator (ISO-FLEX+, A.M.P.I., Jerusalem, Israel). Stimulus 
amplitude was gradually increased and the maximum EPSC amplitudes were compared 
among genotypes. In addition to absolute EPSC amplitude, paired-pulse ratio was calculated 
as a ratio of the second EPSC to the first EPSC when the two stimuli were given at a short 
interval (50 ms). Since paired-pulse ratio was relatively constant across different stimulus 
amplitudes, several responses at different stimulus amplitude were averaged as a 
representative value. Data acquisition and analysis were conducted with PULSE/PULSEFIT 
software on an EPC9 or EPC10 patch-clamp amplifier (HEKA, Lamberecht, Germany). 
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2.4.9. Staining procedures 
After the recording, slices are fixed overnight at 4
o
C in 0.1 M phosphate buffered saline (PBS; 
Table 5) containing 4% paraformaldehyde. After fixation, slices are washed several times in 
PBS and this is done between each step afterwards. Slices are then pretreated by 1% H2O2 for 
30 mins to neutralise endogenous peroxidase. Slices are incubated for 1 day at room 
temperature in 1/100 avidin-biotin peroxidase complex (Vector Laboratories, Inc., 
Burlingame, CA, USA) diluted in PBS containing triton 0.3%. Slices are incubated in PBS 
containing 0.04% 3-3’-diamino-benzidine-HCl (DAB; Sigma) and 0.006% H2O2. Slices are 
placed onto glass slides and covered with coverslips using Vectashield mounting medium 
(Vector Laboratories, Inc., Burlingame, CA, USA). Coverslips were then fixed by nail varnish. 
 
 
 
 
 
2.5. Extracellular field potential recording 
2.5.1. Rationale 
Extracellular field potentials are electrical fields measured in the extracellular space, which 
originated from the activity of single neurons or groups of neurons. The activity of neurons is 
typically evoked by synaptic or antidromic stimulation. The histological arrangement of the 
hippocampus makes this neuronal region particularly suited for the application of extracellular 
field potential recording. Namely, the dense laminated packaging of cell bodies, the 
approximate parallel positioning of apical dendrites, ant the ease with which neurons can be 
synchronously activated (Andersen et al., 2007). When recordings are made from the CA1 
region of the hippocampus, stimulation of the Schaffer collateral/commissural pathway 
produces an EPSP in the dendrites. Extracellularly recorded form of this signal (field EPSP; 
fEPSP) possesses negativity due to the current influx into the activated dendrite (current sink). 
If the synaptic stimulation is sufficiently strong, this causes an action potential in the soma, 
called a population spike (pSpike). The pSpike then induces current influx into the soma. Due 
to the dipole nature of the soma and the dendrite, current influx in the soma results in the 
Table 5. PBS (0.1 M = 10X) 
 12.4 g  Na2HPO4.2H2O 
 3.8 g  NaH2PO4. H2O 
 800 ml distilled water 
 Adjust the pH to 7.4 
 Add distilled water till 1000 ml 
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outflow of the current in the dendrite (current source). Extracellularly, this is observed as 
positivity in the field potential. The summation of fEPSP and pSpike often results in a tri-
phasic shape, positive deflection in the middle of negatively going fEPSP. For this reason, it 
is common to use the slope of fEPSP as an index of the strength of synaptic communication 
since the absolute amplitude of fEPSP tends to be contaminated by pSpike.  
In the extracellular field potential recording, neurons are not directly impaled as in the 
intracellular recording nor are the intracellular components exchanged as in the whole-cell 
patch clamp. Therefore, extracellular field potential recording enables stable and long-
duration recording of synaptic activity, which is a prerequisite for investigating LTP. Taken 
together, the highly laminated structure of the hippocampus, and the stability and reliability of 
field potential recording make this method ideal for investigating LTP.  
 
2.5.2. Preparation of hippocampal slices 
Slice preparation procedures followed those described in Morini et al. (2011). Mice (from 6 
weeks up to 4 months) from both 5-Htt KO and Tph2 KO lines were anesthetised with 
isoflurane and decapitated. The whole head was rapidly immersed in ice-cold artificial 
cerebrospinal fluid (ACSF) comprising the following (mM): 124 NaCl; 2.75 KCl; 1.25 
NaH2PO4; 26 NaHCO3; 1.3 MgSO4; 2 CaCl2; 11 D-Glucose. The ACSF was continuously 
bubbled with a gas composed of 95% O2 and 5% CO2 (pH 7.4). After taken out from the skull, 
the whole brain was cut into two hemispheres. First, the fimbria was cut by a surgical knife. 
Then, a plastic scalpel was inserted below the hippocampus and scraped it out from the cortex. 
The hippocampus was then placed on an agar bed on a chopping plate. Transversal 
hippocampal slices of 400 µm thickness were made with a Mcllwain tissue chopper 
(Gomshall, UK) from the ventral pole. Typically, the first two slices were discarded and from 
the third to ~tenth slices were taken and transferred to a multi-well incubation chamber filled 
with bubbled ACSF at a room temperature. Slices were incubated at least 1.5 h before the 
recording. Typically, the fourth to the eighth slices were used for the experiments. 
2.5.3. Electrophysiological recording 
After the incubation time, a slice was transferred to a recording chamber consisting of a nylon 
mesh, continuously superfused by oxygenated ACSF at 33 °C (2 ml/min). The composition of 
ACSF for recording follows that of ACSF used for dissection of brain and for incubating 
brain slices after cutting but the concentration of Ca
2+
 is increased to 2.5 mM. A cut was made 
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between the CA1 and CA3 area to prevent recurrent propagation of action potentials (Fig. 
2.13). A stimulus electrode (twisted bipolar nichrome electrode) was placed on the Schaffer 
collateral/commissural pathway and electric pulses (80 µs duration; 15 s interpulse interval) 
were given through a stimulus isolation unit (DS2, Digitimer, Welwyn Garden City, UK), 
triggered by PC running WinLTP software (Anderson and Collingridge, 2007) to elicit 
postsynaptic responses of CA1 pyramidal neurons (Fig. 2.13). Prior to the recording, the tip 
of an electrode filled with NaCl was broken by touching a nod of the nylon mesh so that the 
duration of the stimulus artefact becomes less than 1 ms (~0.8 ms) (2-10 MΩ resistance). 
Field EPSP was recorded by placing this glass electrode in the distal third of the stratum 
radiatum. The magnitude of fEPSP was determined as the slope of the 30-60 % segment of 
the falling phase of fEPSP. Recorded signals were amplified with Neurolog NL 104 
amplifiers (Digitimer, Welwyn Garden City, UK), digitised with TL-1 interface (Molecular 
Devices, Foster City, CA, USA) at the sampling rate of 10 kHz. At the beginning of each 
recording, a stimulus-response curve (SRC) was made by gradually increasing stimulus 
intensity (1-6 V (1V increment), 8, 10, 12, 15, 20 V) to know the maximum slope one can 
obtain from the respective recording. The stimulus intensity of test pulses was then adjusted to 
evoke fEPSP that has a slope corresponding to 25-40 % of the maximum slope and was kept 
constant throughout the experiment. Before commencing LTP induction, baseline responses 
were collected at least for 20 min. LTP was induced by theta-burst stimulation consisting of 5 
bursts of 5 stimuli (100 Hz intraburst frequency, 5 Hz burst frequency), called TB5. 45 min 
after LTP induction, SRC was made again and those recordings in which the maximum slope 
changed more than 10 % before and after LTP induction, indicating probable artificial 
changes in recording conditions, were discarded. Then, 10 bursts of 5 stimuli (the same intra- 
and inter- burst frequency as TB5), called TB10, were given three times with 20 sec interval 
to know the maximally inducible LTP in each experiment.  
This theta-rhythm-based LTP protocol used in the present study, i.e. TB5 and TB10, is based 
on physiological patterns of activation in the CA1 pyramidal neurons during learning-
correlated behaviour (Morini et al., 2011 and references therein). Compared to the classical 
high-frequency stimulation protocol, the theta rhythm-based protocol requires significantly 
lower levels of activation of synaptic afferents, reflecting a facilitatory role of hippocampal 
theta oscillation in memory acquisition (Morini et al., 2011). The theta-patterned stimulation 
used in the present study made it possible to detect subtle potential changes in synaptic 
plasticity that could have been masked if protocols producing maximal LTP had been applied. 
This is because the magnitude of LTP induced by theta-patterned burst stimulation can be 
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graded based on the number of theta bursts (i.e. TB5 or TB10), and TB5 induces sub-maximal 
levels of LTP, allowing for quantification of LTP inducibility. 
The summary of experimental protocol is illustrated as Fig. 2.14. Data were acquired through 
WinLTP software (Anderson and Collingridge, 2007) and analysed by WinLTP and 
GraphPad Prism 5 version 5.04 (GraphPad Software, San Diego, CA, USA). 
2.5.4. Quality control of LTP data 
Data which did not satisfy the following criteria were discarded from further analyses: 
 Linear regression of baseline measurement (BSL) should indicate that its slope is not 
statistically different from zero.  
 Stimulus artefacts and afferent volley (see Fig. 3.34) should always be constant 
 Maximum response in the SRC before/after TB5 should not change more than 10% 
 BSL should be 25-40% of Maximum response. 
  
Fig. 2.13. Arrangement of the stimulus 
electrode (Stim) and recording electrode (R). 
Stimulus electrode was placed on the Schaffer 
collateral/commissural pathway and the 
recording electrode was positioned in the 
stratum radiatum of the CA1 field. The 
dashed line indicates a cut made between 
CA3 and CA1 area to prevent recurrent 
propagation of action potentials. 
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Fig. 2.14. Illustration of recording procedure. Immediately after starting recording, 3 mins of steady 
state recoding was conducted to stabilise the whole recording system (3’ setting). Then, 1st Stimulus 
Response Curve (SRC) was conducted and repeated after 10 mins of setting time. After the 2nd SRC, 
20 mins of Baseline measurement (BSL) was conducted, followed by TB5 stimulation. 45 mins of 
steady state recording was done to see the magnitude and maintenance of LTP induced by TB5. SRC 
was repeated after this to see if the max response remained the same. After 1 min of setting time, 
TB10 was delivered three times with 20 second intervals to induce the maximum LTP. 15 mins of 
stable recording followed this to see the time course of maximum LTP induced. 
 
2.6. A dose-response curve and EC50 
2.6.1. Rationale 
i). A dose-response curve 
A dose-response curve (DRC) shows the relationship between drug dose or concentration and 
response to such drug treatment. In in vitro experiments, experimenters normally know the 
concentrations of drugs they applied, so the term “concentration-response curve” is also used 
as an alternative for DRC. Typically, DRC is used to describe actions of agonists (or 
antagonists) when they are bound to their receptors. DRC typically have a standard sigmoid 
curve (when plotted on a semi-log scale), which is quite similar to the plot describing 
relationship between agonist concentration and receptor occupancy (receptor binding curves). 
It should be noted, however, that DRC is not the same as receptor binding curves since the 
relationship between agonist binding and its response is not necessarily directly proportional 
in biological systems. This is typically the case when the response is mediated by a second 
messenger system. This applies to 5-HT1A receptor action, too (see Introduction). In practice, 
however, when the production of second messengers is proportional to receptor occupancy 
and then the binding of second messengers to their effectors is proportional to second 
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messenger concentrations, the resulting DRC still has a typical sigmoidal shape as a receptor 
binding curve. Sensitivity to a drug acting at a specific, saturable receptor typically spans 
several orders of magnitude. For this reason, DRCs are normally semi-logarithmic, i.e. 
concentrations of drugs are converted to their logarithmic values, resulting in a typical 
sigmoidal curve. To be equally spaced on a logarithmic scale, doses of agonists typically have 
such values as 1, 3, 10, 30, and 100 µM, which when covered to their logarithms produce 0.0, 
~0.5, 1.0, ~1.5, and 2.0. (Motulsky and Christopoulos, 2003) 
ii). EC50 
A standard DRC is defined by the following four parameters: the maximum response (Top), 
the baseline response (Bottom), the slope (Hill slope), and EC50. EC50 is defined as the dose of 
agonist that produces a response half way between the Bottom and the Top. In the present 
study, the term “EC50” was used in the sense of “median effective concentration” regardless 
whether it is excitatory or inhibitory. If the data is normalised by its maximum response and 
its baseline is subtracted, EC50 corresponds to the concentration that gives 50% of the 
maximum response. If there is baseline activity which is not subtracted, this is not necessarily 
the case, e.g. if the Bottom is 20%, EC50 corresponds to 60% of the maximum response. EC50 
is one of the most commonly used measures to describe agonist’s potency since it defines the 
location of the DRC for a particular drug. The Hill slope on the other hand, defines the shape 
of DRCs; the higher the Hill slope, the steeper the curve. In the case of antagonist action, the 
Hill slope has a negative value (Motulsky and Christopoulos, 2003). 
2.6.2. Procedure 
DRCs were produced for R8HD and 5-HTP application in the cell-attached recording, using 
GraphPad Prism version 5.04 (GraphPad Software, San Diego, CA, USA). From each single 
experiment, the number of firing at the last one minute segment of each experimental epoch, 
i.e. baseline, R8HD 0.3 nM, 1 nM etc., was counted and divided by time (i.e. 60 sec) to 
produce average firing rates of each epoch. These values were then plotted against logarithms 
of agonist concentration. The following equation (called “four-parameter logistic equation” 
a.k.a. “variable slope sigmoid equation”) was fit to the data to find the best fit curve:  
           
            
                          
 
(Y: Response, X: concentration of agonists) 
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The fitted curve is the curve that minimises the sum-of-squares of the distance along Y axis 
from each data point. This equation gives the best fit value of the LogEC50, instead of the 
EC50 itself. This is more useful when interpreting data since 95% confidence interval (CI) 
becomes symmetrical around the best fit value. Moreover, curve fitting with variable slopes is 
more reliable than fitting with constant slopes when there are multiple data points because 
curve fitting finds also the best fit slope value. The Bottom was most of the cases set as 0 
since the high dose of agonists stopped firing of the neuron (does not apply to DRCs for 5-Htt 
KO mice). 
For creating average fits for each genotype, data were first normalised by dividing average 
firing rates of each epoch by those of baseline value, hence setting Top as 1.0. Then 
normalised response firing rates were averaged for each experimental epoch and curve fitting 
was done on these average data points for each genotype. To test whether the curves are 
statistically different among genotypes “Extra sum-of-squares F test” was conducted. Since 
this test only tells whether the curves are statistically different or not, detailed statistical 
analysis was done on law LogEC50 values taken from each experiment (not normalised) using 
standard statistical tests as described in the following section.  
 
2.7. Statistics 
All the statistical tests were performed by GraphPad Prism version 5.04 (GraphPad Software, 
San Diego, CA, USA). Unless otherwise stated, genotype effects were tested by first checking 
data for their normality by D’Agostino & Pearson omnibus normality test and for their equal 
variances by Bartlett’s test for equal variances. When these conditions were satisfied, data 
were analysed by one-way ANOVA (expressed as F(df1, df2) values) followed by Tukey’s post 
hoc test for multiple group comparison. If not, data were analysed by Kruskall-Walis test 
(expressed as H(df) values) with Dunn’s post hoc test for multiple group comparison. When 
the dependent variable was under the influence of two factors, two-way ANOVA followed by 
Bonferroni multiple comparison test was conducted. 
When data were compared between only two groups, e.g. WT and KO, as in the analysis of 
DRN WC data, data were first checked for their normality by D’Agostino & Pearson omnibus 
normality test. When data were normally distributed, unpaired t-test (two-tailed) was applied; 
otherwise Mann-Whitney test (two-tailed) was applied. If data were normally distributed but 
had unequal variances, results from unpaired t test were corrected by Welch’s correction.  
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For testing effects of tryptophan in comparison to respective baseline, data (change in firing 
rate with baseline set as 1) were analysed by Wilcoxon Signed Rank test (two-tailed). 
In all cases, p  0.05 was considered statistically significant and indicated by stars as follows: 
* p  0.05; ** p  0.01; *** p  0.001; **** p  0.0001. P value of 0.05 < p  0.10 was 
considered to be a trend of significance. 
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3 . Results 
3.1. Loose-seal cell-attached recording from serotonergic neurons in the DRN of 5-Htt 
and Tph2 KO mice (Study 1) 
3.1.1. Rationale 
For maturation and specification of a particular neuronal population, acquisition of neuronal 
subtype-specific electrophysiological properties is critical. To investigate whether the 
deficiency of Tph2 activity and subsequent lack of 5-HT affects the normal development and 
retention of serotonergic neuron-specific electrophysiological characteristics, we recorded the 
spontaneous firing of serotonergic neurons in the DRN at baseline and in response to various 
compounds related to serotonin synthesis to verify the extent of deletion of Tph2 activity and 
the possible presence of autoinhibitory mechanisms in Tph2 KO mice. In the case of 5-Htt 
KO mice, life-long deficiency of 5-HT reuptaking proteins and consequent elevation of 
extracellular 5-HT may have affected functions of 5-HT receptors and autoinhibition 
mediated by such receptors. Thus potential alterations induced by genetic knockout on these 
properties of serotonergic neurons were assessed by measuring their firing rate as the 
functional probe for quantitative appraisal of serotonergic neuron sensitivity to appropriate 
pharmacological tools. 
3.1.2. Identification of serotonergic neurons 
For identification of serotonergic neurons, standard criteria for wildtype animals were adopted 
as mentioned in Materials and Methods. There is, however, possibility that genetic 
manipulation of serotonergic systems renders these criteria inapplicable to serotonergic 
neurons from knockout mice. To assess if the standard criteria are still applicable to 
distinguish serotonergic from non-serotonergic neurons and to establish precise criteria 
particularly suited to the present study, distribution of baseline mean instantaneous firing 
frequency (i.e. firing frequency based on two adjacent spikes) and UDI of all the neurons 
recorded was first plotted (all the genotypes pooled) (Fig. 3.1). As shown here, UDI clearly 
separates two distinct groups of neurons, those with UDI < 0.85 and those with UDI > 0.85. 
According to the standard criteria neurons with larger UDI are serotonergic and those with 
smaller UDI are non-serotonergic. This was actually the case for the present study as well 
since neurons with UDI > 0.85 decreased firing rates or stopped firing in response to agonists 
of 5-HT1A receptors either directly by R8HD or indirectly by 5-HT synthesis through Trp or 
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5-HTP. Neurons with UDI < 0.85 lacked such responses (Fig. 3.2). Since UDI around 0.85 is 
a border line between serotonergic and non-serotonergic, a neuron was classified as 
serotonergic only if it responded to 5-HT1A receptor agonists. If there is no such 
pharmacological confirmation, those neurons were left as unclassified (??? in Fig. 3.1). As a 
consequence, two neurons whose UDI fell in the range of 0.84-0.85 were not possible to be 
categorised either serotonergic or non-serotonergic. As for mean instantaneous firing 
frequency, there was a substantial overlap between serotonergic and non-serotonergic 
neurons: serotonergic neurons had a frequency of ~0.5-4.5 Hz; non-serotonergic ~1-5 Hz. For 
this reason, it is not possible to classify neurons based on mean instantaneous firing frequency 
alone unless a serotonergic neuron had a low firing frequency (< ~ 1 Hz) or a non-
serotonergic neuron had a high firing frequency (> ~ 4.5 Hz). Thus it was concluded that 
neurons with UDI > 0.85 are safely classified as serotonergic. Typical action current shapes of 
serotonergic and non-serotonergic neurons are shown in Fig. 3.3. All the following 
experiments were done on serotonergic neurons identified this way. 
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Fig. 3.1. Distribution of Up-to-downstroke interval (UDI) and mean instantaneous frequency of 
all the neurons recorded (all the genotypes pooled). Ser = serotonergic; Nonser = non-
serotonergic; ??? = unknown cell type; Ser+1A = Serotonergic and verified by decrease/ceasing 
of firing in response to 5-HT1A receptor agonist, either directly (R8HD) or indirectly through 
serotonin synthesis (Trp, 5-HTP). Non+1A = Non-serotonergic and verified by the absence of 
deceasing of firing in response to 5-HT1A receptor agonist, either directly (R8HD) or indirectly 
through serotonin synthesis (Trp, 5-HTP). 
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3.1.3. Comparison of baseline firing rates 
Here Baseline firing rates of serotonergic neurons among genotypes were compared to see if 
there are intrinsic differences before assessing the effects of 5-HT1A receptor agonists or 5-HT 
precursor application on decease in firing rates. Fig. 3.4 shows distribution of baseline firing 
rates of all the neurons identified as serotonergic (n = 250). Kruskal-Wallis test followed by 
Dunn’s multiple comparison test showed statistically significant differences (H(4) = 16.67, p = 
0.002) for 5-Htt-KO vs. Tph2-KO (**p ≤ 0.01) and WT vs. Tph2-KO (*p ≤ 0.05). Mean 
firing rate (Hz) ± Standard Deviation (SD): Tph2-KO, 1.609 ± 0.817; Tph2-Het, 1.902 ± 
Fig. 3.2. Non-serotonergic neurons do not respond to R8HD. In this experiment, 30 nM of 
R8HD was applied during 12-22 mins of the recording. 
40 pA
1 ms
UD2I = 1.56 ms
50 pA
1 ms
UD(2)I  = 0.45 ms
Fig. 3.3. Typical action current shapes of serotonergic and non-serotonergic neurons. Serotonergic 
neurons have a long UD2I (Left; UD2I = 1.56 ms). Non-serotonergic neurons have a short UD(2)I 
(Right; UD(2)I = 0.45 ms). Note also that serotonergic neurons have clear first and second 
downstrokes, while they are not clear in non-serotonergic neurons. 
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0.665; WT, 1.968 ± 0.687; 5-Htt-Het, 1.853 ± 0.736; 5-Htt-KO, 2.123 ± 0.749. WT data are 
pooled data from both Tph2 WT and 5-Htt WT mice.  
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Fig. 3.4. Summary plot of baseline firing rates. Figure shows distribution of baseline firing rates (Hz) 
of all the serotonergic neurons recorded from the DRN in brainstem slices. Serotonergic neurons were 
defined based on the Up-to-Downstroke Interval (UDI; see the preceding section). Data are shown as 
mean ± SD (number of cells shown in parentheses). Kruskal-Wallis test followed by Dunn’s multiple 
comparison test showed statistically significant differences (H(4) = 16.67, p = 0.002) for 5-Htt-KO vs. 
Tph2-KO and WT vs. Tph2-KO. 
 
3.1.4. Comparison of UDI among genotypes 
We also compared the UDI of action current among genotypes to address the possibility that 
action current shapes were altered due to genetic manipulation. Fig. 3.5 shows the summery 
plot of UDI distribution obtained from serotonergic neurons defined by the above-mentioned 
method (see section 3.1.2.). Kruskal-Wallis test showed no statistically significant differences 
among genotypes (H(4) = 1.550; p = 0.8178). Mean UDI ± SD: Tph2-KO, 1.772 ± 0.527; 
Tph2-Het, 1.755 ± 0.580; WT, 1.735 ± 0.493; 5-Htt-Het, 1.778 ± 0.494; 5-Htt-KO, 1.635 ± 
0.393; WT data were pooled from Tph2 WT and 5-Htt WT). 
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3.1.5. Assessment of 5-HT1A receptor function by a selective agonist R8HD 
We first tested the functional response of serotonergic neurons to 5-HT1A receptor agonist 
R8HD in a dose-dependent manner in different genotypes where genetic alteration of 
serotonergic system functions may have altered autoinhibition exerted by 5-HT through 5-
HT1A receptor activation. Fig. 3.6 illustrates typical experiments done on Tph2 WT (A) and 
KO mice (B). Bath-applied R8HD activates autoinhibitory 5-HT1A receptors and reduces the 
firing rate of serotonergic neurons. Fig. 3.6 C shows the change in firing rate in response to 
increasing concentration of R8HD, i.e. DRC, corresponding to Fig. 3.6 A and B. The 
concentration of R8HD which reduces firing of a serotonergic neuron to 50% of its baseline is 
calculated from the DRCs (EC50 (nM)). 
Fig. 3.7 shows logarithm of EC50 among five different genotypes including both Tph2 and 5-
Htt KO mice. Compared to WT controls (pooled from Tph2 WT and 5-Htt WT), the response 
to application of R8HD showed slightly higher effectiveness of R8HD in Tph2 KO mice, 
lower effectiveness in 5-Htt Het mice, and weak effectiveness in 5-Htt KO mice. One-way 
ANOVA followed by Tukey’s multiple comparison test showed statistically significant 
differences (F(4,53) = 48.38, p ≤ 0.0001) between 5-Htt KO and all the other four phenotypes 
Fig. 3.5. Distribution of Up-to-Downstroke Interval (UDI) of serotonergic neurons from all the 
genotypes recorded. Data are shown as mean ± SD (number of cells shown in parentheses). 
Kruskal-Wallis test followed by Dunn’s multiple comparison tests showed no statistically 
significant differences among genotypes (H(4) = 1.550; p = 0.8178). 
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(***p ≤ 0.001) (log EC50 ± SD: Tph2
-
KO, -8.821 ± 0.290; Tph2
-
Het, -8.519 ± 0.185;
 
WT, -
8.516 ± 0.246; 5-Htt
-
Het, -8.223 ± 0.269; 5-Htt
-
KO, -7.172 ± 0.420). Differences between 
Tph2-KO vs. WT (*p ≤ 0.05) and Tph2-KO vs. 5-Htt-Het (***p ≤ 0.001) also reached 
statistical significance. All the other multiple comparisons did not reach statistical 
significance. Fig. 3.8 shows the DRC from averaged responses of the Tph2 KO mice line 
(left) or 5-Htt mice line (right). 
 
 
 
 
 
 
  
Fig. 3.6. Concentration-dependent decrease in 
the firing rate of DRN serotonergic neurons in 
response to R8HD. Typical time courses of 
changes in firing rate of serotonergic neurons 
from Tph2 WT (A) and KO mice (B). In both 
cases neuron firing started to recover within 
15 min after washout of R8HD. (C) Dose-
response curves of normalised firing rate from 
A and B, showing a moderate shift of the 
curve of KO mice to the left.  
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Fig. 3.7. Scatter plot of log EC50 values for 
R8HD in inhibiting the firing rate of DRN 
serotonergic neurons in all the genotypes 
tested. Each data point corresponds to the 
EC50 value obtained from a full dose-
response curve in a single neuron. The 
number of recorded neurons from brain slices 
of each genotype is shown in parentheses. 
Data are shown as mean ± SD. Data from 
Tph2 WT and 5-Htt WT mice are pooled 
together. One-way ANOVA followed by 
Tukey’s multiple comparison test showed 
statistically significant differences (F(4,53) = 
48.38, p ≤ 0.0001) between 5-Htt KO and all 
the other four phenotypes. Differences 
between Tph2-KO vs. WT and Tph2-KO vs. 
5-Htt-Het also reached statistical significance. 
 
 
 
The results obtained from this R8HD application experiment confirmed the presence of 
functional 5-HT1A receptors in all the genotypes tested including Tph2 KO mice. Therefore, 
the presence and magnitude of autoinhibition was then tested by applying 5-HT precursor, 
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Fig. 3.8. Dose-response curves for R8HD in DRN serotonergic neurons. Graphs show firing rate 
changes of DRN serotonergic neurons in response to increasing concentrations of R8HD (log M). 
For each neuron, the firing rate was normalised to the mean firing rate during baseline 
measurement. Data were obtained from brain slices of Tph2 KO (left) and 5-Htt KO (right) mice 
and compared to those obtained by the respective Het and WT counterparts. Each data point 
corresponds to the mean ± SD (number of cells shown in parentheses). Note that the dose-
response curve of 5-Htt KO does not reach the bottom and therefore the EC50 value of 5-Htt KO 
mice is only indicative for comparisons with other genotypes. Note also that some error bars are 
shown only in one direction for clarity. 
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Trp. Application of Trp in brain slices from wildtype animals is known to lead to decrease of 
serotonergic neuron firing rate through the de novo synthesised 5-HT, which work on 
autoinhibitory 5-HT1A receptors (Liu et al., 2005; Mlinar et al., 2005; Evans et al., 2008). 
Such autoinhibition should be absent in Tph2 KO mice, which lack the enzyme converting 
Trp into 5-HT. Apart from Tph2 KO mice, one could reasonably expect from the functional 
sensitivity of 5-HT1A receptors, which has been revealed by the R8HD application experiment 
mentioned above, that autoinhibition level is unchanged in Tph2 Het, slightly decreased in 5-
Htt Het, and greatly impaired in 5-Htt KO mice compared to wildtype controls. We tested this 
assumption in the following section. 
 
3.1.6. Tryptophan: Testing 5-HT synthesis by applying a 5-HT precursor 
i). Complete absence of 5-HT synthesis in Tph2 KO mice (published in Gutknecht et al., 
2012) 
 
Previous studies have shown that application of Trp in brain slices induces synthesis of 5-HT. 
Subsequent increase in extracellular 5-HT then activates somatodendritic 5-HT1A 
autoreceptors and inhibits serotonergic neuron firing as a feedback mechanism (Liu et al., 
2005; Evans et al., 2008; Mlinar et al., 2005). Importantly, endogenous paracrine 5-HT 
release in the absence of Trp is low or absent in DRN slices (Johnson et al., 2002 as in 
Cornelisse et al., 2007). Thus, decrease in firing rates is solely due to the de novo synthesised 
5-HT in response to exogenously applied Trp, allowing reliable quantitative comparisons of 
autoinhibitory function across different slices. Here, the effect of 30 and 100 µM Trp 
application on the firing rate of serotonergic neurons was investigated as a functional assay to 
know whether serotonergic neurons in Tph2 KO mice are able to produce 5-HT. Since it has 
been demonstrated that 5-HT1A receptors in Tph2
 
KO mice are functionally active (see the 
previous section), it was possible to test whether serotonergic cells were able to synthesise 5-
HT from Trp, using the decrease of firing rate as a detector of 5-HT in the extracellular 
compartment. The 30 μM concentration of Trp is based on the Km of Tph2 for Trp (20-50 
µM) and the physiological concentrations of extracellular Trp in the brain previously reported 
(10-30 µM) (Mlinar et al., 2005; Evans et al., 2008). Additionally, 100 μM concentration of 
Trp was tested to see if there were further effects of Trp at a high concentration.  
The result presented here confirmed the complete absence of Tph activity and thus 5-HT 
synthesis ability in serotonergic neurons in the DRN of Tph2 KO mice since the application 
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of Trp did not decrease the firing rate of these neurons, whereas the same treatment led to the 
evident decrease in the firing rate in WT and Het counterparts (Fig. 3.9.A). In contrast, 
application of 5-HTP (the by-product of Tph2 enzyme and the direct precursor of 5-HT; see 
introduction) in Tph2 KO mice reversibly stopped serotonergic neuron firing, indicating that 
the 5-HT synthesis pathway downstream of Tph2 is retained and serotonergic neurons in these 
mice can respond to endogenous 5-HT once it is produced (Fig. 3.9.A). At the end of each 
experiment, 30 nM R8HD was applied to see suppression of firing, confirming serotonergic 
identity of the recorded neuron. Summary histogram of % decrease in the firing rate is shown 
in Fig. 3.9.B. Both concentrations of Trp (30 and 100 µM) did not change the firing rate of 
serotonergic neurons from Tph2 KO mice, but significantly reduced serotonergic neuron 
firing rates in Tph2 WT and Het mice (p ≤ 0.05, Wilcoxon Signed Rank test). Comparison 
across genotypes revealed that the responses of serotonergic neurons from Tph2 KO were 
statistically different from those of WT and Het mice both for Trp 30 µM (H(2) = 16.28, p < 
0.0003) and 100 µM (H(2) = 10.43, p < 0.0054, Kruskal-Wallis, followed by Dunn's multiple 
comparison test). 100 μM of Trp did not evidently produce further decrease in firing rates 
compared to Trp 30 μM (Fig. 3.9.A, B).  
 
ii). Comparison of Trp-driven 5-HT synthesis and autoinhibition among genotypes  
The magnitude of autoinhibition in response to 30 μM Trp application was then measured 
across all the genotypes including the 5-Htt KO mice line, except Tph2 KO mice, for which 
absence of 5-HT synthesis has already been demonstrated (Fig. 3.9). As shown in Fig. 3.10, 
30 µM of Trp reduced firing rates of serotonergic neurons in all the genotypes tested to a 
similar extent. Wilcoxon Signed Rank test showed that decrease in firing rate was 
significantly different from zero (p ≤ 0.05) in all the genotypes tested (% decrease in firing 
rates ± SD: Tph2-Het, 25.62 ± 15.37; WT, 25.55 ± 19.87; 5-Htt-Het, 17.51 ± 12.99; 5-Htt-KO, 
22.03 ± 17.00; WT data were pooled from Tph2 WT and 5-Htt WT mice). Kruskal-Wallis test 
showed that responses across four genotypes were not statistically different (H(3) = 3.336, p = 
0.3427). 
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Fig. 3.9. Time-course of firing rate and effect of tryptophan on firing rate. A)Time-course of 
firing rate changes in response to tryptophan (Trp; 30 and 100 μM) and R-8-OH-DPAT (R8HD; 
30 nM) of serotonergic neurons in slices obtained from WT (upper panel), Tph2 Het (middle 
panel) and Tph2 KO (lower panel) mice. The lower panel also demonstrates response to the 
application of 30 μM L-5-hydroxytryptophan (5-HTP) in serotonergic neurons from Tph2 KO 
mice. 5-HTP stopped firing of serotonergic neurons in WT and Tph2 Het mice, too (data not 
shown). B) Histogram summarising % decrease in the firing rate (FR) in response to 30 μM (left) 
and 100 μM (right) tryptophan. Data are shown as mean ± SD. Numbers in parentheses indicate 
the number of tested cells. Figure modified from Gutknecht et al, 2012. Impacts of brain 
serotonin deficiency following Tph2 inactivation on development and raphe neuron serotonergic 
specification. PLoS One 7:e43157. 
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Fig. 3.10. Histograms of % decrease in firing rates of serotonergic neurons in the DRN in response to 
30 µM tryptophan (Trp). Data are shown as mean ± SD and the total number of recorded neurons from 
brain slices of each genotype is shown in at the bottom of histograms. WT data were pooled from 
Tph2 WT and 5-Htt WT mice. Wilcoxon Signed Rank test showed that decrease in firing rate was 
significantly different from zero (p ≤ 0.05) in all the genotypes tested. Kruskal-Wallis test followed by 
Dunn’s multiple comparison test showed no statistically significant differences among genotypes (H(3) 
= 3.336, p = 0.3427). 
 
3.1.7. Test of 5-HT synthesis from 5-HTP 
5-HTP is the immediate precursor of 5-HT and is converted into 5-HT by 5-hydroxy-
tryptophan decarboxylase (and amino acid decarboxylase; AADC) (Carlsson et al., 1972). 
This step resides downstream of the Tph2-dependent step in the enzymatic pathway leading to 
5-HT synthesis. 5-HTP, when converted into 5-HT, is expected to decrease the firing rate of 
5-HT neurons via 5-HT1A receptors. As shown previously, 5-HTP caused a strong and 
reversible inhibition of 5-HT neuron firing in Tph2 KO mice (see Fig. 3.9). Therefore 
application of 5-HTP allowed assessment of autoinhibition across all the genotypes studied 
here including Tph2 KO mice. Since 5-HTP had relatively stronger effects compared to Trp, 
it also allowed monitoring dose-dependent responsiveness of autoinhibition. As opposed to 
Trp application, Tph2 KO mice may exhibit higher responsiveness to 5-HTP application due 
to a mild functional sensitisation of 5-HT1A receptors as demonstrated in response to R8HD 
application (Fig. 3.7; Fig. 3.8). 
Fig. 3.11 shows logarithm of EC50 in response to 5-HTP application among five different 
genotypes comprising of both Tph2 and 5-Htt KO mice. Kruskal-Wallis test followed by 
Dunn’s multiple comparison test showed statistically significant differences (H(4)=19.00, p = 
0.0008) only for 5-Htt-KO vs. WT (***p ≤ 0.001) and 5-Htt-KO vs. Tph2-Het (*p ≤ 0.05) 
(log EC50 ± SD: Tph2-KO, -5.509 ± 0.410; Tph2-Het, -5.292 ± 0.304;
 
WT, -5.165 ± 0.204; 5-
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Htt-Het, -5.481 ± 0.356; 5-Htt-KO, -5.761 ± 0.125; WT data pooled from both Tph2 WT and 
5-Htt WT mice). All the other comparisons did not show any statistically significant 
differences. Fig. 3.12 shows the DRC from averaged responses of the Tph2 KO mice line 
(left) or 5-Htt mice line (right). As with R8HD, the highest concentration of 5-HTP did not 
always stop firing of neurons in 5-Htt KO mice. 
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Fig. 3.11. Scatter plot of log EC50 values of serotonergic neurons in the DRN in response to 5-HTP. 
Each data point corresponds to the EC50 value obtained from a full dose-response curve in a single 
neuron and the total number of recorded neurons from brain slices of each genotype is shown in 
parentheses. Data are shown as the mean ± SD. Tph2 WT and 5-Htt WT mice are pooled together. 
Kruskal-Wallis test followed by Dunn’s multiple comparison test showed statistically significant 
differences (H(4) = 19.00, p = 0.0008) only for 5-Htt-KO vs. WT and 5-Htt-KO vs. Tph2-Het. 
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3.2. WC recording from serotonergic neurons in the DRN of Tph2 KO mice (Study 2) 
3.2.1. Static membrane properties 
i). Resting membrane potential 
Fig. 3.13 shows initial resting membrane potential (A; initial Vm) and stable resting 
membrane potential (B; stable Vm), as were defined in the Materials and Methods. Unpaired t 
test revealed no statistically significant differences between WT and KO both for initial Vm 
(initial Vm (mV) ± SD: WT, -67.66 ± 9.00; KO, -64.85 ± 7.47) and stable Vm (stable Vm (mV) 
± SD: WT, -66.33 ± 8.38; KO, -67.65 ± 9.22).  
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Fig. 3.12. Dose-response curve of 5-HTP application. Normalised firing rate change of serotonergic 
neurons in the DRN in response to increasing concentration of 5-HTP (log M). Data were obtained from 
brain slices of the Tph2 KO line (left) and the 5-Htt KO line (right). Each data point corresponds to the 
mean ± SD (number of cells shown in parentheses). Note that the dose-response curve of 5-Htt KO does 
not reach the bottom and therefore the EC50 value of 5-Htt KO mice is only indicative for comparisons 
with other genotypes. Note also that some error bars are shown only in one direction for clarity. 
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ii). Membrane resistance and capacitance 
Fig. 3.14.A shows a scatter plot of membrane resistances. Unpaired t test showed that there 
was a statistically highly significant difference between WT and KO (p = 0.0007) (Rm (MΩ) ± 
SD: WT, 961.3 ± 204.5; KO, 752.2 ± 151.5). Fig. 3.14.B, on the other hand, shows membrane 
capacitance (Cm) of the same neurons from which membrane resistances were measured. 
Mann-Whitney test indicated no statistically significant differences (p = 0.1293) between 
genotypes (Cm (pF) ± SD: WT, 45.46 ± 6.90; KO, 53.39 ± 15.70).  
Fig. 3.13. Summary plots of resting membrane potential (Vm). A) initial resting membrane 
potential measured immediately after the whole-cell recording configuration was established. 
B) stable resting membrane potential measured some time after the whole-cell configuration 
was established, when the cell interior was supposed to be equilibrated with the pipette 
solution. For precise procedure to measure resting membrane potentials, see Materials and 
Methods. Data are shown as mean ± SD. Numbers in the parentheses indicate the number of 
neurons recorded. Unpaired t test revealed no statistically significant differences between the 
two genotypes. 
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Fig. 3.14. Comparison of A) membrane resistance (Rm) and B) membrane capacitance (Cm). In both 
cases, data are shown as mean ± SD. Numbers in the parentheses indicate the number of neurons 
recorded. Unpaired t test showed that there was a statistically significant difference in Rm between WT 
and KO (p = 0.0007). 
 
iii). Membrane conductance 
Significantly lower Rm as shown in Fig. 3.14.A indicates that membrane conductance (G (pS); 
defined as the inverse of membrane resistance) of KO mice is higher than that of WT. Indeed, 
as in Fig. 3.15.A, comparison of membrane conductance showed statistically highly 
significant differences (p=0.0012; Mann-Whitney test) between WT and KO mice (G (pS) ± 
SD: WT, 1095 ± 282.7; KO, 1389 ± 315.6). To account for potential differences in cell sizes, 
the conductance was then normalised by membrane capacitance, i.e. G/Cm (Fig. 3.15.B). 
Mann-Whitney test showed no statistically significant differences (p = 0.1042) between the 
two genotypes (G/Cm (pS/pF) ± SD: WT, 24.58 ± 7.36; KO, 27.05 ± 6.05). The result may 
indicate that the higher conductance of neurons from KO mice may be partially attributable to 
their larger size, which is in part reflected as a higher Cm (Fig. 3.14.B), although the 
difference did not reach statistical significance. 
3. Results 
96 
WT KO
0
500
1000
1500
2000
2500
G
 (
p
S
)
(19) (21)
**
WT KO
0
10
20
30
40
50
G
 /
 C
m
(p
S
 /
 p
F
)
(19) (21)
A B
 
Fig. 3.15. Membrane conductance and normalised membrane conductance. A) Membrane conductance 
(G) calculated as the inverse of membrane resistance. B) Membrane conductance was normalised by 
membrane capacitance (G/Gm) to account for differences in the cell size. Data are shown as mean ± 
SD. Numbers in the parentheses indicate the number of neurons recorded. Mann-Whitney test showed 
that the membrane conductance of neurons from KO mice was significantly higher than that of WT 
mice (p = 0.0012), but the difference became non-significant when normalised. 
 
iv). Series resistance and holding current 
As a control for recording quality, series resistance (Rs) of the same group of neurons, from 
which the membrane resistance, capacitance, and conductance were derived, were checked 
(Fig. 3.16.A). The amount of current flow when the neuron was voltage-clamped at -65 mV 
(I-65mV) was also checked (Fig. 3.16.B). Since -65 mV is near the resting membrane potential, 
the value of I-65mV should be close to 0 in an ideal patch condition. Unpaired t test showed that 
there was no statistically significant difference in Rs between two genotypes (p = 0.2647) (Rs 
(MΩ) ± SD: WT, 16.71 ± 4.55; KO, 15.02 ± 4.82). I-65mV for both genotypes remained near 
0pA (Mean I-65mV (pA) ± SD: WT, 0.942 ± 7.090; KO, 1.918 ± 11.23), which was ideal, and 
there was no statistically significant difference between two genotypes (p = 0.7472). 
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v). Sag amplitude 
Most of the neurons recorded had no sags or sags of relatively small amplitude, corresponding 
to the nature of serotonergic neurons (Fig. 3.17). Mann-Whitney test showed that there was 
no statistically significant difference (p = 0.227) between the two genotypes (mean sag (mV) 
± SD: WT = 1.63 ± 2.55; KO = 2.43 ± 2.31). 
 
 
 
 
 
 
 
 
Fig. 3.16. Scatter plots of A) series resistance (Rs) and B) holding current at -65 mV (I-65 mV). Data 
are shown as mean ± SD. Numbers in the parentheses indicate the number of neurons recorded. 
There was no statistically significant difference in both parameters between genotypes. 
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Fig. 3.17. Comparison of sag amplitude induced by negative current injection. Data are shown as 
mean ± SD. The number of recorded neurons is shown in the parentheses. Mann-Whitney test 
showed that there was no statistically significant difference (p = 0.227) between the two genotypes. 
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3.2.2. Active membrane properties 
i). Action potential properties 
Active membrane properties were then compared between genotypes including action 
potential shapes and firing frequency measured in the current-clamp mode (Fig. 3.18. A-C). 
Comparison of action potential amplitude (AP amp) showed trend of statistical significance (p 
= 0.0569; unpaired t test) (Mean AP amp (mV) ± SD: WT, 116.0 ± 6.66; KO, 112.2 ± 6.19). 
Mann-Whitney test showed that there was no significant difference (p = 0.2609) in action 
potential HHW (AP HHW (ms) ± SD: WT, 1.958 ± 0.317; KO, 1.858 ± 0.391). Comparison 
of maximum sustained firing rate also did not show any statistically significant difference (p = 
0.9512; unpaired t test) (FRmax-sus (Hz) ± SD: WT, 10.29 ± 2.44; KO, 10.23 ± 3.31).  
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Fig. 3.19 shows comparison of time constants derived from a two-component exponential fit 
to the action potential AHP. For the time constant of the first component (τ1), Mann-Whitney 
test showed no statistically significant differences (p = 0.837) between WT and KO mice 
(Mean ± SD: WT, 4.51 ± 1.97; KO, 4.70 ± 1.94). Comparison of the time constant of the 
second component (τ2) also revealed no statistical differences (p = 0.443; unpaired t test) 
between the two genotypes (Mean ± SD: WT, 0.42 ± 0.05; KO, 0.40 ± 0.06).  
Fig. 3.18. Comparison of action potential (AP) properties. A) AP amplitude and B) AP half-height 
width (HHW) were measured from an averaged action potential. C) maximum sustained firing rate 
(FRmax-sus) was obtained in response to depolarising current injection. Data are shown as mean ± SD. 
Numbers in the parentheses indicate the number of neurons recorded. None of the parameters 
showed statistically significant differences between genotypes although AP amplitude showed trend 
of statistical significance (p = 0.0569; unpaired t test). 
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ii). Conductance in response to voltage ramp 
Fig. 3.20.A shows average current flow in response to negative voltage ramp from 0 mV to -
125 mV. Fig. 3.20.B shows distribution of conductances obtained by fitting linear regression 
to the current response trace between -113 and -98 mV. Mann-Whitney test showed a trend of 
statistically significant differences (p = 0.0569) between WT and KO mice (mean G (nS) ± 
SD: WT, 1.574 ± 0.513; KO, 2.645 ± 1.663). 
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Fig. 3.20. Conductance in response to voltage ramp. A) Inward current induced by 
negative voltage ramp. Data were shown as mean ± 95% confidence interval (CI). B) 
Summary plots of conductance calculated by linear regression in the voltage range of -113 
and -98 mV (G-113/-98 mV). Data are shown as mean ± SD. In both A and B, numbers in the 
parentheses indicate the number of neurons recorded. Mann-Whitney test showed a trend 
of statistically significant differences in G-113/-98 mV (p = 0.0569) between WT and KO 
mice. 
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Fig. 3.19. Time constants (τ) of action 
potential afterhyperpolarisation (AHP). 
(left) time constant of the first component 
of the exponential fit to the AHP (τ1). 
(right) time constant of the second 
component of the exponential fit to the 
AHP (τ2). The number of recorded neurons 
is shown in parentheses. 
3. Results 
100 
3.3. WC recording from hippocampal CA1 pyramidal neurons in 5-Htt KO mice (Study 
3) 
Using the whole-cell patch clamp, detailed basic membrane properties and action potential 
characteristics were investigated on pyramidal neurons in the CA1 area of the hippocampus 
from the 5-Htt KO mice line. Since the hippocampus has a highly laminated structure, 
synaptic communication between the Schaffer collateral/commissural pathway and CA1 
pyramidal neurons was also investigated. Additionally, morphological analysis of the 
recorded neurons was conducted using the Neurobiotin tracer and Neurolulcida software. The 
motive for investigating this neuronal area is, as mentioned in the introduction, that the 
hippocampus is one of the target regions of the serotonergic innervation and thus lack of 5-Htt 
may have altered basic electrophysiological properties of neurons in this area. Such potential 
alterations may have close relevance to behavioural and molecular characteristics of 5-Htt KO 
mice that have been previously reported. Investigating electrophysiological properties may 
therefore further contribute to the understanding of phenotypes of 5-Htt KO mice. 
3.3.1. Static membrane properties 
As static membrane properties, the following three parameters were measured: resting 
membrane potential (Vm; only stable Vm was measured), membrane resistance (Rm), and 
membrane capacitance (Cm) (Fig. 3.21). Among these, difference in Vm (mean Vm (mV) ± 
SD: WT, -66.39 ± 3.63; Het, -64.29 ± 6.83; KO, -62.93 ± 5.24) and Cm (mean Cm (pF) ± SD: 
WT, 67.63 ± 29.04; Het, 81.28 ± 45.22; KO, 72.36 ± 18.96) did not show any statistical 
significance (H(2) = 3.386, p = 0.184; H(2) = 0.1952, p = 0.907, respectively; Kruskal-Wallis 
test followed by Dunn’s multiple comparison test). Difference in Rm reached statistical 
significance (F(2,30) = 9.413, p = 0.0007; One-way ANOVA). Tukey’s multiple comparison 
test showed the difference became highly significant (p ≤ 0.01) between WT vs. Het and WT 
vs. KO (Mean Rm (MΩ) ± SD: WT, 374.5 ± 172.1; Het, 215.6 ± 74.88; KO, 177.5 ± 36.19). 
Since series resistance (Rs) affects measurements of membrane resistance, the magnitude of 
series resistance was also monitored (Fig. 3.22). One-way ANOVA showed no statistically 
significant differences (F(2,30) = 1.023, p = 0.372) in Rs among genotypes (Mean Rs (MΩ) ± 
SD: WT, 17.65 ± 3.37; Het, 16.92 ± 3.67; KO, 15.59 ± 3.09). 
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3.3.2. Action potential properties 
To characterise action potentials, the following four parameters were quantified (Fig. 3.23): 
action potential amplitude (AP amp; mean (mV) ± SD: WT, 88.03 ± 8.99; Het, 88.73 ± 10.02; 
KO, 90.77 ± 7.72), action potential HHW (AP HHW; mean (ms) ± SD: 2.57 ± 0.44; Het, 2.15 
± 0.43; KO, 2.37 ± 0.74), action potential threshold (AP threshold; mean (mV) ± SD: WT, -
49.58 ± 4.09; Het, -47.62 ± 4.51: KO, -45.27 ± 4.37), and minimum current injection to cause 
the first action potential (threshold current to cause AP: mean (pA) ± SD: 36.00 ± 17.24; Het, 
35.71 ± 13.42; KO, 39.17 ± 20.65). Kruskal-Waillis test showed no statistical difference in 
AP amp among genotypes (H(2) = 0.8032, p = 0.669). One-way ANOVA showed no 
statistically significant difference in AP HHW, AP threshold, and threshold current to cause 
AP among genotypes (F(2,32) = 1.828, p = 0.178; F(2,31) = 2.711, p = 0.082; F(2,38) = 0.158, p = 
0.854, respectively).  
Fig. 3.22. Series resistance of whole-cell recording in CA1 
pyramidal neurons among three genotypes of the 5-Htt KO 
mice line. Numbers at the bottom of each column indicates 
the number of neurons recorded. Data are shown as the 
mean ± SD. One-way ANOVA showed no statistically 
significant differences among three genotypes. 
Fig. 3.21. Static membrane properties of CA1 pyramidal neurons. Data were obtained by the 
whole-cell configuration from the 5-Htt KO mice line. Numbers at the bottom of each column 
indicates the number of neurons recorded. Data are shown as the mean ± SD. Cell membrane 
resistance is significantly lower in KO and Het compared to WT (One-way ANOVA followed by 
Tukey’s multiple comparison test, WT vs. Het, p ≤ 0.01; WT vs. KO, p ≤ 0.01). 
Series resistance (Rs)
R
e
s
is
ta
n
c
e
 [
M

]
0
5
10
15
20
25
WT Het KO
(12) (11) (10)
Resting membrane potential (Vm)
-70
-60
-50
-40
V
o
lta
g
e
 (
m
V
)
WT Het KO
(22) (19) (18)
Membrane capacitance (Cm)
C
a
p
a
c
it
a
n
c
e
 [
p
F
]
0
50
100
150
WT Het KO
(12) (11) (10)
Membrane resistance (Rm)
R
e
s
is
ta
n
c
e
 [
M

]
0
100
200
300
400
500
600
700
WT Het KO
(12) (11) (10)
**
**
3. Results 
102 
AP amp
V
o
lta
g
e
 (
m
V
)
0
50
100
WT Het KO
(12) (12) (11)
AP HHW
T
im
e
 (
m
s
)
0
1
2
3
WT Het KO
(12) (12) (10)
AP threshold
V
o
lta
g
e
 (
m
V
)
-60
-50
-40
-30
-20
WT Het KO
(12) (12) (10)
Threshold current to cause AP
C
u
rr
e
n
t 
(p
A
)
0
10
20
30
40
50
60
70
WT Het KO
(15) (14) (12)
 
Fig. 3.24 shows voltage changes in response to step-wise current injection of 800 ms duration. 
Action potential numbers were counted from this protocol with respect to different amounts of 
current injection. Fig. 3.25 shows the summary of the number of action potentials from three 
genotypes. 5-Htt Het and KO mice had a lower number of action potentials than WT mice 
across the different amounts of current injection. Two-way repeated measure ANOVA 
followed by Bonferroni multiple comparison test showed statistical significance between Het 
and WT at 50 and 60 pA injection (p ≤ 0.05) (main effect of current F(8) = 82.04, p ≤ 0.0001; 
main effect of genotype F(2) = 3.820, p = 0.031; current by genotype interaction F(16) = 1.845, 
p = 0.025). 
 
 
Fig. 3.23. Action potential properties of CA1 pyramidal neurons 
from the 5-Htt KO mice line. Data were obtained using the 
whole-cell recording configuration. Numbers at the bottom of 
each column indicates the number of neurons recorded. Data are 
shown as the mean ± SD. Statistical tests showed no significant 
differences among three genotypes. 
Fig. 3.24. Action potentials in response 
to step-wise current injection. The 
example shows voltage response to step-
wise current injection ranging from -70 
pA to 40 pA. Traces expect the response 
to 40 pA injection are dimmed. The 
number of action potentials was counted 
from each trace. 
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Fig. 3.25. Number of action potentials caused by increasing amount of current injection. The number 
of neurons recorded is shown in parentheses next to the name of genotypes. Data are shown as the 
mean ± SD. Two-way repeated measure ANOVA followed by Bonferroni multiple comparison test 
showed statistical significance between Het and WT at 50 and 60 pA injection (p ≤ 0.05). 
 
3.3.3. Synaptic transmission 
To assess the efficacy of synaptic transmission, the amplitude of EPSC in response to the 
Schaffer collateral/commissural pathway stimulation was measured (Fig. 3.26 left). In 
addition, the ratio of the second EPSC to the first was calculated when two stimuli were given 
at a short time interval (Paired-pulse ratio; Fig. 3.26 right). Kruskal-Wallis test showed no 
differences in EPSC amplitude among genotypes (H(2) = 4.287, p = 0.117) although the 
average EPSC amplitude recorded from Het and KO mice were about 100 pA larger than that 
from WT mice (mean EPSC (pA) ± SD: WT, 210.8 ± 160.1; Het, 304.9 ± 225.0; KO, 294.1 ± 
153.1). One-way ANOVA showed that there is also no statistically significant difference 
(F(2,26) = 0.298, p = 0.745) in paired-pulse ratio among genotypes (mean paired-pulse ratio ± 
SD: WT, 1.61 ± 0.25; Het, 1.54 ± 0.23; KO, 1.54 ± 0.18). 
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3.3.4. I/V relationship 
Fig. 3.27 illustrates how the I/V relationship, i.e. current-voltage relationship, was measured 
in the voltage-clamp mode. The membrane potential was changed from -130 mV to 30 mV in 
10 mV increments for 200 ms. The current response was measured at the end of each voltage 
step, where the current response became steady. The amount of this steady-state current (i.e. 
current not associated with action potentials) at various voltages is plotted in Fig. 3.28. Two-
way repeated measure ANOVA showed statistically highly significant differences (p ≤ 0.01) 
between WT and Het at the voltage range of 10 to 30 mV (main effect of voltage F(16) = 240.1, 
p ≤ 0.0001; main effect of genotype F(2) = 2.743, p = 0.081; voltage by genotype interaction 
F(32) = 2.637, p ≤ 0.0001). When the membrane potential was depolarised above the action 
potential threshold (c.a. above -50 mV), action potentials were generated, mostly at the 
beginning of voltage steps (Fig. 3.27). The amount of inward current accompanying action 
potentials is plotted in Fig. 3.29. Two-way repeated measure ANOVA indicated significant 
differences between WT and KO at the voltage range of -40 to 0 mV and between WT and 
Het at -50 to -20 mV (main effect of voltage F(16) = 84.93, p ≤ 0.0001; main effect of 
genotype F(2) = 6.314, p = 0.006; voltage by genotype interaction F(32) = 3.982, p ≤ 0.0001). 
Fig. 3.26. Synaptic transmission properties measured from CA1 pyramidal neurons in the 5-Htt 
KO mice line. Synaptic transmission was induced by stimulating the Schaffer 
collateral/commissural pathway. (left) amplitude of excitatory postsynaptic current (pA). (right) 
Paired-pulse ratio (see Materials and Methods for details). Data are shown as the mean ± SD. 
Numbers at the bottom of each column indicates the number of neurons recorded. Statistical test 
showed no significant differences among genotypes. 
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Fig. 3.27. Current measurement in response to voltage steps. The example shows current responses in 
the voltage-clamp mode where the membrane potential was changed from -130 mV to 30 mV (Δ 10 
mV) for 200 ms duration. I/V relationship was obtained from the segments at the end of each voltage 
step where current responses become stable. When the voltage steps exceeded the action potential 
(AP) threshold, action potentials were generated at the beginning of each voltage step. The amount of 
current influx due to action potentials was measured. 
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Fig. 3.28. Current (I) / Voltage (V) relationship of CA1 pyramidal neurons in the 5-Htt KO mice line. 
Data were obtained by the whole-cell recording configuration at the voltage-clamp mode. Each curve 
represents the average response of several neurons, whose number is indicated in the parentheses for 
each genotype. Error bars show SD. Two-way repeated measure ANOVA showed statistically 
significant differences between WT and Het at the voltage range of 10 to 30 mV. 
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Fig. 3.29. Magnitude of inward current induced by action potentials (APs). Recordings were made in 
the whole-cell configuration at the voltage-clamp mode from CA1 pyramidal neurons of the 5-Htt KO 
mice line. Data are presented as mean ± SD. The number of recorded neurons from each genotype is 
shown in parentheses next to genotype names. Two-way repeated measure ANOVA indicated 
significant differences between WT and KO at the voltage range of -40 to 0 mV and between WT and 
Het at -50 to -20 mV. 
 
3.3.5. Morphological analysis 
Dendritic arborisation patterns of Neurobiotin-stained neurons were traced by Neurolucida 
software (Microbrightfield, Inc., Williston, VT, USA). Dendritic parameters to be analysed 
included total length of dendritic material, total number of branch points of all apical/basal 
dendrites, and spine density. For 3D analysis, Sholl analysis was conducted (Fig. 3.30). In this 
analysis, spheres of increasing radii (20 μm steps) are applied around the soma of neurons, 
and such parameters as the number of intersections between each sphere and dendritic tree, 
the total dendritic tree extension (i.e. the largest sector intersected), the length of dendritic 
material within each spherical sector are collected (Nietzer et al., 2011). No differences 
concerning total length, total number of nodes and total branch packing were found. 
Concerning Sholl analysis, there were some differences in one single sector (200 - 220 μm 
around the soma; Fig. 3.31). KO neurons have a significantly shorter radius length in this 
particular sector compared to WT or Het neurons (Median in μm): WT (n=12) 103.05, Het 
(n=3) 120.4, KO (n=6) 54.15; p value (Kruskal-Wallis test): WT-Het 0.734, WT-KO 0.014, 
Het-KO 0.024). However, since the number of Het samples was not enough, only the 
comparison between WT and KO was taken into account. 
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Fig. 3.31. Sholl analysis of Neurobiotin-stained hippocampal CA1 pyramidal neurons. Data are shown 
as mean ± Standard Error of the Mean (SEM). The number of neurons analysed is shown in the 
parentheses in the legends. Kruskal-Wallis test revealed that neurons from KO mice have significantly 
shorter dendritic material length compared to WT and Het neurons in 200 - 220 μm segment. 
 
  
Fig. 3.30. Schematic of Sholl analysis. 
Scholl analysis applies concentric circles 
around the soma with equal inter-circle 
distance (in this case 20 μm). Green and red 
dots indicate points where dendritic 
arborisation intersects circles. Such 
parameters as the number of intersects, the 
dendritic length between each circle etc. are 
quantified. 
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3.4. Extracellular field potential recording of long-term potentiation (LTP) (Study 4) 
3.4.1. Time course of fEPSP change 
Fig. 3.32 shows the time course of fEPSP slope change. The figure shown here represents an 
ideal experiment which satisfies criteria for quality control as mentioned in Materials and 
Methods. First, the last 15 mins of BSL measurement before the delivery of TB5 remained 
flat. Second, the maximum slope as revealed in the SRC before and after the TB5 protocol 
(c.a. -30 mins and 55 mins of recording, respectively) remained the same. Third, the stimulus 
amplitude was set properly to produce the BSL response which is within 25-40% of 
maximum slope. 
-40 -30 -20 -10 0 10 20 30 40 50 60 70
0
1
2
3
4
5
T
B
5
T
B
1
0
SI = 6 V, Slope@30-60%
Time (min)
E
P
S
P
 S
lo
p
e
 (
V
/s
)
 
 
3.4.2. Shape of fEPSP 
Fig. 3.33 shows fEPSP measured before and after TB5 (left) and TB10 (right) potentiation 
protocols. In each case, the amplitude and slope of fEPSP increased after the respective 
potentiation stimulus. It should be noted that even though the fEPSP response increased in 
amplitude and slope, their stimulus artefacts and afferent volleys (See Fig. 3.34) remained the 
Fig. 3.32. Typical example of time course of fEPSP slope change. Each dot corresponds to slope 
measured every 15 seconds. Stimulus intensity was set at 6V, slope was measured at 30-60 % of 
the slope amplitude. See Materials and Methods for the description of TB5 and TB10 protocols. SI: 
stimulus intensity. 
3. Results 
109 
same, satisfying the criteria for quality control mentioned in Materials and Methods. Fig. 3.34 
describes details of the fEPSP shape.  
 
 
 
 
 
Fig. 3.34. Description of fEPSP shape. The figure corresponds to that enclosed by a hatched square in 
Fig. 3.33 left. A) Stimulus artefact. This is an electrical signal derived directly from the stimulus 
electrode. B) Field potential associated with action potentials in presynaptic axons, called an afferent 
volley. C) Upward deflection caused by a population spike in the pyramidal cell layer. 
0.4 mV
4 ms
TB5
TB5 (-5/0)
TB5 (40/45)
0.4 mV
4 ms
TB10
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Fig. 3.33. Change in the amplitude and slope of fEPSP before/after TB5 (left) and TB10 (right) 
potentiation protocols. Blue lines represent average fEPSP prior to TB5/TB10 protocols and red 
lines represent averaged fEPSP after TB5/TB10 protocols. (left) TB5 (-5/0): average fEPSP 
obtained from 5 mins interval prior to TB5; TB5 (40/45): average fEPSP obtained at 40-45 mins 
interval following TB5. (right) TB5 (40/45): average fEPSP obtained at 40-45 mins interval 
following TB5 (the same as in the left figure); TB10 (10/12): average fEPSP obtained at 10-12 
mins interval following TB10. Note that in both cases of TB5 and TB10, amplitude and slope of 
fEPSP increased compared to those prior to the potentiation stimulus. Figure within the hatched 
square on the left is further explained in Fig. 3.34. 
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3.4.3. Comparison of normalised fEPSP across different genotypes 
Fig. 3.35 shows normalised fEPSP slope change from the Tph2 KO mice line, where the 
average of baseline slope value was set as 1. TB5 was given at time 0 and the baseline was 
taken from 15 mins-segment preceding TB5 (i.e. -15 - 0 mins). In all the genotypes, 
augmentation of slope was observed. Fig. 3.36 shows the same parameters in the 5-Htt KO 
mice line. 
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Fig. 3.35. Normalised fEPSP slope obtained from ventral hippocampi of the Tph2 KO mice line. TB5 
was given at time 0. Number of recorded slices from each genotype is shown as “n=”. Data are shown 
as mean ± SD.  
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Fig. 3.36. Normalised fEPSP slope obtained from ventral hippocampi of the 5-Htt KO mice line. TB5 
was given at time 0. Number of recorded slices from each genotype is shown as “n=”. Data are shown 
as mean ± SD. 
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3.4.4. Superposition of fEPSP traces and comparison of % potentiation 
Fig. 3.37 shows the time course of normalised fEPSP slope from Tph2 KO and 5-Htt KO 
mice. To facilitate comparison among genotypes, traces were overlaid and error bars were 
omitted for clarity. As shown here, no clear differences were visible among three genotypes 
of the Tph2 KO mice line. In the case of the 5-Htt KO mice line, KO mice exhibited higher 
initial fEPSP slope increase immediately after the TB5. However, after 45 mins of recording 
following the TB5, fEPSP slope declined to the same level as WT mice. As a definition of 
LTP, this indicates that LTP inducibility between KO and WT mice is not different.  
To quantify the magnitude of LTP inducibility, distribution of % potentiation compared to 
respective baseline is shown as a scatter plot (Fig. 3.38) (mean ± SD; Tph2-KO, 46.33 ± 
18.73; Tph2-Het, 47.27 ± 15.98; Tph2-WT, 37.30 ± 15.08; 5-Htt-WT, 40.18 ± 13.67; 5-Htt-
KO, 45.85 ± 16.47). Kruskal-Wallis test showed that there was no statistically significant 
difference among genotypes (H(4) = 3.615, p = 0.461). 
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Fig. 3.37. Overlay of normalised fEPSP slope obtained from ventral hippocampi of the Tph2 KO 
mice (left) and 5-Htt KO mice line (right). TB5 was delivered at the time 0. Number of recorded 
slices from each genotype is shown in parentheses. For clarity, error bars are omitted. 
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Fig. 3.38. Summery plot of % potentiation in response to TB5 stimulation in ventral hippocampi 
across all the genotypes measured. Data are shown as mean ± SD. Number of recorded slices from 
each genotype is shown in parentheses. Kruskal-Wallis test showed that there was no statistically 
significant difference among genotypes (H(4) = 3.615, p = 0.461). 
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4 . Discussion 
4.1. Loose-seal cell-attached recording from serotonergic neurons in the DRN of 5-Htt 
and Tph2 KO mice (Study 1) 
 
4.1.1. Baseline pacemaker firing activity was preserved in KO mice 
In the present series of studies, firing rate changes in response to different pharmacological 
interventions, i.e. R8HD, 5-HTP, and Trp, were monitored. There is a possibility that baseline 
firing rates were already altered by genetic manipulation itself even before any drug 
application. To address this possibility, baseline firing rates of all the neurons identified as 
serotonergic were compared across genotypes (Fig. 3.4). We observed similar baseline firing 
rates among genotypes except that Tph2 KO mice had slightly lower baseline firing rates 
compared to other genotypes. As a consequence, differences in firing rates reached statistical 
significance only between Tph2-KO vs. 5-Htt-KO and Tph2-KO vs. WT. It is known that in 
bran slice preparations, there is very little, if any, 5-HT1A receptor-mediated suppression of 
firing rates when the superfusing ACSF lacks 5-HT precursor, Trp (Liu et al., 2005; Mlinar et 
al., 2005; Evans et al., 2008). This is different from baseline firing rates typically reported in 
in vivo studies, where 5-HT1A receptor-mediated autoinhibition as well as other mechanisms 
to control firing rates of serotonergic neurons exist, which holds in particular for recordings in 
non-anaesthetised animals. The baseline firing rates presented here, on the contrary, are not 
correlated with autoinhibition of serotonergic neuron firing. Nonetheless, they indicate that 
the basic characteristics of intrinsic pacemaker firing activity of serotonergic neurons are 
preserved independently from autoinhibition. The slight decrease in baseline firing rates 
observed in Tph2 KO mice may indicate that, in the chronic absence of 5-HT, neurons adapt 
their membrane properties, e.g. conductance, to substitute for absent autoinhibition and 
homeostatically keep pacemaker firing activity constant.  
 
4.1.2. Serotonergic neurons in Tph2 KO mice and 5-Htt KO mice retain normal 
electrophysiological properties  
 
The results presented here demonstrate that serotonergic neurons in Tph2 KO mice and 5-Htt 
KO mice retain gross electrophysiological properties as found in serotonergic neurons of WT 
counterparts, consisting of a wide action potential width (manifested as a wide UDI of action 
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current in the cell-attached recording configuration) and a slow and regular firing rate. The 
result was rather surprising considering that 5-HT has been proposed to play a crucial role in 
the development of the CNS (for review see Daubert and Condron, 2010). 
As mentioned in Introduction, several types of ion conductance are involved in the formation 
of a typical shape of action potential generated by serotonergic neurons: low threshold Ca
2+
 
current, high threshold Ca
2+
 current, Ca
2+
-activated K
+
 outward current, and IA current. 
Accordingly, several ion channels have been implicated in the formation of such conductance, 
i.e. T channels seem to account for the low-threshold Ca
2+
 current whereas at least three 
different Ca
2+
 channel types (including N- and L-type) seem to be involved in the generation 
of high-threshold Ca
2+
 current (Pineyro and Blier, 1999). The results from the present study 
may imply that genetic manipulation of the serotonergic system did not affect normal 
expression of those ion channels that take part in the generation of serotonergic-like action 
potential shapes. Further investigation is needed to elucidate the mechanism which enables 
serotonergic neurons in Tph2 KO mice and 5-Htt KO mice to retain typical serotonergic 
characteristics in spite of the lack of endogenous 5-HT and in the presence of excessive 
extracellular 5-HT, respectively. 
 
4.1.3. Responsiveness of 5-HT1A receptors were shifted in the opposite direction in Tph2 KO 
and 5-Htt KO mice 
 
The results obtained from R8HD application demonstrated mild sensitisation and marked 
desensitisation of 5-HT1A receptors in Tph2 KO mice and 5-Htt KO mice, respectively. The 
slight increase in responsiveness to 5-HT1A receptor agonists in Tph2 KO mice is consistent 
with a previous immunohistochemical study where increase in 5-HT1A receptor density was 
observed (Gutknecht et al., 2012). Similarly, no change in responsiveness of serotonergic 
neurons from Tph2 Het mice to R8HD is in accordance with only slight, non-significant 
increase in 5-HT1A levels previously reported (Gutknecht et al., 2012). The results obtained 
from 5-Htt KO mice are also in agreement with previous immunohistochemical studies 
demonstrating downregulation of 5-HT1A receptors (Fabre et al., 2000; Li et al., 1999, 2000) 
and electrophysiological studies (Gobbi et al., 2001; Mannoury la Cour et al., 2001). 
Moreover, it was shown in previous electrophysiological studies that chronic SSRI treatment, 
which mimics the effects of constitutive 5-Htt KO, leads to a 2- to 3-fold shift to the right of 
the DRC of 5-HT autoreceptor agonist application (Blier, 2010 and references therein). In 
vitro electrophysiological recordings on brain slices made by Mannoury la Cour et al. (2001) 
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demonstrated ~55-fold shift in EC50 values in response to a selective 5-HT1A receptor partial 
agonist ipsapirone (EC50-WT = ~63.1 nM vs. EC50-KO = ~3.5 μM) whereas ~6-fold shift in 
response to a non-selective 5-HT1A receptor full agonist 5-CT (EC50-WT = ~9.05 nM vs. 
EC50-KO = ~52.7 nM). Moreover, in the same study, it was shown that ipsapirone completely 
blocked firing of serotonergic neurons in 5-Htt WT and Het mice at the concentration of 1 μM, 
while 100 μM of ipsapirone was needed to stop firing of serotonergic neurons in KO mice. In 
the present study, EC50 values was shifted ~20-fold in response to R8HD application (EC50-
WT = ~3.0 nM vs. EC50-KO = ~67.6 nM). In our study, firing of serotonergic neurons in 5-
Htt KO mice did not further decrease in response to R8HT at the concentration of 300 nM or 
higher. The difference between the current study and that of Mannoury la Cour et al. (2001) 
seems to derive from the difference in recording configurations as well as types of 5-HT1A 
receptor agonists. It should be noted that R8HD is a selective full agonist against 5-HT1A 
receptors, although moderate affinity (≤ 100 nM) for 5-HT7 receptors is also reported (To et 
al., 1995). It should also be emphasised, however, that the electrophysiological data presented 
in the present study are more robust than previous electrophysiological studies because EC50 
values were obtained from the average of several neurons, each producing the full DRCs. The 
magnitude of desensitisation in 5-Htt KO mice was larger than that of sensitisation in Tph2 
KO mice. In fact, even high concentrations (>300 nM) of R8HD did not completely stop 
firing of serotonergic neurons from 5-Htt KO mice. This is probably because, in Tph2 KO 
mice, the complete lack of brain 5-HT does not produce any functional consequences 
regardless of the sensitivity of 5-HT1A receptors, thus there is no need for intense sensitisation 
of 5-HT1A receptors. In 5-Htt KO mice, on the other hand, there is an impending need for 
intense desensitisation to counteract excessive amounts of extracellular 5-HT, which may 
otherwise stimulate 5-HT1A receptors too strongly. Our data also showed that heterozygous 
mice of each KO line, i.e. Tph2 Het and 5-Htt Het, are no different from their WT 
counterparts, although there is a trend of desensitisation in 5-Htt Het mice. This would 
indicate that deleting one of the alleles encoding either Tph2 or 5-Htt is not enough to 
produce functionally relevant changes in 5-HT1A receptor sensitivity, probably due to an as-
yet-unknown biological compensatory mechanism. Moreover, one should bear in mind that 
data for 5-HT1A receptor responsiveness in Tph2 KO mice should be treated separately when 
inferring to changes in autoinhibition because in these mice serotonergic neurons do not 
produce 5-HT and therefore in vivo the 5-HT1A receptors are unlikely to be physiologically 
stimulated. 
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4.1.4. Lack of 5-HT synthesis from Trp in Tph2 KO mice and presence of autoinhibition in 5-
Htt KO mice 
 
The result obtained from Trp application experiments confirmed the complete lack of Tph2 
reactivity/5-HT synthesis and autoinhibition in Tph2 KO mice when supplied with 5-HT 
precursor Trp (Fig. 3.9). In contrast, application of 5-HTP readily decreased firing of 
serotonergic neurons in these mice, indicating that the enzymatic pathway of 5-HT synthesis 
downstream of Tph2-dependant rate-limiting step is intact in Tph2 KO mice. The latter result, 
together with the result obtained from direct R8HD application, also demonstrates that 5-
HT1A autoreceptors are functional in Tph2 KO mice. This further reinforces the result 
obtained from Trp application, verifying that the lack of response to Trp is not due to the lack 
of functional 5-HT1A autoinhibitory receptors but indeed the lack of 5-HT synthesis. 
Moreover, the preserved capability to produce 5-HT from 5-HTP, which may in vivo enter the 
brain from peripheral sources, could explain the trace amount of 5-HT found in the brain of 
Tph2 KO mice (Gutknecht et al., 2012). It should be noted that responsiveness to Trp 
application in brain slices from Tph2 Het mice was not different from that of WT mice; both 
led to reduction in firing rate to a similar extent. This may reflect the fact that 5-HT1A receptor 
sensitivity, measured as responsiveness to R8HD, was not different in Tph2 Het mice 
compared to WT mice. Alternatively, the lack of difference in Tph2 Het mice implies that 
gene dose-dependent reduction in serotonin synthesis cannot be directly translated into 
functional difference. In fact, Tph2 Het mice were shown to have only 20-25% reduction in 5-
HT content, and the reduction was limited to the rostral raphe (Gutknecht et al., 2012). 
To our surprise, 5-Htt Het and KO mice retained normal autoinhibitory function as seen in 
wildtype counterparts despite the decrease in functional response of 5-HT1A receptors (Fig. 
3.10). Indeed, the magnitude of desensitisation of 5-HT1A receptors was quite intense as was 
shown by direct stimulation of 5-HT1A receptors by R8HD. Here, even the high concentration 
(>300 nM) of R8HD did not stop firing of serotonergic neurons (Fig. 3.8). For this reason, the 
argument that the magnitude of 5-HT1A receptor desensitisation was not so intense as to 
impair the auto-inhibitory mechanism may not apply. Admittedly, there is a possibility that 
autoinhibition after Trp or 5-HTP application in 5-Htt KO mice might have been mediated by 
receptors other than 5-HT1A receptors. To address this possibility, a selective 5-HT1A receptor 
antagonist, WAY-100635 (50 nM), was applied on a slice from a 5-Htt KO mouse to see if 
autoinhibition is still present. As shown in Fig. 4.1, WAY-100635 completely abolished 
autoinhibition following Trp (30 μM) application, confirming that autoinhibition in 5-Htt KO 
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mice is also mediated by 5-HT1A autoreceptors. The same effect of WAY-100635 was 
observed in two other experiments done on brain slices obtained from 5-Htt KO and two other 
experiments from 5-Htt Het mice (data not shown). 
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Fig. 4.1. Autoinhibition is mediated by 5-HT1A autoreceptors also in 5-Htt KO mice. Supplementation 
of Trp (30 μM) on a brain slice obtained from a 5-Htt KO mouse induced synthesis of 5-HT, which 
then led to autoinhibition of serotonergic neuron firing, seen as a decrease in the firing rate. 
Application of a selective 5-HT1A receptor antagonist, WAY-100635 (50 nM) abolished autoinhibition 
and brought back the firing rate to its baseline level, confirming that autoinhibition was mediated by 5-
HT1A autoreceptors. 
 
It can be assumed that in 5-Htt Het and 5-Htt KO mice, desensitised 5-HT1A receptors allow 
these mice to maintain normal autoinhibitory function of serotonergic neurons in the presence 
of elevated/excessive amounts of extracellular 5-HT, which is attributed to the lesser 
expressed or complete lack of 5-Htt. As opposed to R8HD and 5-HTP application, 
quantitative analysis of responsiveness of serotonergic neurons to Trp, i.e. dose-response 
curve, was not conducted. This is because serotonergic neurons in Tph2 KO do not respond to 
Trp at all and the effect of Trp is relatively small and even application of a higher 
concentration (100 µM) did not further decrease serotonergic neuron firing (Fig. 3.9). 
4.1.5. Serotonergic neurons of Tph2 KO and 5-Htt KO mice are more responsive to 5-HTP 
than those of wildtypes 
 
Plots of logarithm of EC50 in response to 5-HTP application among five different genotypes 
(Fig. 3.11) resulted in a bell-shape distribution; EC50 values decreased both in Tph2 KO mice 
and 5-Htt KO mice with each respective heterozygous mice showing intermediate responses. 
The reduction in EC50 in Tph2 KO mice is probably due to mild sensitisation of 5-HT1A 
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receptors as was observed in response to R8HD application. Alternatively, it may reflect 
potential up-regulation of AADC as a compensatory mechanism to the complete absence of 
Tph2 in Tph2 KO mice. This possibility was not further investigated in the present study. 
Another possibility is that in Tph2 KO mice, levels of 5-Htt decreased in order to increase 
extracellular 5-HT and thus enhance 5-HT mediated autoinhibition. This is not likely to be the 
case, however, since no change in 5-Htt expression levels was found previously (Kriegebaum 
et al., 2010). Moreover, past studies indicate that 5-Htt expression levels are relatively 
insensitive to the level of extracellular 5-HT, although they are sensitive to blockade by SSRI 
(Jacobsen et al., 2012b). Therefore it is rather unlikely that 5-Htt levels decreased in response 
to reduced extracellular 5-HT in Tph2 KO mice. 
The results obtained from 5-Htt Het and KO mice were quite opposite to our expectation. 
Despite the fact that 5-HT1A receptors are mildly and significantly desensitised in 5-Htt Het 
and KO mice, respectively, serotonergic neurons in 5-Htt Het and KO mice decreased firing 
at a lower concentration of 5-HTP compared to WT mice, with the difference reaching 
statistical significance in the case of 5-Htt KO mice. However, while high concentration of 5-
HTP stopped firing in 5-Htt WT and Het mice, it did not always stop firing in 5-Htt KO mice, 
reaching saturation in decrease in firing rates. At first sight, this is consistent with the 
possibility that 5-HT1A receptor density/function is decreased as demonstrated in response to 
R8HD. Another possible interpretation is that, in 5-Htt KO mice, the level of extracellular 5-
HT becomes so high in the presence of a high concentration of 5-HTP, even higher than 
normal because of the complete lack of serotonin-reuptaking proteins, that it circumvents 
desensitisation of 5-HT1A receptors to reduce firing of serotonergic neurons, which would be 
biologically sufficient to maintain homeostatic regulation of serotonergic neuron firing, even 
when it does not lead to complete cessation of serotonergic neuron firing. The limitation of 
this experiment is that 5-HT is produced without any rate-limiting step from 5-HTP and that 
5-HT may have been produced also by other monoaminergic cells which have AADC. The 
advantage, however, is that this would override possible genotype-dependent adaptive 
changes in the activity of Tph2. In sum, the present data show that autoinhibition produced by 
endogenous 5-HT is preserved in the 5-Htt Het and KO mice, in spite of the decrease in 
functional response of 5-HT1A receptors. Data from the Tph2 KO mice line also confirmed the 
presence of autoinhibition at a lower concentration of 5-HTP than WT mice, probably 
reflecting sensitisation of 5-HT1A receptors. 
In behavioural experimental settings, application of 5-HTP is often used to restore 
endogenously produced 5-HT in Tph2 KO mice (Angoa-Perez et al., 2012; Liu et al., 2011) or 
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to further increase extracellular 5-HT levels in 5-Htt KO mice (Fox et al., 2008). Furthermore, 
administration of 5-HTP is used to enhance 5-HT transmission in human subjects (Turner et 
al., 2006; Maron et al., 2004). Although studies on behavioural and physiological responses to 
5-HTP application depending on TPH2 polymorphism in humans or Tph2 genotypes in 
animal models are still sparse, evidence suggests that responses to 5-HTP are influenced by 
human 5-HTTLPR or murine 5-Htt genotypes (Fox et al., 2008; Maron et al., 2004). Of 
course, one cannot deny the possibility that deferential responses to 5-HTP depending on 5-
HTTLPR or 5-Htt genotypes are purely due to the different levels of serotonin transporter 
availability. It can be inferred from the results presented here, however, that one should take 
into account the fact that serotonergic neurons in Tph2 KO mice and 5-Htt KO mice have 
higher responsiveness to 5-HTP than in WT controls in terms of autoinhibition of serotonin 
neuron firing.  
 
4.1.6. 5-HT synthesis and autoinhibition 
Desensitisation/downregulation of 5-HT1A receptors observed in 5-Htt KO mice is expected to 
lead to less autoinhibition of serotonergic neuronal activities. In the serotonin synthesis level, 
this was actually reported in a past study. Kim et al. (2005) reported the conversion rate of 5-
HT into 5-HTP was 30-60% increased in different brain regions of 5-Htt KO mice in vivo 
compared to wildtype controls. Since no alteration in Tph2 mRNA levels or in maximal in 
vitro Tph activity in the brainstem of 5-Htt KO mice compared to wildtype controls was 
found, Kim and colleagues (2005) concluded that this increase in the conversion rate is rather 
an outcome of decrease in the efficacy of 5-HT1A receptors to autoinhibit serotonergic 
neurons than upregulation of Tph2 activity. Indeed, it was demonstrated that activation of 5-
HT1A receptors by their agonists such as 8-OH-DPAT and ipsapirone suppressed increase in 
5-HTP when AADC was at the same time inhibited in serotonergic neurons and, on the 
contrary, 5-HT1A receptor antagonists increased accumulation of 5-HTP (Kim et al., 2005). 
Data in the present study, however, demonstrate that autoinhibition as assessed by decrease in 
firing rate due to de novo synthesised 5-HT is no different in 5-Htt KO mice compared to WT 
mice. Autoinhibition triggered by newly synthesised and released 5-HT involves multiple 
factors including the 5-HT synthesis pathway, reuptake, 5-HT1A receptor sensitivity of 
serotonergic neurons. As evidenced in the present study, it is therefore not possible to discuss 
the level of autoinhibition from a single factor, e.g. the conversion rate of 5-HTP into 5-HT as 
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in the study of Kim et al. (2005). Rather, it should be considered as a result of synergistic 
interactions among factors mediating serotonergic neurotransmission. 
 
4.1.7. Desensitisation or downregulation? 
So far, the term sensitisation/desensitisation was used indiscriminately from 
upregulation/downregulation. What was actually meant was “functional (de)sensitisation”, 
referring to augmentation or diminution of 5-HT1A receptor function. As mentioned earlier, 
this may be directly linked to upregulation/downregulation of 5-HT1A receptors, respectively, 
i.e. the increase and decrease in the number of 5-HT1A receptors. However, a series of past 
studies investigating effects of chronic SSRI treatment on sensitivity of 5-HT1A receptors 
point to the fact that desensitisation can take place without altering expression levels of 5-
HT1A receptors. In human studies, Sargent et al. (2000) reported that binding potential of 5-
HT1A receptors to WAY-100635, a 5-HT1A receptor antagonist, in PET imaging was not 
altered in depressed patients before and after 6-weeks of SSRI treatment. However, other 
human studies indicated reduction in functional responsiveness of 5-HT1A receptors after 
repeated SSRI treatment (Sargent et al., 2000 and references therein). The authors also 
referred to inconsistent findings in animal studies after SSRI administration. Some reported 
downregulation of 5-HT1A receptor expression in the DRN and others reported no changes, 
although evidence suggests chronic SSRI treatment may still alter 5-HT1A receptor function 
(Sargent et al., 2000 and references therein). These series of findings indicate that functional 
desensitisation of 5-HT1A receptor function may not necessarily be linked to reduction in the 
number of 5-HT1A receptors. In fact, in Cornelisse’s study (Cornelisse et al., 2007), reduced 
GIRK currents after chronic SSRI treatment were also observed when GIRK currents were 
induced by direct stimulation of GABAB receptors by their agonists. Since 5-HT1A receptors 
and GABAB receptors share the common G-protein pathway (Gi proteins) to be coupled with 
GIRK channels (Innis and Aghajanian, 1987; Colmers and Williams, 1988; Innis et al., 1988; 
Williams et al., 1988), the result indicates that desensitisation took place downstream of the 
signal transduction pathway not at the surface level of receptor expression. This is in 
agreement with radioligand binding assays showing that chronic SSRI (fluoxetine) treatment 
reduced the coupling of 5-HT1A receptors and G-proteins without affecting 5-HT1A receptor 
levels (Cornelisse et al., 2007 and references therein). Furthermore, in 5-Htt KO mice, which 
model mice chronically treated with SSRI, similar adaptive changes in 5-HT1A receptor-
stimulated G protein binding were found in DRN (Mannoury la Cour et al., 2001, 2004). As 
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expected from the shared pathway, reduction in G-protein coupling was observed in 5-Htt KO 
mice when this pathway was stimulated by GABAB receptors as well as 5-HT1A receptors 
(Mannoury la Cour et al. 2004). However, Li et al. (1999, 2000) demonstrated reduction of 5-
HT1A receptor density in the hypothalamus, dorsal raphe nucleus and amygdala of 5-Htt KO 
mice without significant reduction in G-protein coupling. They concluded that the functional 
desensitisation of 5-HT1A receptors is likely to be attributable to reduction in the receptor 
density but not to alteration in G-protein coupling. Moreover, Fabre et al. (2000) reported 
decrease in 
35
S-GTP-γ-S binding evoked by 5-HT1 receptor agonists in the DRN (~ 66%) and 
in the substantia nigra (~ 30%) of 5-Htt KO mice, which corresponds to the observed decrease 
in receptor density of 5-HT1A receptors and 5-HT1B receptors, respectively. Alternatively, 
desensitisation of negative coupling of 5-HT1A receptor stimulation to the production of 
cAMP is proposed to be mediated by receptor phosphorylation through PKC as well as 
through G protein-coupled receptor kinases (Pineyro and Blier, 1999 and references therein). 
To make matters even more complicated, desensitisation at the level of effectors, namely K
+
 
channels, which are coupled with 5-HT1A receptors via G-proteins, has been proposed 
(Pineyro and Blier, 1999). Caution should be taken, however, that experiments to investigate 
desensitisation mechanisms of 5-HT1A receptors were not necessarily conducted on 
mammalian serotonergic neurons, i.e. either non-neuronal model cells which artificially 
express 5-HT1A receptors or neuronal cells from non-mammalian organisms. It is unlikely that 
results obtained from such experiments may be directly extrapolated to desensitisation 
mechanisms of 5-HT1A receptors in the mammalian CNS (Pineyro and Blier, 1999). 
Given the presence of contradictory findings and uncertainties, it is not possible to comment 
on the precise mechanism of functional desensitisation of 5-HT1A receptors in 5-Htt KO mice. 
It seems, however, probable that functional desensitisation can be attributed both to 
downregulation of 5-HT1A receptors, i.e. the decrease in the number of 5-HT1A receptors and 
desensitisation of 5-HT1A receptors, most likely reduction in G-protein coupling. Similarly, 
functional sensitisation of 5-HT1A receptors as seen in Tph2 KO mice may well be traceable 
both to upregulation of 5-HT1A receptors and sensitisation of 5-HT1A receptors driven by an 
as-yet-unknown mechanism. 
 
4.1.8. Interaction between 5-HT1A receptors, 5-HTT, and other 5-HT receptors 
In general, genetic deletion of 5-Htt in mice is known to induce downregulation of 5-HT1A 
autoreceptors in the DRN (Fabre et al., 2000; Li et al., 1999, 2000). In a human postmortem 
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study, Arango et al. (2001) reported that expression levels of both 5-HT1A autoreceptors and 
5-HTT in the DRN from depressed patients were decreased compared to controls. They 
speculated that this reduction in both 5-HT1A autoreceptors and 5-HTT is a homeostatic 
compensatory mechanism to enhance the action of serotonergic neurons. In line with this, 
David et al. (2005) reported that carriers of the s-allele of the 5-HTTLPR, which leads to 
lesser expression of 5-HTT, had lower 5-HT1A receptor binding potential in all brain regions 
investigated compared to homozygous carriers of the l-allele. On the contrary, in the study by 
Lee et al. (2005b), it was found that s-carriers had higher 5-HT1A binding than ll-carriers in 
pregenual and subgenual cingulate regions while in other regions including the DRN, no 
difference was detected. More recent study by Borg et al. (2009), however, could not detect 
any differences in 5-HT1A receptor density between carriers and non-carriers of the s-allele of 
5-HTTLPR. Instead they found that s-carriers had a superior performance compared to ll-
carriers in a cognitive test. They concluded that functional consequences of 5-HTTLPR are 
not likely to be mediated by differences in 5-HT1A expression levels and that other biomarkers 
must be taken into account to infer differences at phenotypic levels. Similarly, Bose et al. 
(2011) failed to detect robust, intra-regional associations between 5-HT1A receptor and 5-HTT 
densities. Inter-regionally, on the other hand, DRN 5-HT1A receptor levels were shown to be 
related to cortical and paralimbic, but not to limbic 5-HTT levels. The authors inferred that 
the latter finding may suggest differences in 5-HT tone between individuals and underline 
potential substrates more sensitive to variations in DRN 5-HT function. These series of 
findings testify complexity of interaction between 5-HTT and 5-HT1A receptors. In the present 
study using 5-Htt KO mice, absence or reduced levels of 5-Htt were correlated with 
desensitisation of 5-HT1A autoreceptors as measured by R8HD response. As pointed out by 
Lee et al. (2005b), the differences between results obtained from animal and human studies 
may stem from the fact that genetically modified mice incur massive manipulations of 
homeostatic systems while human studies address naturalistic relationships of genetic 
variation which may result in changes in 5-HTT availability. The results in the present study, 
however, attest that autoinhibition is not necessarily a potential substrate or phenotype which 
has a predictive value for 5-HT1A autoreceptor densities/sensitivity in the DRN. Instead, it 
would seem more reasonable to consider interaction between 5-HTT and 5-HT1A autoreceptor 
to predict consequences of 5-HT1A receptor-mediated functions such as autoinhibition. 
Moreover, a past study indicates that there is a complex interaction between 5-HT1A receptors 
and other 5-HT receptor subtypes. For example, Fox et al. (2010) reported interesting 
interactions between presynaptic 5-HT1A receptors and postsynaptic cerebral 5-HT2A 
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receptors, both of which were previously shown to be desensitised/downregulated in 5-Htt 
KO mice (Rioux et al., 1999; Fabre et al., 2000; Li et al., 1999, 2000). Cerebral 5-HT2A 
receptors, when stimulated by (+/−)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), 
are known to induce head twitches. Although stimulation of 5-HT2A receptors by DOI 
induced less head twitches in 5-Htt KO mice, as expected from previously reported 
downregulation of these receptors, indirect activation of these receptors by blockade of 5-
HT1A autoreceptors by WAY-100635 induced 5-fold more head twitches in 5-Htt KO mice 
compared to wildtype controls. The result conveys two important messages related to the 
present study. First, blockade of 5-HT1A autoreceptors successfully increased 5-HT 
availability which subsequently stimulated postsynaptic 5-HT2A receptors, implying that 
autoinhibition was functional as a default despite previously reported functional 
desensitisation of 5-HT1A receptors per se. Second, sensitivity/expression levels of 
presynaptic/postsynaptic receptors alone cannot reliably predict functional consequences 
unless the presence of autoinhibition, which influences firing of presynaptic serotonergic 
neurons and consequently 5-HT availability at the postsynaptic level, is taken into account.  
 
4.1.9. Desensitisation of 5-HT1A autoreceptor is not necessarily associated with behavioural 
changes but may be secondary to the increased extracellular 5-HT 
 
Autoinhibition of serotonergic neuron firing in the DRN has been repeatedly implicated in 
mood disorders. Experimental evidences both in animal studies and human subjects suggest 
that deficient 5-HT1A autoreceptor function leads to behavioural alterations related to anxiety 
and depression (reviewed in Pineyro and Blier, 1999; Sharp et al., 2007). Moreover 
desensitisation of autoinhibitory 5-HT1A receptors following chronic SSRI administration has 
been proposed as a putative mechanism for SSRIs to take their therapeutic effects (see 
Introduction). However, results from animal studies using SSRI administration indicate that 
desensitisation of 5-HT1A autoreceptors is rather an adaptive mechanism to counter elevated 
extracellular 5-HT levels, not a primary factor leading to behavioural alteration. In the study 
by Cornelisse and colleagues (2007), 5-HT1A receptor function assessed by GIRK current was 
no different between socially stressed rats and controls, although socially stressed rats 
exhibited anhedonia, a core symptom of depression. Difference in GIRK current became 
evident only when rats were treated by SSRI, regardless of whether the rats were stressed or 
not. Study by Richardson-Jones and coworkers (2010) also indicated dissociation between 
desensitisation of 5-HT1A autoreceptors and behavioural effects of chronic SSRI treatment. In 
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their study, genetically modified mice with higher expression of 5-HT1A receptors (1A-High 
mice) were shown to have elevated baseline behavioural despairs. Using 8-OH-DPAT-
induced hypothermia as an assay for 5-HT1A receptor function, the authors demonstrated 
marked desensitisation of 5-HT1A receptors in 1A-High mice chronically treated with an SSRI, 
fluoxetine, although behavioural despairs were not ameliorated by chronic fluoxetine 
treatment. As opposed to canonical hypothesis that decreased autoinhibition due to 
desensitised 5-HT1A receptors after chronic SSRI treatment mediates antidepressant action, 
the study by Richardson-Jones (2010) demonstrates that desensitisation of 5-HT1A 
autoreceptors is not enough for antidepressants to take their effects. Taken together, these 
series of evidence demonstrate that desensitisation of 5-HT1A autoreceptors is likely to be 
secondary to altered extracellular 5-HT levels and is not necessarily associated with 
behavioural changes. Similarly, loose-seal cell-attached recording data obtained from 5-Htt 
KO mice, which mimic mice chronically treated with SSRIs, indicate that desensitisation of 5-
HT1A receptors took place as a response to elevated levels of extracellular 5-HT. In other 
words, desensitisation occurred not for reducing or abolishing autoinhibition. Instead, together 
with elevated levels of extracellular 5-HT, desensitisation of 5-HT1A receptors eventually 
helped the organism normalise the level of autoinhibition, which otherwise is too intense. 
 
4.1.10. 5-HT1A receptor sensitivity and its functional consequences 
 
Despite the importance of 5-HT1A autoreceptors in regulation of serotonergic firing 
autoinhibition, past studies rarely investigated autoinhibition of serotonergic neuron firing per 
se. Instead, functional levels of autoinhibition in human patients with mood disorders and 
animal models were indirectly inferred from 5-HT1A receptor agonist responses or from 
binding affinity to those receptors (reviewed in Drevets et al., 2007 and Savitz et al., 2009; Li 
et al., 1999, 2000; Bouali et al., 2003). For example, one of the most consistent findings 
among depressed patients is their blunted hypothermia in response to 5-HT1A receptor 
agonists (Jacobsen et al., 2012b and references therein). Such responses are usually ascribed 
to desensitisation of somatic 5-HT1A receptors (reviewed in Jacobsen et al., 2012a). In fact, 5-
Htt KO mice were previously shown to have reduced hypothermia in response to 5-HT1A 
autoreceptor stimulation by R8HD (Li et al., 1999, 2000; Bouali et al., 2003), implying 
functional desensitisation of 5-HT1A autoreceptors. Desensitisation of 5-HT1A receptors is 
consistent with the findings from DRC of R8HD application shown in the present study. 
However, this does not mean that, as demonstrated in other experiments using Trp and 5-HTP 
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application, autoinhibition of 5-Htt KO mice is impaired. In other words, as indicated in the 
present study, neither responses of serotonergic neurons to 5-HT1A receptor agonists nor 5-
HT1A receptor expression levels are necessarily reliable measures of 5-HT1A autoreceptor-
mediated functions such as autoinhibition of serotonergic neuron firing. 
On the other hand, unaltered 5-HT1A receptor expression levels or G-protein coupling do not 
necessarily indicate that 5-HT1A receptor-mediated hypothermia is also unaltered. Mice 
homozygous for targeted insertion of G1449A, which substitutes Arg
439
 with His
439
, are 
known to have 25-40% of the normal 5-HT content compared to WT controls, while their 5-
HT1A autoreceptor levels and G-protein coupling remain unchanged (Beaulieu et al., 2008; 
Jacobsen et al., 2012b). Hypothermia via 5-HT1A autoreceptor stimulation, however, was 
shown to be blunted. The authors (Jacobsen et al., 2012b) postulated that blunted hypothermia 
in response to 5-HT1A receptor agonist in the absence of any change in 5-HT1A receptor 
expression/function could be attributed to decreased baseline extracellular 5-HT levels. 
Taken together, functional consequence of 5-HT1A receptor stimulation cannot be inferred 
simply from receptor expression levels. This is particularly true of autoinhibition of 
serotonergic neuron firing since its direct assessment in human population was hindered due 
to experimental limitations. Evidence suggests that hypothermic response to 5-HT1A receptor 
stimulation does not necessarily reliably predict autoinhibition. Moreover, hypothermic 
response itself is not directly related to 5-HT1A receptor expression or its G-protein coupling. 
It is likely that functions of 5-HT1A autoreceptors depend on the baseline serotonergic tone in 
organisms, which is influenced by several factors including but not limited to the availability 
of 5-HTT and the activity of TPH2. 
 
4.1.11. Conclusion for Study 1 
The present study showed that intrinsic basal firing rates of serotonergic neurons are similar 
in all the genotypes tested, whose genes encoding important mediators of serotonergic 
transmission are genetically modified. This means that, despite different levels of life-long 
availability of 5-HT, there are no major adaptive changes in pacemaking properties of 
serotonergic neuron firing. Moreover, it was demonstrated that 5-HT1A receptor functional 
response, as assayed by direct agonist R8HD, changes markedly only in the case of an 
extreme increase of extracellular 5-HT availability as in 5-Htt KO mice. The general 
conclusion that could be drawn from the series of experiments where in vivo 5-HT synthesis 
was simulated by in vitro application of 5-HT precursors, i.e. Trp or 5-HTP, as presented here, 
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is that autoinhibition is such an important property of serotonergic neurons that it is 
homeostatically regulated to function regardless of 5-HT1A receptor sensitivity, even when the 
sensitivity itself is changed due to alterations in 5-HT synthesis or uptake, which have been 
incurred by genetic impairment of these mechanisms. In other words, serotonergic neurons 
buffer the changes in levels of extracellular 5-HT through changes in responsiveness to 5-
HT1A receptor stimulation. This was particularly evidenced as the presence of autoinhibition 
in 5-Htt KO mice despite substantial desensitisation of their 5-HT1A receptors. Desensitisation 
of 5-HT1A receptors is rather an outcome of adaptive changes in response to excessive levels 
of extracellular 5-HT due to genetic deletion of 5-Htt. The same logic seems to be applicable 
when the extracellular 5-HT is elevated by SSRI treatment. Studies investigating molecular 
mechanisms of functional sensitisation of 5-HT1A receptors in Tph2 KO mice or linking 
autoinhibition with behavioural changes of Tph2 KO mice are still scarce. However, results 
from the present study suggest that the overall principle of 5-HT1A receptor desensitisation in 
5-Htt KO mice may still apply to Tph2 KO mice, i.e. autoinhibition is maintained regardless 
of 5-HT1A receptor sensitivity. The result therefore poses precaution in directly inferring the 
level of autoinhibition from 5-HT1A receptor sensitivity. 
The findings presented here have significant clinical relevance since responses to 5-HT1A 
agonists, e.g. 5-HT1A binding potential or hypothermia tests with R8HD, are commonly used 
to draw conclusions on functions of the serotonergic system, especially in patients with mood 
disorders, although responses to 5-HT1A agonists may only reflect adaptive responses of 5-
HT1A receptors to keep the serotonergic system functioning at the proper level and are not 
necessarily predictive of the serotonergic tone in vivo. Moreover, therapeutic effects of SSRI 
were believed to be mediated by reduction in autoinhibition, which was traditionally 
attributed to desensitisation of 5-HT1A autoreceptors. As the present study suggests, even if 5-
HT1A autoreceptors are actually desensitised following SSRI administration, it does not 
necessarily mean that autoinhibition is also attenuated. The results presented here further 
imply that depressive and anxious behaviours of organisms are not necessarily mediated by 
deficit in autoinhibition of serotonergic neuron firing and that other endophenotypes must be 
taken into account when ascribing behavioural phenotypes to genetic predispositions. 
Moreover, based on the finding that autoinhibition is maintained in animal models of 
emotional disorders, it could cautiously be inferred from the present study that human 
subjects with genetic polymorphisms in genes encoding 5-HTT or TPH2, which have 
secondary effects on expression levels or sensitivity of 5-HT1A receptors, may still have 
normal autoinhibitory function of serotonergic neuron firing. In sum, the present study 
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proposes that Trp and/or 5-HTP challenges should be used instead of direct 5-HT1A agonists 
to estimate autoinhibition of serotonergic neuron firing as well as the serotonergic tone in 
organisms.  
 
 
4.2. WC recording from serotonergic neurons in the DRN of Tph2 KO mice (Study 2) 
4.2.1. Membrane resistance was decreased in neurons of KO mice 
The whole-cell data obtained from serotonergic neurons in the DRN of Tph2 KO and WT 
mice showed almost identical electrophysiological properties between these two genotypes. 
The only parameter which showed statistically significant difference was membrane 
resistance, with neurons from KO mice having lower resistances (Fig. 3.14.A). The 
conductance of a neuron, defined as the inverse of membrane resistance, therefore became 
significantly higher in KO mice compared to WT controls (Fig. 3.15.A). However, when the 
cell conductance was normalised by cell capacitance, which correlates positively with cell 
sizes, the difference in cell conductance became non-significant. Thus, it is possible that 
higher conductance of neurons from KO mice may have derived from larger cell sizes. To 
confirm the potential difference in cell sizes between WT and KO mice, direct histological 
studies are necessary. Other parameters which showed trend of statistical significance were 
action potential amplitude (Fig. 3.18.A) and conductance in response to voltage ramp (Fig. 
3.20). Action potential amplitude is susceptible to the membrane potential when the action 
potential was generated. As shown in Fig. 3.13, the resting membrane potential at a steady 
state was not different between WT and KO mice. Moreover, when the action potential was 
generated by step-wise current injection, the membrane potential before step-wise current 
injection was adjusted at around -65mV by steady-state current injection, so that the action 
potential shapes were measured under similar conditions (see Materials and Methods). It is 
therefore not possible to attribute the difference in action potential amplitude to the difference 
in membrane potential when the action potentials were generated. Action potential amplitude 
is a rather fixed parameter determined by internal and external ionic composition and their 
reversal potentials. This means that action potentials are generated in an all-or-none fashion 
and its amplitude is normally not graded. Due to the nature of the whole-cell patch clamp 
recording method, i.e. the washout effect of the intracellular component, the intracellular ionic 
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composition should be similar across the recorded neurons. It is therefore possible that this 
trend in difference in action potential amplitude is only transitory and the difference may 
diminish when more recoding data are obtained. 
 
4.2.2. Neurons from KO mice had larger inward-rectifying current in response to negative 
voltage ramp 
 
Increased conductance of neurons from KO mice in response to voltage ramp is in accordance 
with increased conductance at a steady state, calculated as the inverse of membrane resistance. 
The current observed in response to hyperpolarising voltage-ramp showed inward-
rectification which started at around -95 mV. Williams et al. (1988) reported that in the 
absence of 5-HT1 receptor agonists, there are two kinds of voltage-activated inwardly 
rectifying current in the voltage range more negative than the resting membrane potential: one 
is activated instantaneously (< 5-7 msec) at around the potassium equilibrium potential (EK), 
termed inward current (IIR); the other is activated slowly (0.5-1 sec till full activation) when 
the membrane potential is stepped to potentials more negative than -70 mV, which resembles 
IQ or IH current as has been observed in other neurons such as hippocampal pyramidal neurons 
and in smooth muscles. Since the inwardly rectifying current shown in Fig. 3.20.A was 
activated in response to slow voltage ramp (over 600 ms range), it is likely to represents IQ 
current. Like IIR current, IQ current is activated at negative membrane potentials and is closed 
at positive potentials. While IIR current is predominantly composed of K
+
 current, IQ current 
derives from an ionic flow of both Na
+
 and K
+
 ions (Edman et al., 1987). It has been 
suggested that, although the IQ current contributes to only a small portion of the total 
membrane conductance of dorsal raphe neurons in normal extracellular K
+
 concentration, it is 
under the influence of neurotransmitters and the opening state of other potassium channels 
and thus plays a role in determining the activity of dorsal raphe neurons (Williams et al., 
1988). Moreover, evidence suggests that kinetics of IQ current is modulated by the second 
messenger cAMP, implying functional significance of this current (Hille, 2001; Chapter 5, 
p.158). The difference in the IQ current we observed between Tph2 WT and KO mice, 
although it did not reach statistical significance, may therefore indicate a potential difference 
in the activity of dorsal raphe serotonergic neurons. 
 
In sum, the whole-cell recording from serotonergic neurons in Tph2 KO mice revealed 
electrophysiological properties quite similar to those of WT counterparts. The only 
statistically significant difference found was decreased membrane resistance, i.e. increased 
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conductance in the neurons of Tph2 KO mice. Together with increased conductance in 
response to voltage ramp, the results may indicate that a certain type (or types) or ion 
channels are more active in the neurons of Tph2 KO mice. 
 
 
4.3. WC recording from hippocampal CA1 pyramidal neurons in 5-Htt KO mice (Study 
3) 
 
4.3.1. CA1 pyramidal neurons from 5-Htt KO mice had increased conductance 
Whole-cell patch clamp recording from CA1 pyramidal neurons in the hippocampus revealed 
overall similar electrophysiological properties between 5-Htt KO and WT mice. One 
consistent difference, however, exists in terms of conductance, i.e. neurons of KO and Het 
mice showed higher conductance than those of WT mice. This was first observed at the steady 
state as reduced membrane resistance (Fig. 3.21). Moreover, increased conductance was 
evident in response to voltage changes (Fig. 3.28) as well as inward current accompanying 
action potential generation (Fig. 3.29). Although it did not reach statistical significance, the 
amplitude of EPSC was also larger in 5-Htt KO and Het mice in comparison to WT controls 
(Fig. 3.26). Moreover, the reduced number of action potential generation in response to 
current injection as observed in neurons of Het and KO mice is a reflection of reduced 
membrane resistance and increased conductance (Fig. 3.25). Namely, the injected current was 
less effective in raising the membrane potential to the action potential threshold since 
substantial amount of current went through the neurons without raising the membrane 
potential because of the decreased membrane resistance. In a biological setting, this may read 
as decreased excitability in response to a certain synaptic input.  
In the following section, potential mediators which endowed neurons in KO and Het mice 
with higher conductance were discussed. Due to the nature of these mediators, they may have 
also served as compensatory mechanisms for the lack of 5-Htt to keep the balance of 5-HT in 
the extracellular space. Overall retention of electrophysiological properties in 5-Htt KO mice 
may have been attributable to such compensatory mechanisms. 
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4.3.2. Non-5-HTT mediated serotonin transport may have compensated for the lack of 5-HTT 
and contributed to the increased conductance in CA1 neurons of 5-Htt KO mice 
 
Past studies suggested the presence of two different types of 5-HT transport; one with a high 
affinity and low capacity, the other with a low affinity and high capacity, termed uptake1 and 
uptake2, respectively (Zhou et al., 2007). The uptake1 system solely consists of 5-HTTs, 
which work in a Na
+
/Cl
-
-dependent manner. On the other hand, the uptake2, whose molecular 
correlate is also known as the extraneuronal monoamine transport system (EMT; Lazar et al., 
2003), may consist of several different types of transporters, including members of the 
organic cation transporter (OCT) family and the plasma membrane monoamine transporter 
(PMAT). Here the possibility that these mediators of non-5-HTT serotonin transport system 
compensated for the lack of 5-HTT is discussed. Moreover, the possibility that these transport 
system contributed to the increased conductance of CA1 pyramidal neurons is also discussed.  
i). OCT3 
OCTs transport a wide range of organic cations. They work both as a sodium-dependent and 
sodium-independent manner (Koepsell, 1998 as in Schmitt et al., 2003). So far, three subtypes 
of potential-sensitive organic cation transporters, OCT1, OCT2, and OCT3 have been cloned 
and characterised. Whereas OCT1 and OCT2 are mainly expressed in the kidney and liver, 
OCT3 were shown to be present in the brain (especially in the cerebellum, the dorsal raphe, 
hypothalamic nuclei, the cortex, and the hippocampus), as well as intestine, kidney, and 
placenta. A wide spectrum of substrate specificity has been reported for OCT3 including 5-
HT and DA, albeit with a low affinity. (Schmitt et al., 2003 and references therein). Similar to 
5-HTT, OCT3 is also a target of several types of psychostimulant drugs, such as MDMA, 
cocaine, D-amphetamine (Amphoux et al., 2006), implying relevance of OCT3 in emotion 
regulation. Moreover, it was recently demonstrated that corticosterone, which is released as a 
stress response mediated by the HPA axis, inhibit 5-HT uptake by OCT3 (Baganz et al., 2010). 
Past study revealed that the expression level of OCT3 was upregulated in 5-Htt KO and Het 
mice, including the pyramidal and granular cells of the hippocampus (Schmitt et al., 2003; 
Baganz et al., 2008). Study by Schmitt et al. (2003) also confirmed that OCT3 is preferably, if 
not exclusively, expressed in neurons and not in extraneuronal cells, e.g. astrocytes and 
oligodendrocytes (in this sense the term EMT may not be appropriate for OCT3). The authors 
assumed that upregulation of OCT3 and resulting enhanced 5-HT reuptake may be a 
compensation mechanism to counter increased extracellular 5-HT in 5-Htt KO mice, playing a 
critical role in maintaining 5-HT-dependent functions of the hippocampus in 5-Htt deficient 
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mice. In fact, a past study using an OCT3 blocker, 1,1'-diethyl-2,2'-cyanine (decynium-22; D-
22), demonstrated that D-22 reduced 5-HT reuptake and exerted antidepressant-like effects 
only in 5-Htt KO mice but not in WT mice, suggesting greater contribution of OCT3 to 5-HT 
uptake in 5-Htt KO mice (Baganz et al., 2008). 
OCT3-mediated transport is electrogenic, associated with the transfer of positive charges into 
the cell (Kekuda et al., 1998). Such function of OCT3 is shown to be membrane potential-
dependent (Kekuda et al., 1998), having higher conductance at negative membrane potentials. 
Given that OCT3 was found to be upregulated in 5-Htt deficient mice, it is probable that the 
larger amount of inward current observed in 5-Htt KO and Het mice in comparison to WT 
mice at negative membrane potentials might have derived from increased expression of OCT3. 
Such a hypothesis is also supported by the fact that most serotonin is positively charged at pH 
7 (Chattopadhyay et al., 1996). Since 5-Htt KO mice have abundant 5-HT in the synaptic cleft, 
positively charged 5-HT passing through OCT3s may have contributed to the increased 
current flow. On the other hand, the increase in current flow was previously reported only 
when the membrane potential was in the negative potential range (Kekuda et al., 1998). The 
result in the present study, on the other hand, showed increase in current flow also at the 
positive membrane potential range in 5-Htt KO and Het mice (Fig. 3.28). It is therefore not 
likely that OCT3 alone accounts for the increased conductance of 5-Htt KO and Het mice. 
More likely, some other factors also contributed to the enhancement of current flow as was 
observed in the present experimental data.  
ii). PMAT 
PMAT is a type of organic cation transporter which shows a broad range of specificity for 
organic cations and endogenous biogenic amines, working in a Na
+
-independent manner. 
Among the monoamine neurotransmitters, PMAT has the highest affinity for 5-HT and its 
mRNA is widely expressed in the CNS. PMAT is known to be expressed in neuronal cells but 
not in astrocytes (Dahlin et al., 2007). Unlike 5-HTT, however, its expression is not limited to 
serotonergic neurons but various neuronal subtypes including pyramidal neurons and 
interneurons which receive serotonergic inputs were shown to express PMAT(Dahlin et al., 
2007). Although the apparent affinity (Km) of recombinant PMAT for 5-HT in heterologous 
expression systems is much lower than that of 5-HTT, PMAT has a much higher transport 
capacity (Vmax), yielding grossly comparable uptake efficiencies (Vmax/Km) to 5-HTT (Zhou et 
al., 2007 and references therein). Therefore, 5-HT transport mediated by non-5-HTT 
transporters may play a non-negligible role in 5-HT clearance in certain brain regions, 
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especially where 5-HTT expression is low, and/or when extracellular 5-HT concentrations are 
abnormally elevated due to pharmacological blockade of 5-HTT or genetic deletion of 5-Htt 
as in 5-Htt KO mice. 
Itagaki et al. (2012) performed a series of electrophysiological experiments on PMAT and 
revealed that PMAT-mediated transport was associated with inward currents, i.e. net transfer 
of positive charges into the cell, and the magnitude of current flow was increased as the 
membrane potential became more negative. In the same study, it was shown that histamine, 
one of the substrates of PMAT-driven transport, became protonated to a singly charged cation 
and mediated inward current flow into the cell at negative membrane potentials. Although not 
directly demonstrated, the same mechanism may apply to the transport of other biogenic 
amines such as 5-HT. It was not tested in the study of Itagaki et al. (2012) whether PMAT 
mediate augmentation of outward current in positive membrane potentials in a voltage-
dependent manner. Moreover it is still unknown whether PMAT is upregulated in 5-Htt KO 
mice (Daws, 2009) although it is likely given that OCT3 was shown to be upregulated as a 
compensatory mechanism to the lack of 5-Htt. Since the hippocampus is one of the regions 
where PMAT is richly expressed, there is a possibility that PMAT-mediated flow of cations 
may have contributed to the increased conductance of hippocampal neurons in 5-Htt KO and 
Het mice. 
 
4.3.3. 5-HT3 receptors may also have contributed to the increased conductance 
Unlike other members of the 5-HT receptor family, 5-HT3 receptors are known to be 
ionotropic receptors, directly conducting ions in response to the binding of 5-HT. The ion 
channels of 5-HT3 receptors are permeable to N
+
, K
+
, Ca
2+
, and organic cations. As mentioned 
earlier (see Introduction), upregulation of 5-HT3 receptors has been reported in 5-Htt KO 
mice and there is a possibility that this upregulation contributed to the increased conductance 
of CA1 pyramidal neurons. However, past studies demonstrated that 5-HT3 receptors are 
mainly expressed on hippocampal interneurons, not on pyramidal neurons. Therefore, it is 
rather unlikely that 5-HT3 receptors are the direct mediators of increased ion conductance as 
was observed in 5-Htt KO and Het mice. Indeed past investigations in the pyramidal neurons 
of the CA1 region aimed at detecting rapid response to 5-HT application, which is supposed 
to be mediated by ionotoropic 5-HT3 receptors, produced negative results (Yakel and Jackson, 
1988 and references therein). Another more plausible mechanism for increased conductance 
of CA1 pyramidal neurons is that 5-HT activates 5-HT3 receptors on interneurons, which then 
4. Discussion 
133 
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
-1
3
0
-1
2
0
-1
1
0
-1
0
0
-9
0
-8
0
-7
0
-6
0
-5
0
-4
0
-3
0
-2
0
-1
0 0
1
0
2
0
3
0
C
u
rr
e
n
t 
(n
A
) 
Voltage (mV) 
I/V relationship with symmetric Cl- solution 
KO (n=5)
Het (n=14)
WT (n=6)
release GABA onto pyramidal neurons. In principle, released GABA can activate both 
GABAA and GABAB receptors on pyramidal neurons. GABAA receptors are ionotropic 
receptors which, when activated, open Cl
-
 channels. On the other hand GABAB receptors are 
metabotropic receptors, coupled to K
+
 channels. Given that the resting membrane potential of 
CA1 pyramidal neurons remained near -60 mV and that the reversal potential of K
+
 ion 
channels is around -90 mV, the contribution of K
+
 channels to increased conductance is likely 
to be small. Contrarily, the reversal potential of Cl
-
 channel is near the resting membrane 
potential (-60mV) and changing the ionic composition of pipette solution to artificially 
change the reversal potential of Cl
-
 channels to 0 mV (symmetric Cl
-
 solution) shifted reversal 
potential of KO neurons more positive than in neurons of WT mice (Fig. 4.2). Importantly, 
Cl
-
 channels have been implicated in depression and the mechanisms of antidepressant drugs 
(Goren et al., 2007; Tunnicliff et al., 1999; Tunnicliff and Malatynska, 2003).  
 
 
 
 
 
 
 
 
 
 
 
Potential increase in Cl
-
 conductance cannot, however, explain increase in inward current 
associated with action potentials (Fig. 3.29). This may suggest that the increased conductance 
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Fig. 4.2. I/V relationship obtained with symmetric Cl- solution. K-gluconate in the pipette solution 
was replaced with KCl to make the concentration of Cl- inside and outside the neuron equal. 
Therefore Ecl becomes 0mV. The point where the I/V plot crosses 0 current axis shifted more 
positive in KO mice than in WT mice, indicating higher Cl- conductance in KO mice. The inlet is 
the magnification at the voltage range from -70 mV to -20 mV. 
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in 5-Htt Het and KO mice is attributable to several different types of ion channels and 
transporters, which were discussed in previous sections, resulting in the net increase in the 
conductance. This is evidenced by the fact that the resting membrane potential remained the 
same across the genotypes and the reversal potential of the IV plot was near the resting 
membrane potential of the neuron. 
 
4.3.4. Morphological analysis 
Overall, there was no striking difference found in the morphology of CA1 pyramidal neurons 
among different genotypes of the 5-Htt KO mice line. Although there was statistically 
significant difference found in the Sholl analysis at the 200-220 μm segment, the result is 
rather difficult to interpret. First of all, the difference is only evident at this segment and there 
was no significant difference at other segments, both segments closer to the soma and away 
from the soma. Moreover, it is unlikely that the difference in this segment is related to 
electrophysiological differences observed in the present experimental data. This is because the 
whole-cell patch clamp mostly reflects electrophysiological properties of neuronal material 
close to the soma. In fact, electric signals significantly attenuates along the somatodendritic 
axis (for review see Spruston, 2008). The morphological analysis in brain slices is also prone 
to potential errors considering the fact that dendritic arborisation might have been severed 
during the slicing procedure. To avoid this problem, it is necessary to record from neurons 
located relatively deep inside the brain slices. However, staining reaction on thicker brain 
slices as in the present study (300 μm thickness) entails difficulty in terms of penetration of 
staining reagents into the tissues, as opposed to standard immunohistochemical studies, and 
recording from neurons deep inside the tissue makes staining even more difficult. Overall, it 
is not possible to draw a more reliable conclusion from this study due to the relatively small 
number of neurons investigated, partly because of the above mentioned difficulty. At least one 
past histological study done on adult 5-Htt KO mice (Nietzer et al., 2011), however, 
demonstrated that there was no morphological difference in CA1 pyramidal neurons in the 
hippocampus. Given this, it is still probable that there are indeed no morphological 
differences in hippocampal CA1 neuronal morphology of young mice used for the present 
whole-cell patch clamp recording, although caution should be taken since results obtained 
from adult mice may not directly be extrapolated to the case of young mice. 
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4.4. Extracellular field potential recording of LTP (Study 4) 
The results obtained from the LTP study showed that intensity of LTP induction was not 
influenced by the level of brain 5-HT. This was rather unexpected given numerous past 
findings demonstrating effects of 5-HT on LTP and synaptic plasticity (see section 1.5.5.), 
although it is at the same time true that 5-Htt deletion has been demonstrated to have less 
impacts on terminal areas including the hippocampus than on the central serotonergic origins 
(Fabre et al., 2000; Mannoury la Cour et al., 2001; Li et al., 1999, 2000).  
There are several possibilities to explain this lack of differences. One is of biological origin, 
either by as-yet-unknown compensatory mechanisms to counteract changes in the level of 
brain 5-HT, whose possibility is discussed in other sections of Discussion, or by interaction 
with some other neurotransmitter systems. Another possibility is that LTP inducibility is 
dependent on experimental conditions, such as behavioural paradigm used in combination 
with LTP induction. Moreover, the result obtained indicates that LTP inducibility at the 
particular pathway investigated, i.e. Schaffer collateral/commissural pathway, was not 
necessarily associated with changes in 5-HT availability. These possibilities will be discussed 
in turn. 
4.4.1. LTP was possibly maintained by interaction with other neurotransmitters 
One of the plausible explanations for the maintenance of normal LTP inducibility in Tph2 KO 
mice is interaction with other neurotransmitters. In general, 5-HT works adversely to LTP 
although facilitation of LTP by 5-HT has also been reported (see section 1.5.5.). On the 
contrary, evidence suggests that NE promotes protein synthesis-dependent late phase of LTP 
(L-LTP) in the DG via activation of β-adrenergic receptors, which are positively coupled to 
adenylyl cyclase and thus leading to increase in cAMP and activation of PKA (Stanton and 
Sarvey 1985; Andersen et al., 2007). Similar LTP enhancing effects of NE were seen in the 
CA1 in vitro via activation of α1 receptors (Izumi and Zorumski, 1999). It should be noted 
that although an in vivo study using a SNRI reported suppression of LTP, this was likely due 
to enhanced release of 5-HT induced by activation of α1 receptors on serotonergic neurons in 
the DRN (Tachibana et al., 2004). Moreover, DA is also known to work positively for the 
induction of L-LTP in CA1 with a similar mechanism to that of NE. Importantly, Gutknecht 
et al. (2012) reported consistent reduction in NE content across brain regions and 
hippocampus-specific reduction in DA in Tph2 KO mice. Given these lines of evidence, one 
possible explanation for the absence of changes in LTP inducibility observed in the present 
study in the CA1 area of Tph2 KO mice could read as follows; if the depletion of 5-HT is not 
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accompanied by reduction in NE and DA, it will probably enhance LTP inducibility in Tph2 
KO mice. However, since NE and DA, which as a default promote LTP induction, are also 
reduced along with the depletion of 5-HT in Tph2 KO mice, the overall efficacy of LTP 
induction is unchanged in these mice. The same surmise seems to be applicable to the case of 
5-Htt KO mice. Namely, the adverse effect of excessive levels of 5-HT on LTP induction 
could have been counteracted by enhancement of NE transmission. Indeed, it was shown that 
chronic treatment with a SSRI fluoxetine, which is partly comparable to knockout of 5-Htt, 
led to an increase of tyrosine hydroxylase (TH) gene expression in the LC (Brady et al., 1992 
as in Gutknecht et al., 2012). 
 
4.4.2. Changes in LTP inducibility in 5-Htt KO and Tph2 KO mice may become evident in 
particular behavioural paradigms  
 
In the present study, LTP induction of 5-Htt KO and Tph2 KO mice was investigated without 
any prior behavioural treatments. It seems that, to investigate influence of 5-HT on LTP in 
these KO mice, it is important to combine the LTP induction protocol with behavioural 
paradigms which are most relevant to functions of 5-HT in emotional processing. For 
example, Dai et al. (2008) demonstrated that without behavioural treatments, there was no 
difference in LTP inducibility in CA1 between WT and Lmx1B KO mice, another animal 
model of central 5-HT deficiency. However, after foot-shock stress paradigms, WT mice 
showed impairment in LTP induction while Lmx1B KO mice were resilient to the stress 
paradigms and maintained the same LTP inducibility as was without foot shocks. Effects of 
environmental factors, including stress, on genetic predispositions are called gene-by-
environmental interactions and have recently attracted attention due to their significant roles 
for the development of neuropsychiatric disorders (for review see Canli and Lesch, 2007; 
Lesch, 2011; Gross and Hen, 2004; Dick, 2011; Caspi and Moffitt, 2006). Although not 
directly demonstrated in terms of LTP inducibility, environmental stressors were shown to 
influence learning abilities of Tph2 KO and 5-Htt KO mice at the behavioural level. CMS, 
such as overnight illumination, tilted cage, food or water deprivation, confinement to a 
restricted space, was shown to enhance cued and context fear learning of Tph2 KO mice 
(Gutknecht et al., submitted). Moreover, prenatal stress (PS) impaired object recognition, 
which belongs to a domain of memory performance, in 5-Htt WT controls, whereas 5-Htt Het 
mice showed resilience to PS (van den Hove et al., 2011). Since 5-HT has been repeatedly 
implicated in the modulation of stress response in the hippocampus, it would be plausible that 
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differences in LTP inducibility between Tph2 KO or 5-Htt KO mice and WT controls become 
visible only after some behavioural stress paradigms. This would particularly be the case 
given that the hippocampus has been implicated in contextual fear learning. Moreover, 5-Htt 
KO mice were shown to have impaired fear extinction recall, whereas Tph2 KO mice have 
enhanced fear learning (see section 1.6.2.). As mentioned earlier (see section 1.5.5.), ATD is 
also known to enhance learning abilities of human subjects in response to aversive stimuli. 
The results in the present study indicate that those behavioural alterations may not derive 
from LTP inducibility at the baseline but rather LTP inducibility may have been modified 
after experimental behavioural paradigms. 
 
4.4.3. Alterations in learning abilities of 5-Htt KO mice and Tph2 KO mice are not correlated 
with changes in Schaffer-collateral- CA1 LTP 
 
As mentioned in Introduction, 5-Htt KO mice are known to exhibit deficits in fear extinction 
recall (Wellman et al., 2007), while Tph2 KO mice show enhanced fear learning (Gutknecht 
et al., submitted). The results in the present study indicate that these learning 
impairment/enhancement are not related to changes in LTP inducibility in the Schaffer 
collateral/commissural pathway of the hippocampus. There is a possibility that factors other 
than LTP may have contributed to behavioural changes of 5-Htt KO and Tph2 KO mice, 
related to learning and memory. Given the multitude of LTP induction protocols proposed so 
far (Bortolotto et al., 2001; Malenka and Nicoll, 1999), it is also possible that other LTP 
induction protocols may have teased out potential alterations in LTP inducibility. However, 
evidence suggests that dissociation of memory functions from LTP is still possible. For 
example, past studies demonstrated that MDMA enhances LTP in the CA1, although MDMA 
is reported to cause memory deficits in the behavioural level (Rozas et al., 2012; Morini et al., 
2011; Mlinar et al., 2008).  
On the other hand, the highly organised and hierarchical structure of the hippocampus 
suggests that some other pathways or subregions of the hippocampus, either singly or in 
harmony, led to changes in memory functions of 5-Htt KO and Tph2 KO mice. For instance, 
the CA1 filed in the hippocampus has a unique function, combining the present sensory 
information with past memories. As a centre of intensive cognitive computation, the CA1 
field of the hippocampus is particularly suited to act as a comparator between present direct 
sensory information and past associative memory traces. This is because CA1 receives 
information from the entorhinal cortex (EC) through two distinct pathways that terminate on 
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segregated regions of the apical dendrites of the CA1 pyramidal neurons. One pathway 
directly reaches the distal dendrites of the CA1 pyramidal cells in the stratum lacunosum-
moleculare (SLM) through the perforant path (pp) and provides sensory information. Another 
pathway terminates on the proximal dendrites of the CA1 pyramidal neurons in the stratum 
radiatum (SR) through trisynaptic indirect route; the Schaffer collateral (sc) from CA3 to CA1, 
the mossy fibre pathway from the DG to CA3, and the pp from EC to DG. This indirect 
pathway is proposed to provide mnemonic information. Due to the trisynaptic nature, 
information carried via the indirect pathway reaches CA1 field 10-20 ms after information 
from the direct pathway (Dudman et al., 2007). On the other hand, Otmakhova et al. 
(Otmakhova and Lisman, 2000; Otmakhova et al., 2005) demonstrated that the direct pp-CA1 
synaptic inputs respond to modulatory effects of monoamine neurotransmitters, such as 5-HT, 
DA, and NE. It is possible that changes in learning behaviours of 5-Htt KO and Tph2 KO 
mice do not necessarily require changes in LTP at the Schaffer collateral/commissural 
pathway on the CA1. Instead, some other pathways or subregions of the hippocampus may 
have more relevance to learning alterations of 5-Htt and Tph2 KO mice, either by themselves 
or in combination with functions of the Schaffer collateral/commissural pathway. 
 
4.5. Impacts of changes in the 5-HT level could have been buffered by as-yet-unknown 
biological compensatory mechanisms 
4.5.1. Tph2 KO mice 
i). Residual serotonin  
It should be noted that, in Tph2 KO mice, a residual amount of 5-HT was detected in the brain. 
This is probably due to unintended contamination from blood which contains cells with high 
5-HT content, such as platelets or mastocytes (Savelieva et al., 2008). However, even in mice 
with double knockout of Tph1 and Tph2, which should theoretically eliminate 5-HT from the 
periphery too, a small amount of 5-HT was still detected in the brain by HPLC measurement. 
This could be due to another neurochemical with similar HPLC mobility or to another enzyme 
which has tryptophan hydroxylase-like activity, such as phenylalanine hydroxylase (PAH) in 
the liver (Renson et al., 1962). Another explanation for a trace amount of 5-HT found in the 
brain of Tph2 KO mice is that 5-HTP produced in the peripheral tissues by Tph1 crossed the 
blood brain barrier and was converted into 5-HT by 5-HTP decarboxylase and AADC, which 
is rather ubiquitously expressed (see section 1.2.1.). In fact, the data presented in this study 
confirmed that serotonergic neurons from Tph2 KO mice are able to produce 5-HT when 
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supplied with 5-HTP. On the other hand, the possibility is ruled out that 5-HT synthesis in the 
brain of Tph2 KO mice is mediated by Tph1 as a compensatory mechanism since a previous 
study showed that Tph1 is not upregulated in Tph2 KO brains (Gutknecht et al., 2008). 
Moreover, in the case of prenatal mice, the possibility cannot be ruled out that a low amount 
of 5-HT comes from the placenta of pregnant mothers, which may have contributed to the 
almost normal development of Tph2 KO mice (see discussion in Gutknecht et al., 2012). It is 
rather unlikely, however, that the trace amounts of 5-HT from all those possible sources 
mentioned above alone can compensate for the dramatic reduction of brain 5-HT levels 
observed in Tph2 KO mice. It is more reasonable to assume that some other as-yet-unknown 
adaptive changes in Tph2 KO mice also enabled these mice to retain gross morphological and 
electrophysiological properties of the serotonergic system as seen in control animals.  
ii). Upregulation of 5-HT1A receptors 
As demonstrated in the present study, 5-HT1A receptors in the DRN of Tph2 KO mice were 
mildly sensitised, i.e. shift of EC50 from c.a. 3 nM in WT to 1.5 nM in KO in response to 
R8HD. This is consistent with quantitative autoradiography study by Gutknecht et al. (2012), 
where upregulation of the density and G-protein coupling of 5-HT1A and 5-HT1B receptors 
were detected across several brain regions of Tph2 male KO mice, reaching 11.7 % increase 
in the case of DRN 5HT1A receptors. As for the hippocampus, they reported about 20% of 5-
HT1A receptor upregulation. The functional extent of 5-HT1A receptor sensitisation in the 
hippocampus was not electrophysiologically investigated in the present study but it is likely 
that a similar level of sensitisation will be observed in brain regions outside of the DRN as 
heteroreceptors as a general compensatory reaction of receptors to the lack of their ligands. It 
is, however, still questionable whether the functional sensitisation, if at all present, is 
sufficient to maintain 5-HT mediated function from a minute amount of 5-HT detected in 
Tph2 KO mice. At least for some brain functions where 5-HT is involved to some extent, 
such as aggression, this upregulation is not sufficient to maintain normal behaviours from a 
trace amount of 5-HT. For example, although stimulation of 5-HT1A or 5-HT1B receptors by 
their agonists is known to reduce aggressive behaviours and 5-HT1A and 5-HT1B receptors are 
upregulated in Tph2 KO mice, these mice still exhibit high aggression, confirming that 
uprelation is not sufficient to reinstate normal behaviours from the trace amount of 5-HT in 
KO mice (Gutknecht et al., submitted). Similarly, it is rather unlikely that the lack of 
difference in LTP inducibility between Tph2 KO and wildtype counterparts is solely due to 
the potential functional upregulation of 5-HT1A receptors in the hippocampus unless the 
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magnitude of upregulation is so intense as to compensate for almost complete absence of 
brain 5-HT.  
iii). Interaction with other neurotransmitters 
There is a possibility that impacts of lack of 5-HT are compensated by some other 
neurotransmitters. This is because some of the serotonergic receptors are known to share 
common second messenger signalling pathways or ion channels with receptors for other 
neurotransmitters (reviewed in Ciranna, 2006). For example, activation of GIRK current in 
the hippocampus was shown to be mediated by multiple receptors. (Sodickson and Bean, 
1998 as in Ciranna, 2006). To be precise, it was shown that agonists for serotonin, adenosine, 
somatostatin, and metabotropic glutamate receptors all induced GIRK current that is the same 
as the one caused by GABAB receptor stimulation. In fact, the common downstream signal 
transduction pathway between 5-HT1A receptors and GABAB receptors has been previously 
demonstrated (Mannoury la Cour et al., 2004; see Introduction). The difference, however, 
exists in terms of half-maximal effective agonist concentration (EC50) and the latency for the 
activation/inactivation of GIRK current caused by each different receptor type. Importantly, 
when the concentration of those agonists is at the sub-saturating level, they work 
synergistically to produce supra-additive GIRK current. Moreover it was demonstrated that 
both carbachol, a non-hydrolysable cholinergic agonist and 5-HT induce low-threshold 
transient (LTT) Ca
2+
 in dissociated interneurons of the CA1 lacunosum-moleculare (LM) 
layer (Fraser and MacVicar, 1991). Prior to this finding, LTT Ca
2+
 currents had been shown 
to induce theta bursts in other neuronal types and both cholinergic afferents from the septum 
and serotonergic innervation from the raphe nuclei are believed to play a crucial role in 
generating rhythmic theta bursting in the hippocampus. Given the importance of theta 
bursting for learning and memory formation mediated by the hippocampus, this 
interchangeable role between acetylcholine and 5-HT bears a particular significance, 
especially when one of these neurotransmitters is abrogated. It should be noted, however, a 
resent in vivo study revealed that 5-HT supresses hippocampal theta rhythm through 
activation of 5-HT2C receptors (Sorman et al., 2011). The same group also found NE either 
enhances or inhibits theta oscillations depending on the behavioural states of animals (Sorman 
et al., 2011 and references therein). As mentioned earlier (see section 1.6.1.), complete 
absence of brain 5-HT in Tph2 KO mice was found to be accompanied by reduction in NE 
contents. This may indicate compensatory mechanisms of organisms to keep balance between 
excitation and inhibition of various biological functions, including theta oscillations of the 
hippocampus. 
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In sum, a series of evidence attest that part of brain serotonin function in Tph2 KO mice could 
have been represented by some other neurotransmitters which all converge on the same 
effector, e.g. ion channel. Although this possibility is described only for the hippocampus here, 
it is likely that a similar compensatory mechanism may have taken place in some other brain 
regions such as in the DRN. 
 
4.5.2. 5-Htt KO mice 
As discussed previously, OCT3 and PMAT are potential candidates that ameliorated 
consequences of 5-Htt deficiency. Additionally, it was demonstrated in past studies that DAT 
and NET can reuptake 5-HT into catecholaminergic neurons (Schmitt et al., 2003 and 
references therein). 5-HT transport by DAT is particularly evident when normal 5-HT 
reuptake by 5-Htt is abrogated. In detail, DAT was shown to reuptake 5-HT in 5-Htt KO mice, 
but not 5-Htt WT or Het mice, although the expression level of DAT was not changed in 5-
Htt KO mice (Fox et al., 2008 and references therein). In addition, Pan et al. (2001) 
demonstrated that in midbrain-hindbrain cell cultures obtained from 5-Htt KO mice, DATs 
reuptake 5-HT. Similarly, Ravary et al. (2001) observed low-affinity serotonin uptake in 
dopaminergic neurons of the substantia nigra in vivo in 5-Htt KO mice. In brain regions with 
high DAT expression, such as in the striatum, contribution of DAT to 5-HT transport is not 
negligible as was evidenced by enhanced reduction of striatal tissue levels of 5-HT in DAT 
and 5-Htt double KO mice compared to 5-Htt KO mice (Schmitt et al., 2003 and references 
therein). Moreover, a blocker to DAT was shown to be effective in reducing or abolishing 
ectopic 5-HT accumulation in dopaminergic neurons in the substantia nigra and the VTA of 
5-Htt KO mice (Zhou et al., 2002). However, it was found that elevated levels of extracellular 
5-HT was present even in the striatum where DAT expression is high, indicating that DAT 
can only partially compensate for the absence of 5-Htt. Moreover, the tissue level of 5-HT in 
the hippocampus, frontal cortex, brain stem, and hypothalamus was not further decreased by 
additional knockout of DAT in 5-Htt KO mice. Taken together, in brain regions apart from 
the striatum, other transporters, such as OCT3 mentioned earlier, are more likely to participate 
in clearance of elevated extracellular 5-HT in 5-Htt KO mice (Schmitt et al., 2003). 
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Conclusion 
In a series of studies presented here, 5-Htt KO and Tph2 KO mice showed some 
characteristics which differentiate themselves from WT controls. At the same time, these mice 
displayed remarkable levels of resilience to genetic manipulation, resulting in almost the same 
characteristics in some electrophysiological parameters. The main finding from the 
investigation of autoinhibitory function in the dorsal raphe serotonergic neurons is that 
autoinhibition is maintained despite the fact that 5-HT1A receptor sensitivity was altered. This 
may have clinically important implications since the autoinihibitory mechanism has 
substantial relevance to the mechanism of antidepressant action. Whole-cell patch clamp 
recordings in the DRN of Tph2 KO mice and CA1 pyramidal neurons of 5-Htt KO mice both 
displayed electrophysiological characteristics almost similar to those of each respective 
control animals. The only difference observed was increased conductance in the neurons of 
KO mice. Further investigation is required to infer its functional significance. In the case of 5-
Htt KO mice, findings from past studies hint the upregulation of other cation carriers which 
may have contributed to increased conductance of neurons from KO mice. Finally, 
comparison of LTP inducibility in the CA1 area of the ventral hippocampus revealed no 
difference across all the genotypes tested. This was rather surprising given that the 
hippocampus and one of its main functions, i.e. learning & memory, have been repeatedly 
implicated in the aetiology of emotional disorders. It could be that the difference reveals itself 
only under a certain condition, for example after stress exposure. Alternatively, behavioural 
alterations in 5-Htt KO and Tph2 KO may not necessarily be reflected in the LTP inducibility. 
Overall, while some findings from the present study may have improved our understanding of 
the serotonergic system in relation to emotional disorders, they at the same time presented a 
few new open questions. The complexity of brain function together with potential biological 
compensatory mechanisms counteracting genetic manipulation makes it difficult to unmask 
underlining mechanisms which led to behavioural phenotypes of the KO mice. Further 
investigation addressed to open questions raised here, with some support from newly 
developed techniques such as conditional knockout mice, which may circumvent potential 
compensatory mechanisms concomitant with constitutive knockout, promises to produce 
further findings which will enhance our understanding of the serotonergic system and the 
mechanism of emotional disorders. 
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Appendix B. List of frequently used abbreviations 
5-HT 5-hydroxy-tryptamine = serotonin 
5-HTP 5-hydroxy-L-tryptophan 
5-HTT (5-HTT) serotonin transporter of humans and in general (gene) 
5-Htt (5-htt) murine serotonin transporter (gene) 
5-HTTLPR 5-HTT linked polymorphic region 
AADC aromatic l-amino acid decarboxylase 
ACSF artificial cerebrospinal fluid 
AHP afterhyperpolarisation 
AP action potential 
C capacitance (F) 
CA1 Cornu Ammonis 1 of the hippocampus 
CA3 Cornu Ammonis 3 of the hippocampus 
CNS central nervous system 
DA dopamine 
DRC dose response curve 
DRN dorsal raphe nucleus 
EC50 half-maximum Effective Concentration  
EPSC excitatory postsynaptic current 
fEPSP field excitatory postsynaptic potential 
FR firing rate 
G conductance (S) 
GABA gamma-aminobutyric acid 
GIRK G-protein-coupled inwardly rectifying K
+ 
channel/current 
Het heterozygous (+/-) 
HHW half-height width 
I current (A) 
KO knockout (-/-) 
LTP long-term potentiation 
MDMA 3,4-Methylendioxy-N-methylamphetamin = ecstasy 
MRN medial raphe nucleus 
NE norepinephrine 
OCT3 organic cation transporter 3 
PMAT plasma membrane monoamine transporter 
R resistance (Ω) 
R8HD R-8-hydroxy-2-(di-n-propylamino)tetralin (R-8-OH-DPAT) 
SSRI selective serotonin reuptake inhibitor 
TB10 theta-burst stimulation consisting of 10 bursts of 5 stimuli 
TB5 theta-burst stimulation consisting of 5 bursts of 5 stimuli 
TPH2 (TPH2) tryptophan hydroxylase-2 of humans and in general (gene) 
Tph2 (Tph2) murine tryptophan hydroxylase-2 (gene) 
Trp L-tryptophan 
UD2I Up-to-the second Downstroke Interval 
UDI Up-to-Downstroke Interval 
V voltage (V) 
WC whole-cell 
WT wildtype (+/+) 
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